var title_f11_44_11968="GB adenomatous polyp US";
var content_f11_44_11968=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71629&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71629&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gallbladder adenomatous polyp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 317px; height: 317px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gallbladder ultrasonography showing an adenomatous polyp. Note its homogeneous appearance and density that is similar to the surrounding liver tissue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Salam F Zakko, MD, FACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11968=[""].join("\n");
var outline_f11_44_11968=null;
var title_f11_44_11969="Fenoterol: International drug information";
var content_f11_44_11969=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Fenoterol: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10329126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Berotec (AR, AT, AU, BE, BR, CH, CZ, DE, DK, ES, FI, FR, GB, HR, HU, IE, LU, NL, NO, PL, PT, SE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10329127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Beta2 Agonist",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F10329164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bronchodilator used for symptomatic relief of asthma and other conditions such as chronic bronchitis or emphysema",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F10329166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Bronchospasm:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metered-dose inhaler: 1 or 2 inhalations up to 3-4 times/day as needed; maximum dose: 8 inhalations/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for nebulization: 0.5-1 mg every 6 hours as needed; in refractory cases, up to 2.5 mg every 6 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: 2.5-5 mg 3 times/day; maximum daily dose: 15 mg",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F10329167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aerosol for inhalation: 100 mcg/inhalation (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for inhalation: 0.1% (20 mL, 50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 2.5 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15545 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-983B24DA49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11969=[""].join("\n");
var outline_f11_44_11969=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10329126\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10329127\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10329164\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10329166\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821250\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10329167\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/15545\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/15545|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_44_11970="Mini-case session #1: Water and sodium balance: Part A";
var content_f11_44_11970=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mini-case session #1: Water and sodium balance: Part A",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/44/11970/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/44/11970/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/44/11970/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/44/11970/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/44/11970/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/44/11970/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/44/11970/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 28, 1995.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     CASE 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;An 80-kg, 43 year-old man has chronic glomerulonephritis due to IgA nephropathy. He is found to have a plasma creatinine concentration that is stable at 1.2",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    A 24-h urine collection is obtained with the following results:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;Urine creatinine &nbsp;= &nbsp;100",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine volume &nbsp;= &nbsp;750 mL",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;Calculate the creatinine clearance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35190?source=see_link\">",
"     \"Calculation of the creatinine clearance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;What factors limit the accuracy of this test?",
"   </p>",
"   <p>",
"    &nbsp;C. &nbsp;What factors normally determine the plasma creatinine concentration?",
"   </p>",
"   <p>",
"    Because of some concern about the accuracy of the above results, the patient was given a priming dose and then a sustaining infusion of inulin; this resulted in the establishment of a steady plasma level of inulin. During this steady-state, a one-hour urine collection of 60 mL was obtained and, at its midpoint, a blood sample was drawn. The results of these studies were:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;Plasma inulin &nbsp;= &nbsp;0.2",
"    <span class=\"nowrap\">",
"     mg/mL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma creatinine &nbsp;= &nbsp;1.2",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma urea nitrogen &nbsp;= &nbsp;20",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma sodium &nbsp;= &nbsp;140",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma potassium &nbsp;= &nbsp;4",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine inulin &nbsp;= &nbsp;12",
"    <span class=\"nowrap\">",
"     mg/mL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine creatinine &nbsp;= &nbsp;108",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine urea nitrogen &nbsp;= &nbsp;800",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine sodium &nbsp;= &nbsp;70",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine potassium &nbsp;= &nbsp;40",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;Calculate the clearances of inulin, creatinine, and urea.",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;How do you account for the differences between these measurements?",
"   </p>",
"   <p>",
"    &nbsp;C. &nbsp;What fraction of the filtered sodium and potassium loads (calculated from the product of the GFR [using the inulin clearance, since it is available here] and the plasma concentration) was excreted in the urine? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8472?source=see_link\">",
"     \"Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)\"",
"    </a>",
"    ). What is the explanation for the large difference between these two values?",
"   </p>",
"   <p>",
"    &nbsp;D. &nbsp;What fraction of the filtered water was excreted during this one hour collection?",
"   </p>",
"   <p>",
"    Over a period of years, the patient's underlying glomerular disease progresses until the GFR has fallen to 10",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    (or 14",
"    <span class=\"nowrap\">",
"     L/day).",
"    </span>",
"    The patient is hypertensive but has no edema.",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;Can you predict what the urine volume might be at this time?",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;Is this patient still able to excrete the daily sodium load? What adaptations allow this to occur?",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CASE 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;What would happen to:",
"   </p>",
"   <p>",
"    &nbsp;1. &nbsp;The extracellular and intracellular fluid volumes",
"   </p>",
"   <p>",
"    &nbsp;2. &nbsp;The circulating levels of ADH and sodium regulatory hormones (aldosterone and atrial natriuretic peptide)",
"   </p>",
"   <p>",
"    &nbsp;3. &nbsp;Urinary sodium excretion",
"   </p>",
"   <p>",
"    &nbsp;4. &nbsp;The urine osmolality",
"   </p>",
"   <p>",
"    in the following settings?",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;An infusion of isotonic saline in a normal subject.",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;Ingestion of a water load that is excreted so quickly that there is little expansion of the extracellular fluid volume.",
"   </p>",
"   <p>",
"    &nbsp;C. &nbsp;Ingestion of a water load that is not excreted due to the persistent presence of ADH (called the syndrome of inappropriate ADH secretion).",
"   </p>",
"   <p>",
"    &nbsp;D. &nbsp;Sodium, rather than glucose, is mistakenly added to infant formula, resulting in a hypertonic sodium solution.",
"   </p>",
"   <p>",
"    &nbsp;E. &nbsp;Vomiting-induced volume depletion without change in the plasma sodium concentration.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7244 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-F6FDDAB425-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11970=[""].join("\n");
var outline_f11_44_11970=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      CASE 1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CASE 2",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35190?source=related_link\">",
"      Calculation of the creatinine clearance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8472?source=related_link\">",
"      Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_44_11971="Hematogenous nodules CT";
var content_f11_44_11971=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F68287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F68287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hematogenous nodules",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan demonstrating innumerable small, hematogenously disseminated metastases of non-small cell lung cancer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11971=[""].join("\n");
var outline_f11_44_11971=null;
var title_f11_44_11972="Phenazopyridine: Patient drug information";
var content_f11_44_11972=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Phenazopyridine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/7/41075?source=see_link\">",
"     see \"Phenazopyridine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/23/7539?source=see_link\">",
"     see \"Phenazopyridine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F208696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      AZO Standard&reg; Maximum Strength [OTC] [DSC];",
"     </li>",
"     <li>",
"      AZO Standard&reg; [OTC] [DSC];",
"     </li>",
"     <li>",
"      AZO Urinary Pain Relief&trade; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      AZO Urinary Pain Relief&trade; [OTC];",
"     </li>",
"     <li>",
"      Azo-Gesic&trade; [OTC];",
"     </li>",
"     <li>",
"      Baridium [OTC];",
"     </li>",
"     <li>",
"      Phenazo [OTC];",
"     </li>",
"     <li>",
"      Pyridium&reg;;",
"     </li>",
"     <li>",
"      Urinary Pain Relief [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10028077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain from a bladder infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10028076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to phenazopyridine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703648",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Kidney disease, kidney infection during pregnancy, poor kidney function, or very bad hepatitis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10028081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is not to be used instead of an antibiotic. It will not cure a bladder infection.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697700",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may change the color of urine or stool to orange or yellow.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may stain contact lenses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect clothing and fabrics from staining.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10028082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10028084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698486",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow up with the doctor if signs come back.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10028079\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10028080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10028085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10028086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10969 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-F708DC0240-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11972=[""].join("\n");
var outline_f11_44_11972=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208696\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028077\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028076\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028081\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028082\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028084\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028079\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028080\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028085\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028086\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?40/7/41075?source=related_link\">",
"      Phenazopyridine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/23/7539?source=related_link\">",
"      Phenazopyridine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_44_11973="Hot liquid balloon ablation";
var content_f11_44_11973=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52237%7EOBGYN%2F75368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52237%7EOBGYN%2F75368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hot liquid balloon endometrial ablation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 413px; height: 248px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Thermachoice system",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hot liquid balloon endometrial ablation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 354px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Uterine coverage with Thermachoice uterine balloon endometrial ablation system.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Loffer, FD. Gynecare ThermaChoice Uterine Balloon Therapy System: First on the market, long-term results. OBG Management 2005. Copyright &copy; 2005 Dowden Health Media.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11973=[""].join("\n");
var outline_f11_44_11973=null;
var title_f11_44_11974="Actinic keratosis histopathology 2";
var content_f11_44_11974=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54208&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54208&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Actinic keratosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 327px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFHAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3qLVrN9Vm02OdDexRiSSP+6p6GtAHIK8HjH1rwTWLjWtK8Xyy21ncXE80SBnI3KBnByw6j+Ve1aXFP/Z8KXEzSSEAl+hz6VpWoqnGMk9zrTbbTNIhVRhzwM8HpiorGcXluk6oUD87WHIqY/Lx3FcZ4o8S3mm3Zht40EQGQ+O9ZQg5uyN6NJ1Xyx3OzijVTlUC9TkD+dPyOCQQa4bTvFk5jSS7KN6jG3HvmtFfGmlxDEk3zfxBRuIpuhNaJFywtWL2udV9TjP6mo4VWIBEXanrXOTeMdMIUWjSXEr8BUXGfrmsu+8V343KlqY1PTawLA01QqPpYmOHm+ljsdTlhispWuZPLiKkMe/I7Vwu7Woit5ZxQxwx7j5kqnc4xwGFWLO/vb6Jf7Rhn8pTvSIJkuf9pq2UuJJ2ElzaXHlDpGV2qD681pGLpableyUPiVzLTVtQuI0a7t7iFGX/AFgQhPqB1xVcT6lIzCxguGU9ZHBUH860rrxbYWk8kcUEkkjHLLG27P8AT8Ka3ii6nVfsWi3jnP8AF8oqkp/y2NYzlH7JQjXW1TZ5Stk5JwQfzrN1XWtRtiFkQFvdua15ptW1ByL23uoE7RQgj8z3p8Om6ePlmsLySTqVZSSapNL4kn6GiqpayS+RyS+M9StmKoFyf4c5FQv4o8R6idlupX0Krz+dd1CmgW7hZLFLd+n76LH69KXXJvDuk2yzaq9nawucK0hwGJ9KTqwvZU9QliKa15Dzp7TWmuVudVR5o1PKPJnePQkV0uiwaHHPDqul2sFnes4huQvBA9/8as6tJokduj2hJD8/un+UivP9ZNsZT9iMkiPwS3ylfbjqKpR9stVY1ivbpX0PV9b1y00u3zI8Zc8CINluntXkHiuW78Rsd1w6Y5THRTng/Wmx2rBTI8qquMksSSfpVFb2Zma205GmvG+4FXdg9if8KdKhGlqtzopYaEE7asgvLWfS9Mt7aOT55WMs5A++T2HoKZomu6P4VupL68s2vLojOyP+92LGt240uDRbMaj4v1FRehN4tgRvPtjtXmWmS39/qd9eQrDBZXDYNu8YcuO2B2NawSq3vt+YpzUIclPVs3PFPxM8Ta+pt9JtjZxSnaipyxB9/SuXbRfsMpn129a71Fk3rCpJA+p713elaZ9j06S6dkRQ23eerN/dUU2G3F3Ok7ZeX7p+UZA+tbxcYrlpqyOeFJXvI5TQPDd7rDLNdF7KyA6IMM3so7fWuytNM0/TYAtlbR/McF5Dlm9ya1V2eWY3kAYjAC9qhOnxswFxNL5ZbgqPm+lS5OT12NuVR1ijKsrS1kupNsMSuU/5Z8Z9yetTJYeXLtWJmycnJ4rbk+wx2rWdnFgsQzzMP3jgdvYVJFY7oi4yqjqS2KXPYIq6u9DPNvIlvNOXULGBn3yeBUWlXn2qeSBNruoJIAxkDrWgyxuhMb7o2G04PDClsymnh5BFH5hUoJX/AIFPXHvSurPuN897xKJ0u2BaSFDFIehBNU5tLfPyTtkdyvU1qhPM6FifXdTxA3Y5A75pqbXUtxRiQ2MwdvtMiSDHy9c/nVuO3MbA7yj9Mq1XxBk/ezRLGiRMQGOO3c0cxSTSKzwyMdwkDN3L5ORVY28hUCSVSxOcqMVLFfweaIpA6MegPatHy4yAw2sP73p+FF3EL8xlrbLhQzZOflx1+lWorVCOQpGf4hmrEcABLMUY+o6mnm2GGBLHdnr79qTY4y7lKa10/YRNFHIR/wBM+ay7i2sImylhEvoSMV0BtAMA9e2O1YlxpCX1w2y8aOXsD0P0oSQ3UUVpuRRQJcSbbeCIt3CnmrVqLyzkxEuEYYKOMqazT4bvbSXzLednYdMn+VdLZ/afs0X2pcygfMBVSUejuEa0no0WbC/is+X06EEjscCn3t5pkxy9ncwFuQUAZabHHBJbvFcDBYkx47N6H2NUifNtWhBOUOVGefcVjypstK/vLcw74xi4Jgjcp3yMHrVWWC4uJCImCKOq7etdGlsqDJXJA71MpjC7QAPYAVdrbGrqXWpyv2S4iTK25BHUgZzQdVFv8lzZTA/3uQP0rrH3beAQPpUEmCrE84HAI70tOwnUbOf/ALRjl3eWzIQOjc5qhfI8sYZEtW553DkV0zQ20ihpEQMQMjHI9qqT6dZ7Mxxq3rzzRbqaRqrZnN2k8tvKyzKY4+q7Zd4/I9KupJHJIGhuVBPGw4596sXFjAkZJtSV77eSKoXejW8gd413Fe3Ix9Kdluy4zsrI27OKJ5At1KkangPsLD8cVs/8IpdXg36RfWF0v9xCQ35GvPIoru2b9zcuYs/ckOR+B7Vfg1i4tJEaPfHKvIYH+tJwfRkT556xlY7NPCOuR8T2jMB3jIP9aSPwrqbP+8spETrufn9BVXTvihqsAVLhYLlB3PDf/XrVuPiqxUFLONDjOS/9Kzcat9kcbq4tPlsmS2/hiFX/ANIllZsfdUbQK2LDQ9K89Fmt3cjoC2c/WuLuPilesw228fHfbWZq/wASNRkQ7EjgJHVRyar2dVmclWmve0+Z6P4s8ZWHhuEW9uI9yjG1egryXxL461HVgdsrxxnrtGK5C81GfVb4tMzSMT1JrYt7VWQKqgAdvU1vChGmtdyKVKEdt+5zE9xJNcbpS7889ya6nSoSIEYW5jz2PJNXbXTFhZrmaONAR+VXrRkmdpuqKcALWzlfRFKLTu2QWWnXzks5EKnoQaK6a0SZlX5Aieh9PpRU87Whk4pu7PopYoXiwqKFIzx/npUE2p2lplWkHmDjavJripL/AFLasKw6iiYwN0f+FSW9tIE3PFcbzwPNG0V5Kw6juzkjhktZs0b7xDc3DGO3Ro06HZyx/HoKwJ7aa/dlggUueN0splb8hwK2ng0uCP8A4md9v4/1MfAP5cmox4p0nT08vT7JwMYBC4rWOi9xG0Zcv8KJXtPCV3csjagzOsY4VvlVR9BWwmhaVboEWEPL2VFyTXO3fjC/mYtE6QKB025qnb+KZVdm8/8AeH+LoTVOFWW7G4V57s7iLw7bBg0oESd1jH8zWhb2um2K78RKccsxGRXDReI4pDmbdMR1zMRVLUPEccjDyY4o16Y6/jzWbo1JO0mZewqS3Z1+p+KpDcCz0S3+1XB/jP3RUUXhzUdTYS69fvtPWGI4AHpWPYeMNI0qARWVtLK7L+8lOASfXNRTfFKBEPl2TsQepan7Oov4cbefUXsprSET0DTdIsdNXZZ26IRxuIyT9TV4HGfm4ryRviuc5NpGR7GpV+JxdM+TEn+9kispYWs3d/mQ8LVe6PVS5Xqc98e1Y+reILDTlxJLvkP8EfzGvJ9X+IctzlWutqHjZENv61x2peOLWDIDr5jdicVpDBv7RtTwMt5nrGpeOYrotbW+nCTPB877v1rmdR08XtvjUJrdogdyQv8AvNn0FePal4wlu5GWKWRwP4IVOP0pLPxLrdrtktbe/A7MR+tdccPyL3NDqVKlBWUl+Z6umh6jdKF0y1uZIxwDt2Lj2zVoeF57C2+0a7f2mnwgZxJJuY/8BHevNF8XeNbmIlbi5jjHGXmxj8qxru/1CUm51DUYjIvIDvvYn05p+yqvS6Dmfey9P87Hqg02TXXYaZI1tpKf63Ubv5A4/wBgVna74z0LwJZPY+HNl1qJ4a7Iyc+1eXy614i1iMQtPL5OflCAtgew6CremeHEikE93IkbnoZGEjg/yFN4fX949O3+ZLqSnpBaef8AWpSZNc8T6oJrpnUO24zTZx+A7muxNnJplullpsTyTMMvLtyzGrmlwTS/La7Y1XjzGO5j/hV5IYLQHzriWUnr35rRy6dOxpGla7b1fUrXa6he2tpbXUMVqkOSPJbeTn1Hr71ftkeztClovzseWbk4qzaRm8mXgIu0tkddorOg1dZbtljgZYFO1WZvmP0FRq9LCcYx0NBgIYg0hVZD97J6ms83s15FPHbsLcxHBcjP1yPer0oFyjIUSQ9QH6Z7VX0jQ4rAzshcNOd8m45GfQe1JNLfcck3ZLYt2YjDGeSHE7DaT3x/hU15PanSrgX0pggGGLkZUY9qnMYkXEaguBj2pslskls0dyqurDDp1B9am+txuLtYwfD17b3U8i24kKqu4bhgEHvipfGNpNeaDLFaMPODBwpHD4/hq3pmm2ejpc3NrGy+YfmLHcSfSobXVor+6e2YBgOPl4INNtuXNHoKK93lnuzlfhvquoXMN/DexkLbuqIrdVPcV3ENwzPtaJc+oFLbWFrBcSKihCx3tg8sa0FW3hOUiG7vk9KmpNN3sXRp8kVF6mZdXDRNglUB65HFMgL3MchR4y8eN4Q9Ae9J4olSPQ9QkjjJnWJigUZyccAVw/wevdRuItRtbknyYypLsvzZP8JPXFOKvBy7EzquFSMO53phjlkXz4yzY4YDBqyIEwDH8oPTH9akSNwTzkdME09HCthuPbHFSpNm/IraEKxHIDKCe2OKXDoOMdejVYMo24HT2qAO7v8AICyjvii5DgxzYKjBAbrUakI5ISN2P8W3kVeQvCjLcW4IcemWHuKrgucfMoUnqF6UJkuPciRiAM4HNSq3yklcntzWLeajOu9reN5dj7GXHSr9vI00TDOHHX2qnHS5MWmx810FbLwhk7jOP1rPtru0aeQxbdzngE5x7VYXYH23QYoylTjqM96y49AtYLrzI713XPChecU0o9TZycdEa891HFES8akDnA65rGbXrEvzH0bae+D9BWqvkgkTKxXptz1+tL9nQD91FGvOdwQFvz9KIuK3RM1J/AxLGeG4UDjn+43b6VZW3gccu2fQHNReTDDyUXd+AqRXCYwBUvyKjGVtRs9hAcbY9uOpznNJFY2rNtUdfU9KlDyMGAU47mo5jnCoMO3RsdAP50ajk7Cz2kMGeBwOSGyazrpFCFh8wAOVA7e1aYjGMGQH3NQyxMBjg49BTSJ52jjdRjgMxaFiHB5KqRVa4gmQMWUPnnCiusuoWZOPvdaxZbiQSbJI8AnDcf1q9xxquJyN1cqr7XtGBqW3to3iWTyuvI3GumFxbSHy1eJm6cjNR3NtMwzBGjnPOarm6WsF+t7mOyxpGWOBjsKy7oxXTqrIVX1JxXUR2EjIA6jf32joKrnRC1xu2Ejv3NOLS1Cbk1Yz7PTYokVkCgYzn1rZjRIdixRFnPU+lPh0na/mXD/uxyAO1Q+ZPeSMLTMcYOFUdW+tPdmblZWLUsAmiMUgDITk+1aOj2UZcLbx7UXlnY9BWhpekuoCXK4cj5gfp1q5JbOLaeO2RXaOJnRAMbyKjm6IznK2pAUjzgTDHbPeiuO8P2+pXesNeXnneWg53AgZPRRRVTjyuyZlGXPqz2u4+I7byqWyBcnlmzWFqfii51CUyXLgx44jD7QK801fxKguhbx27X0y8GODgIPwrB1HVtYY77axtrZDzgfvH+mTUU8NHorGkqdCjstfvPVjq4DbRKhJ6cgmnzF4YPtN08cKH+OWUfoBXkdvJqV1/rWJyOWdQu36VNFpb3DOus3zyWycrFHLk49wK1dG3UPbRfwr9DrLvxIksnladb3V8uSPMQbUJ9jWD4h8S32moj3Fi9ssmQhZt3Srmm2FpbKsFnPqEMLEFURXxn8elaN74YSY75I57ojkCQ7gvvin7sdwUqjWlvzOVsPFtzPGClrK+f4iSo/CtOHxBfMpcBAw/hYE5q9/wjtw0qSbEjjXj95yMemBTJNGlUssYllHQHAjQfieaLxexSnUW+pnXXivU/JYNbhFHXICisQXmp6pMyLdxwo33ScnP44xXTf8InKV5Nsq9QSS238TTX8O2R+S61CQgfeSJsA/lQnBbEylVa7fgczJpclpNnUNctznou9gfbgVVEzW7j/iYMUB5ChiTXWDR9Nhk8u1lkR+m4Rb2Hvk1Zi8NXTRtJFe+csYwFlg5P0NVzq2pkoTvp+f/BOSTTn1GNmg1G4mYnPlD5No9OafL4Xs7eENc3MKuwwpkfexPsK6I6XJb2rD7HNIzjkohU+9NtbC3jKi0s1jmXBZpQSV9duaL9mEo3tzK/r/AF+pV8NaZe/atthqi7EADq1vjj24rp7rTrSFlN7fuznjYzgD8qoLpV7NGq2srLuOC7khQP61bGg2FtIJL2VryYDgOflH0FZSs3e5tTTirJDv7M09oA4WS6DHgbjj8hWdNpsHzsNMt4weBlM49Oa2yyBTsuEij4AEY7UgWBkDq7zc4JY4CmkmzRpMyoLCZxgyiJBzlRjHsKvw6TaQK9xJHJIB3Izn8KjLXyujW6xkMcbQK1k80AeaQrEcjNEriikzNgvy7GKALHuOAPX0q3Dp86tvnwrE9M8/gKtxrFvwsKnHTC1YSN8kgGMt1PtScrbFcj3bCIPAwMe4bemOKR4jJul8uNWPG4YzTb6WSKJViPsrEZFVbK2uSfMm2L2wp+971PS9xN67E1vbRWnm3Dgh26/NxT4L1bqTapKnOM5/T61POBJDsY5IGBgZ5qnYWUFhKGCKHZs7EJOCe9CaabYNWehoTy/ZsIowT270szLjypJUWUjhc8ip2WP7YjMyugPPPNc1qkE/29nMnlAtkcdTUxSloDdjdktne28tyNpOdwqnbrbi6SHzIUnRslVXDE+9X7JJ1txI8ZLABlPqRXP3miXa+Ip9SsMTQSneFQ4ZCeqkUR1umxPdaF2SCaDUjIclWb8CDV9mEKMXUkDrjqangjMiBZedvVfQ1YiktyPL2q3qc5qJSubJ8py51hHucbjAB0BXcSfetbT7eOMSSW8YjaU72ZBjefU1JdWVqJc+UMk8nb0rQt7dVRDDxzndmiTj0ViE2t3cqQ28rSncWUnrk5H/ANamzbQC8csZVSQ53dCOo+ta0ci8If3gAPAP9ailjtWnSMRKoyG3bASfUf8A1+tTzMftGijb27SoXLbYyMk98UT3PkIViwsYHXuRWlLewJCEklSE9FOKrS2MF1F5to0ZAH3FPH4UJ/zCdS+jMabV2IYrIfMUdD1NYcXiqJ9TaxjuXa4UFpABlR9TXRavoUllDHLjIl5H/wBeubTRYmmlkhe0sJScsX4Lmt4ODVzCblo4vQ37G4juE8xRl+h7fjWpB5RgWMRBEz/DwT7n1rG8OxPMZTIUPk9CvQ1f1W6S1CuyscnHHapkteVGsbNXZcltI2TIO9Omc81XOnIf43X2NZFl4ghutQ+zxfKemfU10sLs6KSAe3tUtShuF29mVIrCJWO8byBx2/GpmiRfvRsw9M80+aN8+aAQDzkHNQrKxxtLflS3C7MXXJpELC2jjRVGWBOHb6E1m6W2oSXERtLhnLH5o5BnaK6qZFnQiaIMQODjkVNbxQxxFIVEaMMEgAGtFU5Y2sS073uNkLJhQRu/i21G9qWUSADKHIHfHcU9omjPy7R3xnilhkyxBJA7msy+mg2NvLGY9pJHLbcE04uXI3DOPSn+VubJPy5wCTSNIY8hUBbPGelBJSvoIpAN6cD8Oax7jS43Tb8wBGCc5FHiCK/uLgCMHyc/wd6n0jT54Lcm5V9zHhT0Hua0tyxvcFK7tY5+DwvbpcmaOR2z2B4rYjsnZSANvHXPAFWL6xwR5cqw7+WCdW9zVq0aNY0iRSxAwSehPrQ5Nq7Y01H4UZ4giibDuAcf5NT+VEYf3TFs+9Vta0vz3VknjEjkj5TnaPf0FT6XpstpHGrsHQckA9adla9xqo2Q/ZHkzhOaIrUQyYT5C38WMVfkdl+4rFWb5R6/SpbqGSGQ/aZkWNE8xmPRV/xoT6EyklqyfT0JjSTIcBfm+b5mPvU18skLBogUZRlSD0Nc5ZeINFvL1ba2nuUnb7kkigKx+g6Vdna4kIYy7Apy3PX/ABocGnqYxan8JM9zJI0bXRJ5JXsM/SimMss5+QiQHrj+dFFl1B2Whz0Ph8WKeXBJ5cePnXbksT61dg0iAW4AtsEdzn5j61uWlnFBgzOxHXBqw91DEAu35evTvT55M6nRipaHOrpk4gSCO3LRJzkkKD7Gq0VrFokk0zWpkuH+Z3xnYAOw9K6uG9DgfKrITzjtUd1axqC7D5Ccfe5PtTVToyJULbGbo95d3M5nkkU2rL+7Aj259D61pGSbPyxhhnoDT4zIkRQIAuAMY7Ux2IHHUGk9XexUYWWrKsq3chIyIQOmOaglhETDfIjnrukO4/gK14Yw2FfknrnpTNVij0+EsAnPJbrtFLm1sOyRgXoR13K7ysp4Tpn6Cl0+2gnODAMk8g9RVnTvL1C4AEgkjkzscY4PpVuOIQhlLxqQSCMHJqm7e71FZP3r6CrFb2xJiSND6gZIpG/ecpNIW9AMVTuLOSeQOCwQ9g3WpJJpbS0YRo5ZR82OSB61NtNA9SxsaPdje2O5NVZZVIJdGGevHzVQsNSkkuBvV/KY9e/1+la4HnvymFXnOKbjy7he+xV2qVBVpT35qmumszlpcMre/IrZjhEcR8lMKB9apCUeaFVW5ON1JN9B6dSpLbW9nAo2k4P3m61NaTKQwMahcdl61amjX/loufU460RGNIyMZBNDd0CjYqmTZJtgiUM38QHP41Y8gjLSDLAZ61EZnGdiBQf1qaMTNxIvB7UBcdayZBEa4I6CnRMzyEvIpI/hBqG9ja3gKwEjjnHpWVp6TNOwuNq4bgL6e9CV9RNu50BIYc85PTHFRmVc4/D2qG9uGt2WPYzIeOOCKicRmNWUsQegz0qUgbuWJLlUuFi3YI6jHWtS0ijhVgqDd1LHk1iNFGAtxNjcgwCeprQ0m+W5t98JyB8vuaUlpoF9bMgki82VnU8g8jNaNtGJYy1wmSOnqKILbyZ2dslTz0qx9rCXEUWAqMv3sfxelRKV9EPbUqXVyQzZ42jg56fSrlotteIrSjE3QdQG+uO9JLB5kq7/AJdx4/Cp5MQANwcfdkHG38KTemhL2GPZrawO3mjLEqM9R+Nc8bTyZ9wZt5Ocg1pvqC3jyxEtkcnPb3rMDSvPtcNmqgmr3GtVqays2AHG/wCvNQ+ILh7K3RY1O1l59ax77W0tdTgtJLcrA4w0ueVPr9K6FgLqxl88q+whfqD3FJpws3sJ2bsjD8Han9rnmjyXb7y57V0LJiV5Xf7nJ44rM0W0srK5K24COx5bOTn0rQnPmvJHHkhhx+FObTldEWa3KHiGxOr6esUEnlTByyN6+1c9pGoXugXvk6rBKLd22s+M7B2PHaneKPENxp+opbRxD7IAGGRyW7nNQ+J9bx4W+1RBi0nykeox69q0ipWUWtGZSas2uh3N55kPlvFO0sb8pHIOCPxqndWNvfwGaKL514ZWHQ1F8NL/AP4SD4brb6hKXuolbYT94Y+6RUWo6n/Y1rY3coJ84hZc9Cc1hFNScFumVSnzRvsaNlaSGDyERIQeV4+8ajuYjtKyxEgfKykdao+JVujcRXNkzNbTKHQK3fvVXWNVurPT4JGLNOzBPm7DvVxi5Wd9zSLtr0L1rp1hHP5sFikcx/5aAk/kPWtOfaln8p5B249KbbkG2inUhlON0fcE1bkSCEoAh8wjJ3jj8KlydwbS2RmwxXGAwJU8kDPWrCoxjzLGSw7rxTplknBEZwexzmmy3MdnGZbpisa9cUasHIVoyUBQ4xyQev41XYeWhfaATwMHn/8AVSW2o215unsnDx5wc9j71fk06WVPMKsNvzFvQU/h3Ep6FK2icuPOyVbp3ouLaUBmH3T6fzxVDVdQlsYlCcknAbtVHQ9cnu7wQXEW3rhx0q1CTXMgbszXcSxNF8ymNsHIPB+vpRqJZ5g2Cp6H0/CmCK4OtW5JZbCRG3Adz6miWf7FGwnceSpwGNHYE7/IkiR7eMSyAqjjIHc//Wqa5nhtIY7icHy5ATtDVLK8dxbQOHBG35WHI+lUdStBNZ/NxgYJ9Km6e5K1KVlNZ6kZBaSESr/A/B/CszxNDfvpyyaflkjG2QD7yHPp6e9MsdPu7bUo5YwHUN8zo3b6V1M0DMBcwyFA42sV9fStW1CSadydZK0jgfCum3VxdDzt2WO0Z4yTXVaxHqGlatDDEwG7ClCMgj0qfU5otLtAPN/ezMreaP4SOcVqX96motBcuiKyKACORmiVRuSlbQTW0VsQjyTM0kgKpwfp9KztQNqoH2mVY0uTiNZGwXFMlngnu/kmG7dgoDx/+usDX7O9uPGkN0YzNYqgCE/dUAdMdjmiEddRSbVkixH4btf7RimiTaQc4HQVD4ynnY2cdkNxbPGfQ4Ga6eKRFhi3K7yyDjaM8elW7260uHTwTbFZo+WZhgj2FCqPmTauOfZHO+HdMurezJvZXjUEuzDqAe1FWYDczW08tw+IXf5AT1z/AEopv3ndsSv6GnIFLMxOT2ArmtXa9JbaskaA4BCnmuq8nAYKu3B5OOtET3dvJtgbbn+LaDj86UZ2dzunBtWiYmgm5SDddDDn7oYYYr710NuoVCN27H949PamQwZlae4Lux6sTVjMSZXAz97cTyB9KiUuZ3HFWjYrzKCY8Yxu+bJwVHqPX6e9RyRBk3xgsB1zTreaG+slvLKQTWk2SkoUrnHB689qlhRhENiY3HIx3NJSG0mrohibYgcBs9Oe1S3wxCjmNZFH3kYcMO4p2ow3h0tlggd5u7AdPcUWc8phQah88u0eYDQ3fUy0u0ZNnZWNncrJYJJBCpLOknQGprzybhVuoCssLk8qwPI61Lf32llmtpLiMrINhUnn6VZh0y2hsEt7FESNQNiqeAPSm5a3Y1ZKyZmWrxEbPw2mqcupvFdbYowOcdOPfNXktQJTnI2Dk+lVZLFQfNimJiPVRzjNWuXqJ3sWodhKN5SDzBnKrjFULq5l3EQrlFOAM8mtJJD5RJTaiD5RWRdTJuZsMuBkgdTRFailojQgd0jDODwM49az7y6McpOxNhPTpgVesZDNA247hjiq955L3CwuoaQ8cdvrQtHZjeq0CJ2dQU+6Rk7j0HvVgYLHywu49jQir5ZRCCU9ayCt417iSaNV42oSAQf8KErilLlNeOBmYsVVaz7i7lEwCAbM4OTzWzOIwVAmLMQNwUZGaq30wt4DJHHG8p4EhTkVKYMRsqmZcEY4BqCGKORshmQ9cY61naXfy3E09vcnegwQwrVLiCHhctng+lU4uIc10PvIklAEmAR0IOD+dRKqxQc4CerN3rO1ZzPMCWKRhR065qvqiNLpaB9zYbJ29WFCWi1JclroaV1btdWn7grlSeC1LpEB05VDtuZ+cKc7aq+GzstW2Fwm7CiReV9q0zH5u6RWCqOp7Um2rx6BGztImudRmtJMgb4+Nyg84p1/MPsKTwEvGRkc8iqz28VyA4cEkY3jsasaJEDayQSjK5PWodkrlap2YtxrsFhYWlzdco52n2rTGpRSou8xgMBtJP3hXN69o/2/Q5LJHAKHcm7sfTPpVPU9LvT4ahNs5N5ZxrvQckqOpHrinyQkvmRK8HqtDrTb2zziVF+cDnHcVXFqIZzhiydiRzj0NY3gzUZryz23IPmJ3P8AHXUuQyIcZPY46is5JwdmaRel0ZV/psN4p8xQc80yyZVtnti+XUbevK46Vp3EW1Nob5fUd65mNJYtbfIIDH8xTj7yaH5soaZqJTWBAQRh9rNXZaEHluLp7kL5cD4GD1rlb2yeLUMhRs3BtwHPXpXa2Ee2NVGNrtuP1xVVWmrmMk0rHPeJrKyu18ufah/hJHIz70J4etp9OjsmZREE4c9G9ah8SW8y+ZKXAU5yMZJ7baYNVXTtHsTc4Z3baFz1H1o5Zcq5WZxld6nQaFptpo1mYYn3EjkoOo9B6VkeL4LXV/D93BaPG00S71Ctkgj29asJfj7V5RBAIypPQg1zJtxaeJnjtHwxkw0TdweuDShBuXM3ruOXutC6Vr8kHgCSeS1lu5LVgFRD8w7HPtVTwzr1r4pXy7q2e3nhk5j3ZGe1b+hWP2GC9iRgQ0hIHpmuN0DRr+TxYEEbofMaR2KbQFFax5XzffcU1KDWunY9K1K4ms9IuJhGuYsEfTuag0bxHF4itWUhluYEMec8t6Va81JBNFMSyOpQ56Vy2meGptL1x721uVSxILOjHke1ZwUXFqW/Qqad0zS0i1urfVWSWVmXkOCeKs6nfwyf6NIokh/iyev+FbA8maNJIpI2Eg+8K5TU9Ol+0qiqSS/II+Uj1pxfPK7J6aGrpdra6VLE9tueOeUMVbGFrbu9Ukl1GWUMqqRsManjHvWS0HlWEOwfMp4PvWPpscxuXdpwck5yMEH3o5VO7YNJWOgu4IZn+aNXR+qnpXK6hrMemX5gtrJBECBkHBPqa6a8YrZhhw6jPBrDv7X7XBvnj8+PrwMMPxp07dSpN20NqS4aSKFkJ24HI71neIybvTfKQbmDZIHf6VcsYfMsI40VlVR8qseRTzp7ujb+fQjvRFqL9BNXK3hxXTShFJuwrfKD6U291i6sfE8FqVR7KXAO7gr/AI1oQRiGAxnO/Oap+IdNa8lt7uHl1+VvqOlCac/e6kyi7WRJrlsY3a4tGxjllB7UzTbhp7ExbiPn31diRnlidztPAceoqNLYW1w+0L5RYkYpX0saL3tGc/4+B/sG2fkATFSQOnHFXPDM6voEG87gpYZ9yOK1byFJYJLe6iElvJg496p2sMVpFLCibEGNo7Yp8ycOUPZ63MDTvD5juhcreySPncY9mMH6963nmijlgt3GJZQTkdAB1pdNvUn85JU8tojgehFQTSfbWngiOOOGI7/4U25SeoRSiiHxJdyWnhi9ubJtk4Kwq6nkKTyQfWsnwXbTX/hm8e4aSRY5eGc5yO9b1/awW+jx2cyI9qq/vGk7tnOfaqvhe7guLWf7ArC0hJ3DHBp81oNLuYJe/wA7ILq9+0iSyiOGiAH4UVHDZR215LMsjO8hOFI+7miq5rbF8t9zuZ7qCzh3zlVU8KSeKqQXUdzHJJHINuevYfjXK+NfOS0tFViUK/LkcZzWz4KtJItKC3KnLEsc8fSs3BKHMdXNafKbdtHJCd0zY3H61w92uoLq0pZH8xJOCM8eld9KvmYAPy42kHtVWMyOAjyMQowM88VMJ8uo7cxNpM0s0CLdKS2PmAHQ+1Yk97cDVlijicRKTz2xV9dZt47xIIkPytjzOx9jVHxI89vHFPBkwzE7ioz8w7EURT5tVuHMlqbT6rHpdtG0rEeZ82FyfxqeCG1vbZ5Y3Uu53DJ+96VwsuqPcWEUhU+bCpUjngVo6FdSLZFlLqEfIHse1Do2jdbk3u9DK8RG3l1dN9mYIgQrFF5HP3s12sFt9jjgVZPMjKDZL/eGO/vWVqunieaC5mnEUD4Z9x6+wrYsJxeKYUQeSv3CPanUlzRVuhMfdlqY3imVo7YiMODJxuXrWfoCObZ+WdX6HGMGth5I76aSIESCPhgRyvuahQx2s6wqCMcYHY0KVo8qRs463Oc17XmsLjyoSqxocNkZZz6CtWSOK7jikKlSyhiR/WoJNJaS4lVnXyGbcVK5b8DUd+7i/gjhlCIvVe5HpWl07JGOqu2acKCGNnJRIlIySeKz/K/01pRygPHf8jTdRieWCBEm8spLnDDIarrgQux+6g59OKnbUa1dmZc63trdOQjDcvycZBrU0/R9NW1kublpJNVZcAycqM+lMtb8XG5Y33AcYz0NWLmYQIrSuqIByTzk0NyegnFbsq28Tx3GWbaB1GaY90DM0flhkJxk1YtLuK+jZ4ZFkx0I6/jUOAk/yxAnrknp7il11He+qEEaQqD5e3JwMClcKr5IySMDJ4qPULhYI8yDcAOMVHp0w1JJEt2US7SUyeM9qNbXC6WhPsEnyjt7VXaONkcnJjHU+hqHTFukmTzFKnO2VXOPyFahjhQMF4U5yAetD00JTvsZ8c0MVnIgZhltxdRkip7KE3enTCKbzIGICyYxhvQ1XeeC2iJt1EoJ2sRzj2rVgnD2keNkURPCKAAW96HsLroUdCtbqK5kjlTMePlHbPtW20jWyqAvBbPTv6VEjfunCdWUjOcGuY8J61cxalNo+pNlkyYy5ySuamznd9i+blsuh1l9NB9sUDAWeMHbjj6UkVgEuovLnZIghkEg6r6iqut2BJilEvl9wSeq5p11cm906VLKQF4ud/vis7aKxV+haOnhG8+CVAnXgBSfwp91qVtYxp9pkVGl4Vev4iuF0nX9ROpxWsuGVDh1I5x612t/oNtetb3VzlZEIOR0FVKHI0pslO8dDWtrU3MeUQLI3CD1FU57F7dz5sZBBxgDPNaiDzIUkTcqn7pDciqvnR2gCl9r53Luc5J/GsE22LmaKy2SXN00IaI3KruMJPIX1qyUMbKNpXgHn1qpp+lJHqkuqNLJNdzg7pXbovp6YFasxjlKg/6wDoOmPWqbs7Ii8pfEYl3p8U7u5yu45bB4z61x3iqyudQ1iw0/TYmZjjbt6Lz1PtXX6rLPasqm2uZomGS8I3Y+o61Lo0bajG4tg0ZThllHltj0+laxm4LnJaVmrlS9tEEkSxuH8kKhYdyOtK+nRm/S8lBygyM1qi1Xzijskan+582ParRhgQAFGlcjA3ccfSs/aWLdtDCgtysZ5yJR19DVq1e5EXkvKzoBgJjkj0z1xV2O40Yp9nQyzXhJBVQRs/PjFWo4mUOsCR8jDMefypOXdB7VS6GZdae0IA+WTcuSU521Bqlg4sjBIwVZVK7x2OOBW0qPuVRHnyht+XoP8aUqkpYgAIewHQ/40c7Vhc99Gec6JZ3+kmZLtg0RPyqGyfrXQQXYkwk2drdOc4rbvdOtJNpRmDEchlwR/jWZc2CxqDZyQl+vz5GK1dVTd2OLilYtNGrQmMn3BqpHBC0hcoqSD73H3vemaTHe29zI2o3VtIj8IijkfTNa1ynmqrRlMZyCOce3FS3ysm99DNvWLqpQDbjPTpSWyny3woAXpmoF1iO31aGy1GQRW7nCTSR/IfbIrWuZoIblVtJbe4JBOF5H41TTXQXtEnydSOJCo2qMlqrTGeP7hHB+6aj1S/1+cxJZaXaxxgjL+bw3tWnLFIIA80SmXbkorZ59AaWq1dhKWuqK0ObmJgSA46A9v8avfYWjhYPMgIA+UdK5m61LUldY7XSpd/ZpDgA+tb2mxTrp2dTlR7l+SF+6Kc4ta3FKXYkhtYpbhbdZ0FwVyI/4mFWDp8eShkZGQEHI4rIl8PW0l6t9GZY7hfuurkVYhilESrOTIVznA/Wk7NaMhSk3uSX0bRgksrR44VT3xWBo2ryXLXGnarpUkV196OdRlCo96kuLC9XXH23MwsiAdpTgewPetd2iht0j8xcg9G4zT0irb3KWqvczLl7KylVZZEDt/Ce4rOtJrZL+9aN2M0SjcuchQelaOtaFDqUZMzMoUdVIzXKGGWHU9bESnyDCgWQjqwHT61cOVrfU0bfXYZf3d9rlhfW9gvmtwAg4K81taUo0vSV023wAVG9h3OOa5u0vm02K002BM6hcNvlY8bU96ty6vKbqG3tQDuk2u5HatZRb91bGcUrXkaRlVnIDDK9R6jFFQw2IjuZpN+fmPHbntRReJootndywW00UAnRX8v5hv6A1Sl1ODdtimjz6McD86m0wm4jlBBzszXMweFZhqXmPkwMc7ieMemKwgo6qTN6l09DtLdB9ie4kYIoIBYngZqIQGeN/II3YIBPQ/XHapJtME2hNBKzK24H5eSAKmeaK1mFop3KFGCBx0rO99iVKzOGnUWRmmuQFki6p159M9/rUNl4l8m6+z3hzpWoLmBiP9XKOxPvXW+IdNivmdVGzcAOOcH1rDTwlE2kPp15KztJLvWTHMfuDXRGcJL3iJxcrW2HafGk07JE7nBy2VGUH9a2G0sxqjmRXinGd4AA+mBVnRLSGGMJdIRdRAIZAPvEdCT70zU7ltNsnRkZrfflWHYnrWMpOUrI1hpoznPHkci29jborFdvUDI3Vq6BKttpQieVTcRpk7TzWjOiXlgJlYAbMBz0yK5pLaW3ug8ltLGXO3eOh/wD11afNDlfQlJcxF4Hh82LULxnLGecRLzyADkk1pyWrfankkwAWyCO9XdIsodMs0iV186TLcn19qXUXETspAIVQwHek53k2i4ro2Y939oN6dnA3Yx60Xlmm8ybsPxwelS280c92xYHP881T8SQvK0Qj+6D90nGfxq1ulsS9rlmyj6lgAAejc81DrERmtz5ZyxbJyetTwMYrdEIYuBgDPNRPIy/f/i7EcUutx2Keh2P2WSSZmYI3JVu1XdQhF2AYpRgHPI6+1PkUm2cxg5xkgVl2ySFiqO5ZuSD3FO7buTZLQt2VjFaRuUABPOB0qrJcSLKQcBh2PcVoqrKcP3HT0FMmbMWF2nb93IGaSeuo/JFdoBdQBWAORgof4hSwW0dv/q4xG2AAF7Uy2idS0jAc+lSOzbjjOT3FNvpclb3H3TyAiS6kAQdW71majB5kn2y1lZkbjah+79farEsSyQyQOSA4+8Oq+9TWUSWcACtnB6HvQnbYTV9DLsrFbS7KpMgLrl4s5PNWGMN/aiK2uAPLY5P9KdPaCW9F3Eccgn1psWkpateSBgsMxG3nkd6q6e71JV1pY04/MTTsP880YGGxjNZtzEl9Pb3E6eVew/NHKoxuHoauXPnLaRz25dwq/vIwM5A7062f+0Iobk7kLN0f1H8qhaajfY0rYLf6XJbSozSIpAf2JrJ8P2d1a6y0bQfuXU+Y38OPWta1iaCZ2LYDdFz0NZEmrSnWTZbdycjjqD61Cu7pbFStv3NC2tIZLwOiRl1baW28geldNNIphiTgkDLY71i6Qm2SSYn5sDd/te1Sa9Z6hqNusdpiOE/M7dCfYVk1eSTZc3bU6WJEZYFBCK5GW9B6V0EllbSII5beJ1HA3qDXA6DaagVB1IlokG2NC2CBW6dQU7o4b8/u+JIycMPSsalN3smcFRc1tS1rc9rp0KqkCO7HCxJgZrEe6uJFkddJMMoGMhh196syLCyMJlDOvzeZ3qWR0jUljtG0HLnHHqacbRVrXKV4mJbard29vPc6vCoghQsWA+b6Cs3Q/Elv4kvjFBaSqFBOR29ya6W5t7a4V/KUSrImGBOUYHr9aTw/4ctNJhlk02HazsCVDZHvVqcLNta9C3JLWLJbaF5JFhthhsZ+YDp61zPjnVrzQbISRWwmJJBPYY/qa7Fy1vdLLbsrADGPUelUdemhl/1kfyHiRWXIpQlaSbV0Z87k7I4/wn4l/wCEhdEki8h2QsAhB6HnkdK7O3tUhAWIuR1z3NZ+laPZWb+ZZWkcMrnkxDbuFa5BIJfhzwQDVVJRcvdVkS5SSs3cgYfvCGGw4+9nr9ahlIj2Krxo0jbQ0hwDU0cbvL5YQylecKMkfU1h+KdKbWIfIEhjKHO08EH1ojZuzehSbWxvana/2dZPd3d5FsUfxJxn2rzXWPFq30r2H2SQW5I/fwNhse1dPFZyfYbbSr+aa6SLJ3O33fY1U12zg0vT1uobFJHRgq4/hGevvWlHli7PV/cL3mveYumeGLcPbXMcl23lruHnNnP1/wAK2dGvLW980QSFXVipBGCPwp+iXwu7RZehIwap3eg+bqsOoWVy9s6NiRcZVx9KTk5Nqoxc1tFoa4t7aWOSOSKN1xkb1zk+oFIkEUSsFjVTkYCgc06RgCSE3OoLbR3FRx3KzSoSBheoAxWav0Hds53xTqV/bCODTYmDMdwYJn8BWnpst29hC13hZ+rY7VqSBHfjK9hu6CqbXUMc5RmG8djzmr57xUUgWr0LYJ2KZcHgMMjINYuq6U1+QWu5IWU/IF4H0Iq2qmVzLI7Ig6DOPyrStIUupzGDklcsvrUqTg7oG7FDTontYRAZjcFQcsx/TFJFPfNOY4kiaAHPHUiui/sdXUBiY2A5IrMeH7PcvDcA+Yi/JInQj6UKopNkKUXsVp4pGIdGJAGNvpTLfRrbVJA88a5iOBIw5z3wKmeZEKocq27A5+Y++PT3pFupdNzPGPMtXI3r3B9Qad2l7pbk3Gy3H6rp/wBmMYik3LJwVPXiuXuEQSNI/wBwE4X+tbGm6zdazHdXFzb/AGdICVjVhyfxrC1WQLaEKu7cuWJ7DuKqEWnaW5vQcnGz3OM0W0lvNRvtQlBLXDGOLjogPUVbuLu1tL2OOOFTcHC57/hWlpyyRhE2lWYbuBwi9hUVzp8DXr3SE4JGF7Z9a6+ZX1FJaWRYWUgurD5v85oqkS32puuFH50UuW5SlbY9DtEdY7h4ADIqcAn9K5u+1O/yzxyblHVV4wfcV0trf27xqY+WUkE+lVrvSkvZRJbny2fqRWEJKL95G0rsi0LVZpkWUAxuo2PFjjFW72Im986P5V2Zx602001rXdGX3P8AxbjWhDEwYbjuQcZzzUuSTvEaV0Z+nSvcO4n5PcYx9K17dJWXDxR5LHapbOR257E+lVLyexsY9zSCH+HMjD5m9hWvYlLiAeXGWBw2QOBUTf2kiG7IpmF2xJboxcfK0fUlf8RWTrkZudFnS3cyx+YA+Odh9K6KdXQEQKVJ5JB5z7VgwRf2HZ6kba0lupJyX8oSDCPj396UJdepV3a6Qq/uNE8oAFYkLD3PvXO6NNJNP5qSeZDnax/uE+1aWgahdahpyfbrSSGXcY5EZcDHqPam6NpR029vVQr5MhwFz79a1T5VJPcLPRorMEXXLq9u3Ait1CwgnHPrVHS5ptUv59Rk3bAxhiGew6ms3x3NJLrq2dsrDYoZ8dM9q0nil06wgj3BIIo8uQQMnvWtvdT6sFuyxeyW9rJ5kiFc/wB3sKz9Sma7kiNuquhHTfj8vegXcGtxTPaKzKh2EPwWHrU1nALSFi0RAJ+VM56UJcu+4nLm22H2MczWJDbiwJCluuPrU6oXtz5x3FRwagXUBKXBJXaMnj9KgsNWt7gvGCyk5HPek09dBppaCLfO96IlAK5wADknNaEYWNyQoBHvVa0t4raQ3OQ8v8I24x7k0+aN3XcrcE+nWm7PYFfqPlJ5GckjrVOaSKDa0jAc/nViMFYyGAwOmKx7uxuL243KGZR1THH1JpR8we1zWiZZIC6Mc4yMjpVeMyvlS5Ze2elNEqWxWIfNtUKT6n2qwrKvJGOMgU9idxHHkwu5UEHjAPSmW0sZQyHAz2Y8UTESQ+VtIVv4uvNQC3T7MY5c7PUcYo6aj63LKzKp2xp8vrmmHbdxlJEwQc4z+tLbwrFCSrb1POKitJDOlwgdEk6I6/yNKwm+5Kbk6ZbMu6QRSjaxjOce9aJtEktcLcZSQBkdf4T61nLbzBUjnG7IwSOh+tLGJYtsULmI53LkZBH0pNXC3Y0LZ8ssFy4Eq9G6ZqJdM26itxjHOST3qpqOopAFTUoiA33J1GK2tFke5iMbMH2Dej9mFQ7xVyk01qM0282XU8HljEYyxNb8DKYjLNKfLjxlR61hS/Z7KQPO20SyAMfX2JrZvndRaRWkSvbyvuYn0rOS5mrCqSsvMvrcCaMyFSo7EjtXMrpP2fXZdXmuQCwOYyhwR2rpC6pDkOxYHkdh7VxfiW91PTiZreEyxAffY5AJ9faikm3aOlzmstzohHJOd3PkHsTtNZmoeGorxJEkvbopLkhN2QnsD6VS0CLXL1I5blz5bck9gPpXZNuMRWBFCooJOOlEuak/dZMpXM/SA1hawWksBiES7IyT973rRkcLbtIpK9upAJ96dDEZopZGYMykDmpJgFjASWIg8DjrWLldkaCWckS3BNzKq4GFReRn1qG5WO65dg4VshTx070CCQFRsIz+dV9TvbXSFjk1SVYFc7VY+tUld+7uS7LUnVhEDz83TPp9KcW2k/MpfGfl78VCtzbXUayo/mISOV7io5BtUfu8FSUXnkiixSs9zo9GaJrGLycZPLnjJbvmuL+JuoRWtnHPp1zF/aAkCFUYMxH0qXVdGN7bumn3EsJUZyGKk+xIrJ8OeF7ayZ7i4tYzeDoSxbv796unCEZe0b+RnyvmunoUdbm1SX7DLaSvHBIFMxVfmDHqDXWq0U9ssE6ZyBk+tOhWOR9rKmWPPPQf41meIdUh0PZdXCGSJpBGSOwPervz2ilqW7LU1Y4o8bVVFVegU9KkXIjba+HI6Y/WqUVwk8EckRDRyDcjDjIqVWBbYyPv6knjArNx7hvqSsP3CjIEqfeb1qvcloIwYowZFHT++aq+KY54NMLwFgwwQV6496z9C12O5tCucTA4kVuenpVxg3HmQkZc2q6/ezJHY2C2vzFZGmO7b9Kk1B/EtstjbWcNvdXVySz3IjwETPTnpXQ2wN0OA21j25zWndPtWC3t1O1QQcdQat1EmkoobXQqiB4raJJmjefGXKnjPoKk0i/tbS7aNQ7+Uu2QjkrnnPvUUyg28jJueXG1ePlzVDR7B9Nt5PNk8yaY+Y7e/pUKKadxbqx3yXMLwiTzVZPvA5rntUujdXbCEbYk480DJzVdljMS7Plkx+ealeOaO2A8wBlw7BfT0NZxgo6kQSi7opXF1DbK73MihcYJY7cj/PaqGra3Y6dpsFzcEtbyn92sZzkVa1rS7XWY9l3EJkQhgN23n1qrc6TYzWMdpLbBoUBVQf4c+lbR5NLml30MmHWoruC1+wORa3HmBs9yD2prQfaLzbI4EaJu939BU39mWumQW1nbrst43Ai8w5IJ96NWmg0m2uJruQJK2FBzwFq7q9onVGXLDfVnLane311qBgtiYoQ23K9/XNaDyrDhSRtQYLevvVaLUENhLqEcJW2HCsRyx9v8ar2tw+r6W1wImTD7V9/pW9vuRndJ+pbRkc7wfvcc0VWgQxx+S2fMU55ooaLuddpyxoxZchV5wT94VetNRtWm2Qzo2DwuQcH0qtNp8omZrcjyurL3xWBc+FJI7pbqynAZm+ZTwR9KyXLPdm8m1sjvNOxPcAMChJ5yc5qk19djWjbLC32dGx5nbFaOlpshUsSVxyT+vNbOxrC+jeVQ0Tx7o2IyG9q5nPlfcUmjA1HwxZeIbm386N1kTpIjc/l6V1ek+GzY2Udr5zlYxhTnmq3h65hvNfkFvtAiB3IDjbn+ddDrtxcW1huttqyswUM3RfesqlSelO5x1akudRicpr9wuiRXE1ySyRgPkdRWPpWqWWqSK+nyiaQj5lKnK/hW3JaxXUDHUZPPWT7ysfv/AF9BVPRfCVwszzWcNvYQHhBGPmZfrVpw5XzPU6FU5FeTJ1UbGLgtGnDcdD7VVdUi/eKpJzjJ7CujvdPis40EUfzHIG5s7iO9cpq10lvHGs8qo0zbeR39qmL5vhNqVRVNTm5LCC41ma7ZizyD6AY7VDr0Ek+kymD5pWYEAjsO+K0Re21xdPBaMpMWFYehPqaLtpGEEUYQEDLE8cV0ptNX6FTafuo53QbKazsHa6wZmbJULgCrFzfQRSBbksBJ93/Zph1aFruaHawCDd5g6YqBbWDVZFusZiY4Hpx2rbd80jO9laJoRRReWWjxkjg9etU0tT9pjJijEanOUA+Y1Z1GUWUatHGcZ2hfXFZj3rrasCrIQ2SF68+lJJvUcrGvK6KnB69vSnKcqMdqp2glltI2mXD87lPUVZG5xnn86lq2g1qrhM2yHcQC3QDNZ8d6JWaF0wc844zVmZkAVHLc+gqD7MJLgJbxmSYDge1UvMlkrog24UFuoOKUhXHTmq8pkikwcPjjCuMCrcbKVLMAOwFDVgjJMjEhd/u4XPH+NVtUDi2yoJHWtCKJH3FWIx1HrUOpyi2ijVEaRmIBA/hpJ6g3ZamdokzG2kSRRtU/Lu9fen205id47i38tWPDDuaRmEVtv8shCSHz0X6VYsBBep9pSbzdvGOn4mm+rI10sVI4tRt7j5Xee3Y5x3FS38Mks7QymT7PNxlTgxn1/Opn1E296u5BsB7dcetUZba7GrF45GeE8k9QRQr3uxabIgZb6aCbQdfiZirb7a8UcNj3rY0GZtJMUcrltow2fSpLeaOUmJXQSj7rOc4P0rM8+7W7aC/jAHTd/d/+tR8SaYRSg9TpNz3WrS216olsr1P3TqOEIro7WzCxCKNyRF8oGeorl7W9+xQwABXgLbCWP3SehFdRY3BtrzyJIi8Uq8OOxrnqX6DastCyIjFjcQBjOT/Km3dpbX9u4njRoyBujYEjNWCUNs0ZYBkPQDkmopS8h2I3LYJAHSsr9TmbdyTTraSG2XysRW5woCjgfh6VPeRsitEjLvfGeyiokuGiIijZhGPlAHc+v0qC6RY22qzMH7571NncjdiXauLDZGdtxggmPJGexPrTbaEpZwtciRmY7ckY/GtEXHkWMQMI85l3EYwKqzXE0m0zEmJjgBR92hNicrk14joypHJuBHHYiqV7p4lt8TJFMrclXXOKWWCVJkd9xj67e9H2hZHLlj0+VVOB+Ipq62YkVdPsorK1dICixltygHOPYelX7S1kdVmQBl9c5xUKOF+TyMS8kj+VTadfETF9hSLOHUHofXFOTk7sG3a42SSTfsDBgWzux29KZdq21vJPyD7zHqPpVqby5bppLYK7OclT/PFVndRcKJyrMBnAPP5UJiXkVoHjwAiHd1yeufWs3XNPh1KLyb9BONwO0Gti6uLVURY23Bum4YK1nXNxFEjg4jUcl2PJqot3ui733MW88R6Vo11FbTmRdvACDhR6CtzTb37bAt1bMXjkyykjqM1mR2mk6wI7ia0juAwO0OpHOa6Sa1tbOzjt7YeVtA2omNuK0m4qytqR1KzT+ZGyyDeMEYY9PauU1/wp5imbSiySucNEDgE+orZ17VINNeJHjaZpPuhRyPatDT7sSWqSSIU3DKq4wfpiiLlBc0Sk7HF6N4Y8S6frlsV1FVtY8MUY5yO4xXWarcxadDLLNujVMnJPf606SULOCAw5yCTzWeHfU5b+31Aq0anaAVwCp7VTlKbvPoFuwaHq0OrW8pWNo5ogCVByDz1FaSzBCTxnuTyKzNI8OjS7zNqhRZEIWPdmtF4ZIl/eLtxxtNKbi37uwkujLzXFvclRNFtYcKycY/CmtD8o2uEQ9Mtwa5Kw8Qxza1cadJb3EEkfKFhwwrqoVZ0Iyv4nilKDhoxehJsKkbQrHJ5XtVZwqTvGvVOqt6Vnatq4tLyCMROxlwqsvG2nzO7tuIxu6se9Lla1fU0jHuZWu3DXmpWdnAv+qkFzK56Iq9B+Nc1rt3bjUPP1UPJE2Si9h710l+8Vrb4kYK07Fmdj+grmNauraC3X7XEs8bglSO59zXRTW1jaygiWS8itbXzpbkT2RxtiI4AI6VJDdxz6cHsDtRDt2AYxVG/Fpc6NaLPbOgb541iboOn5VPZW0en6XutIWGW3OHOTirsrEp3l5D2nX7UsTffZeSRRVaWJ5L2C46Rvg4/pRQ7aGibPS5QYZFKghQOlE8QaLcgyy8r71HpE51O1IBUyJwf9r3qwN6KAykcbTmuXZ2Z0p32LWmwyT27o4CqOxPBFPg1a2uNQt9E1GUq0cZlSTdz6BRTNMOxWikLqWJOSc5/+tVK30pXv9UviwS4kiEUD7dxi98e5qdG3zGU02dL4R8OjSdbu7jzt/nR5X35rb8T+Y1ifsu17ldxiU93C8A1U0/7TDa6fLOweVAFdwNobPHSrWvvGPs4+USB84HeuWUpSqJt3OFpuomef+B4tYe0mk8XOTeu58qPphe+7H8q2Ne8fQ+GLK3iubeSeZgThDgKvatJ7PZMcZ+boSaxtRWxOoC2vEjlkYFgWGQorduNSd5q/kjdwhOPLfYrNruoeIZLG9sIjHbudzrKeUX2965/xsLi81fT7WIBQMuHbu3pmu4s5bNIitvsaIDkqw+UVj3IhuGb7YFRIJAUZu4PerjLlldKyRvRtsjD8KaINPiuFdvOncmWZl5GegUetQapfWlvqMunzSSLLIu3K/wAHFdFet9jgKRY3zDgjoB2rztdOnF3d3WoyCNWc/PIf61tT99uUmOV09C1ZaRaTwSxwXLzIH/eyY6j0+la7FGO2BFjggXCoo4AH9aykuLe0tFg09HlifhpUfqfrVq0h+ys0vnAwMOmc7s1crvVhC3QhuLhLt1tHU5blSO1WoLGKC28mVFYHn73T3qS2gjVzJH3/AB5+tOllIjYqnb8c0m+iHa+rMS8vfs5YphIkOMAZzWvbPvtwwPykZ6VnNYbstK5C9SAOtLNdvHErIoSIHuetU7S0QbIuyxo7gjJI5A9aTSnEC38UjhbiaPKSdOAeVpIcCKN92FkXeM9T7VQ1KLzJF/dMy9U2ngeuTSSvozOTvHQWydpoWTyAkgYhlI6D1qxLtDKOShG3K9R71Gk20bnZvLUYwOKbJqNsCFgCtIe7dqb1YLRal6IFWDCTecEE4xUbxM7kg7Q3Xjg1nm6mGWdSUBxwe9alqfNiGThh7UmrajTT0EeBWtmgGNmDgEdTWBp9nc2V9vRj5QzuUcVvyKeqsfSoVBXK7vvDg0k2kUkmV57m2nlCjaWJ5BpJrpYkkt1ZRLsO0Z71UlsSs4YSEEnoRVXWbOdbsSIiMrnILLnFNRjdakuTtsUdPt7/AO2hpY3jRW6nq1b+qana2jRi7SaWRQMlUzj2zWp4ZhZpIjeEsqjG01DrXiQz6m1lptnFJHnHCf54pOTlO1jJtQ0ILK4tNVs3S3cnIzg8NXXWKSQ2FqxuGk3ICWI5Uj+tcnfW0FokTxiK1vZFyUHG4966Hw7It7ZXEEu5J0XIIOGFZVfh5lsaqWhsswltw8Yw55fHc9qYs7LaPdSlY2jUtJz2ArnvA+pXF7BNDfBna1lKFum4Z/nUd54lsp9cu9IltpEhf92WY9fwqHTlzOK1sYNprUveENYvtXtppr20ENvvIix95hnqa6JJmDNHHIsUCfMzEcmvPk1GLw34lkjlzDZ3mxEZmJUP6AV2uxWC+VcjA5xjp9adWNndbMxXYTxBeXD2sj2sgDlMR5PQ+/vXNeHb/WZLkrqUbRIvG8jk+ldHc6SmpRB5hslhkBRh8oaqT6rNpGsw2l9ZibT3YKJlHzQsex9qINcrjFXZTaSNb7PNJZvJbTfvAec8kVTtLUW6kNIXJYsWJ61sXUBs9UEtuh8iROcdj7VlX0sa5CAMgydwPNZwk5Kwl3QSXVwLkHyn8sL9/wBvSpLOZDJmMBmHYmo7BllmiWXLwyfLj61zPiXwxrVlqr3Oi3m1ZDl42bAz/WrjGLfK3YT7I668kaGExowWZnzIynnnoKjMYYLcbNoUYLEdTVMQSiO3W4dd4jG90GRv71budbsNLtIrS6l5uGKxs3GTUWf2dRbWDywXRnVSD6jr71HLbI128dzGrkjJDDOKRyQAUYNF2OcVTivTq6Lf2xZY3yAfocf0qlF7jvZ2JYbSNrkoG2lWAUjgfQVdKiS58pSxVThj0zVeG3bynkY/NkY9zU1q6i0kYBjO8nyY9aJXBu497yygnSIQfaJgT+8wDsHtU1zbqxSZOjHJPbFZflqkymLBmJzlB39auLLcLCYps/Zx85Y9Sfala2omuxYtbISxNKTmJMlc96z9SHlRCTapByxPqB607+1mkjeGPaI2H3e+PrVTWLuVtHuVGHVEPG3nn3pxUubUFdPUbZXsV0iyW0xYg8nPIPpVtzJ5jNcOdxGRnOCf8a5LwIskdnJKxJDN8u72ruVm89AkyokuPlPvWlVcsrIezuULeNTIN6KJj/EBzir8ESumAUjIO5mJ5I9Klms5o4y6wZJGCVPSqcUMrSGNUOSOM8ZrO91e4m77Ed2kLuhIG5SSgPzZqu/KENt37sfnWjLFLbW7FlTLcHPUfSsOS4UBHBzhlBI6kg81UddjWldsoeI7IG4EUyGTyE+6p4ya42WdUl2GGHy9+DG3T866DVro3Oo3Fw07wuzZRSOMds1iXOr6ebsQa9pzWjSHb9rgb903uf7tdVJO1tx1JONrmnPOvyRiEEqvBxwPYVXsJ7o3LrIyOCCBjjj0NaMVvHawCOFiYs/u2Lh8j/epgTaCTsAPA7Uk0WtVcp3twkXlxsTy3A9KKravatJe278sMcFD/OitEo2C7PQfD9pJaXJBXCkHOK6NGXziwQZ6YYZFUbSOQxxsVyrKGJ/u/jV5ELQqq/eJArgm7u5voW7gRytF5NvJ57cMMcGsvU5pNLhybRpSZAMLwcZ71u6pM0BiWE7XGCxJ6CuN8Wazb/bRHJJP9okGIwBlT9fSppJya0M4N212OtvrgzzhrSU+U8Y3Kemfb3FQ3KXTSrPIrbRgD/Gub+HMuoXnifVbTVYJDawRArMykLu9FzXRz6pHa6lHaSXP751JRSeqjvRKLhLkWuhjGavyx6FrfIi4AJboQTWXLoJuLye7vkdVKFAnoKZp2tWutXt0NPuvOltWxIoGAT9e9amm3l4JJnulaSJxghxjGPSk1OHkyovS8ThR4Zls7stpd1JEzEE+aMqRnpx1ra1LTmm065SQ/NMpTI6ZxxitySe3AUeXIqk5b2+ntUd1JFLAxCbU6DPaqdWctWbQk4taHGee9j4bhfUwXuLdNrKD19Oa4zUbmXxMY7FWSDYS6qp4z6Gu+1OMmQRXASe3ZMMjDGR6e1YQGn6eZP7FtFhvG4aRjvb6DNdNOS3tqVNNOy2Ob0rSRexmymnkjELbm29x3xWnrOn3NxHBaaS8SwR/KVZ8Ee5NatnaCW5N08Sx3JUg4ON3viqU6pbXcjIhabqCelX7RuQuROJft4IdN09LdZfOaNfncdGbvj2qva3wvJJEQD5Qc4PT6+9MsGuLqCQ3HcbRxjFS2FktuCSUGfvds1Lsr33HG6tYge6BuBCAMjjB707yYvmS5WV4Cc7IwBz9TTnhjWcE9uh9PpTUu4HuVT5hnuRwafoD13LK5uZ4z5awxKuyOMHO0e570uoeUI1VOoPrTppkUF9wAC4J6D60yKS3kJIkKkjqy9ai73EkloY91e2qI4nmChMfu0GWNYUIW4meZVywP+rTk47c+tdLJDp8KPJIFfru46+1Y1zqrou+wt3xnACpjH4f1raL7IyktbtmrBazzKJvLMYA4DHmrSB4FBKnDDIB9KytG8TRXx2vlpIyQ46EEdeDW1eSw3G4SrKTIRseM8j/AOtUS5k7SRSkmrxIVu8vhlx7DpUjEMgdkxlscdqZNalX80jCqMYI6iq8d1I0flkDyy4J/wBmptfYtSCcMJgRuYEYAxmrQOwRqzDdg/KfWnRgkKVKvzkisu/txLcZDncGz9Pahe9oDdtR0/8AalvqhuLaSNrRsAq7bcVuaPqunCQytbRyTp1KgEH8utZN3Fb3VoLe5AcnnrjBqq8UWi6a7WcBfke+aJJTjZmbhrcyvESahrfjWKVjDHBComIMgG0E4UH36nFdbpN1LZ6iss2cJ8rMvQg1xsUNvqNxLJtmiuZjudgcjIHH0rodOnMMaWszb8cBj39qco+7yhTVr+Z2mgwWdlYzRLl55Zmm3D0PakvtOtbi6inlt1aRPusBz9Kj0G6ihcLtViydD/CPWtKRgX2xsVHbnP41ySbUmyZrldkc94p0mPU9IcC3hkvoiJbcz52qfwp3hyLU4tIC6wwku3bIK9h6H2rbfdHGVcu0m7pt6n/CsXUTJqrCGx1AW0sEoMiLzu9QfStIzbjydDFw15up0c9lNK1jcrN/x65LKrcMPce1VZ1M1m86qTCTtJbqfepNPSWeSNC29WDDjjA9awfFtxr9lPDDp8Ec9lGBujBGWNZwV5ctw1+462cvPods87MJFGQynrisV7KS4tPtUe3YjY54LetVbPVbu7tYobi2eCRDkJ2A9zWlczzzwBWUOmOCOOaaUoaCtYp6JJ+9CRRYaJyfLPX8DW5fXCzsouImhZfukjJP0rkNb8xoo7SPUDZXeRIHTBYY9u4rSS5AgjTLPOo2iVj1z7VU6d7SJl70jYmuLRYEjO4ovUgDNYmvaRZa7oktrhwpYt5rcGMjoRVDxBeS6X5JCCSWTsf4RWp5rLYozERLKo+TPf60lBxtJMLFG30c3Gmw2jXTmKKMI23gyfjV+yt4raBLaFFSCMbRGOAP8aSKZVkUBt74wQKtzwSQWiu4ODzn1pyk9mN2GvIirtQg4HPPeo7RA+4BisYyGb0HtVVATmReh/n7VJBc+WVDk7ASw77j2/Cjl00DYsFSsKm3QFVbucEe5p6yqSftBcAnC4Paq5+1M+RkMfmywwPxqRjJKA0o+b+JW53D2pW7iaIXhiiuWZXJUfxDnFY/jDSbzWNO+y6ZdeSJJAzknGRW/KpSAoygK+MKev1qqSCoOWx09DTi3F8yDfci0zTjY2cUDTKQigFiOpq00Dsdq4Ric5Y/yqlealHbsPMkG5ugJ5/KtC3ujcWyHYvUsrHtVS5viYO5euriRljhhkdiqjfzjNVT5mCRkMO3UjFJt2ozM3zsMfWiLaGBLbCDx6GoWisiUDP5p8yRiSBjNc7q27cJVOxFPzAdDnvXQyEPnkD1CjisfWV8yFU3BST98LnH4VUHqdNJpaWMC+06DUECXEx2EghkPFYl7HcaezRQQGa2Y9GAYEe+a1mgZPM+1TI8SgsHhyOB7VlQ+IbJrgW6XEmT90yDiuqN+mqB8r3LNu0UEKCK3EKPztGfl+napL+GWeHbAyiXqMnrWhHulXLskY/id+FFRuqIxkDoyrzlTkH6UlLW5X90p6aGhtmW5zwwKn0NFSR3Auty54B4HTHpRVeovQ76z1ayum+z2d8Qf+efHNa0MwEQ3ERlASS3b3rzyz0DTReK0moSocjCKvIrqdYjZfDt39lLPmMqrE8kVyzhFNKJsrsueHtZTxBLPPIrBVbacn72PSug0+xt77UxPJaI4gOELJyK5XwraWun+ELeRFzLcN84Pb0r0Dw9biO1MqnK44J6Ed6wrtRb5fQxqytAz/GWqyWNjPFEmSsZkOOBgdq8T8Oy3ni7xBNOxliBG3zFP3QR0HpXp/jO0/4SCcQmZ4rYAhgpwW9qr+F9EtdEtlhsYmUb9xBOWY+pNa0Zxo0tPiZnCGxN4e0GDQ7FLW1ALO25m7s31rZFzIlp+/LkKcgv2+lVohOXEkwIGThU6e5zUtxGr2UpcEgjaADySayk3J3lqX5GddL54Rrc7l3ZPORt71UgtrlbYxXk2+QMdpAxkdvypdP0o6ZuS2neS2fOY3PKk+h9KvTwqI1jWTdKhBz6Z/nVtpaR2NYvXUxNUjDLndyD26n6VyOrW2oLdwPpaRHecyF2wc/U9K7jVIWiWPLAc7SevNcNdym51j7HbxE4bBz39c+lbUX2NqjVvUj1CGOW6R3vRFd8bvLbcoPsan1H7Y7xQQMd5GPNIzn/AArJne3tdWZYLd3YNgAnj8Km8W6je6bd23lOUheMMAR19a3Sd0jJySR0Fvava2iRm48+cjLvngH0qOzl8yZ43GQf4jUOi3kl3ZRXEqbHYYwP5irBZYNzbcsfbrWdnqmWtVoNuVD8K3bFUhZzC7E0r7IyAojyNvHepp7lmhdo1xKP4fb1qDT3dmYOOc5znjFUk0gdrl4wR3FhLA/Qvu+bkEelc/r+pCzhxFzGrBXdRnH0ren3GzcIDnqcelYWstENKuAtuuQp5PUHsR+NFPczqaJmXhprFfJf5pRuVWP3sdsVvW9zBJYCOFzBIoGSEz9QaydK02eKC2TIkXIkkcDBcn37DNL4huYtMiaSOVlZhwFOAWq5Wk+VGaTUbszvE2nfaNYtLu3MkEiknzFG3cO4NdDY6hJHZeZIhRVOOOePWuUsrjV5SJroxJk5C/fOPSuo0u6mLiK4hjRX6HPB9qck0rPWwQs233NyCfz7bjL7hkEVlzwswypYLnle9aSN+7IiABUYHYU7czIvmAK56rwcVjexsjLtmZiysGUJwrHimX2ppbyZ2IFDbd7Dkn+lX7pYY2Al4m6qAefyrPljjdj5io6OfmSQHH1FUmm7sOmhZRFkiWRz8rGlvHWBA7+YR0CgdakedEIUxhEQBVUc4FVry6dnGzj0HrUbjLdtPHLaM+Ett3QuOR71nxaZrkV6hVIr20kOWnjIwo9fai4tvtkSOzlD0KtyDUBubix/cxSZVjyA1NK3wmckzWtrv7Dr0W5i0bwlSD2wR/jXbfZjIEWEh2PON3UV59DFJfahZTCMtlHjkjA6KR1rpvCd7PFFJYavCxeIERyocq4HofX2rOrHS63RMk3dm0ZZJbfbG2XjG1sDnbmua1Lw21zrlvqtpffZ2jb9+oGPNFdK820F0TZuG3b7UkKqZVL55xlSeCayjJwd1oYsy79L2WIDSJfKmZ+svT86ztN1C907V0tPEUyAzHbFMgyin0JrsJLKP7PJIjn1YZ4X/PrWPLp+mX0Qj1KOWXByu3sfrRCpFqzWn4ibuamoEWULXMtxGsSj5i2AtU7W9t51H2RkOTwOqn3FR3ZhmjMMluGIG0q2WTbS6XaaZp9uZIIY4owclOcLjklalJKOu4ku5emhs7mUfarWB54xxKoyR7ZqDUhG/kvZxKgztI285FV9Mu7Z/D02o28vmJPJgbhgjBqhdSXJs1WzZmuDkqMetVGDv6CWuxZvYfOtc3cSlkbKufT0rJ09TFrd0jXDNBOoaKGRvut0OM9Kr2VxqGp30VleQzIivl5QCF49al8SaJFcWIaSRomWVT5idcA5wPrW8Vyvlk9wa00OlS0gt4nKLukjH7x/U+lV79pmeISyliVyyg8D6UjXbCzjtoxncA7nPQVha5rkOjWrXtwGklPyonc1lCDk9AWmrN+2h+1TGBQUGOoql40v4vDWm28kqrMdwUYHHuD70/w9I13DHepK0auu/wCYchsZ5qhr9nb61bPBqEjMpbIdeCp9RTStU97ZFWvszQsdQtry0inDt5rAbcHKuKvok3mGSOQBwMn5uv0rj9E0iPQyI7e7uZF5+V/u/hXW2sYjgBuVlXcOAOQBTqJRfuk8rWjLT20skiylNzSKN8h7gf1qtKsEUJmeVQTnjHFSy2kzonkOdvJ68D2+tYmu700mVhyCNp9RUQV2lcIpFhvCthr1tHqE0s8bxgj903DDrUirHDFEkbEMAMc8Yq74FHleE1aQEEBsZ/Sq8UaqrCVAR1+lPmfM4t6IW7ZMQAGBYhh1GOKx7/V4LPU7WxAV3nUndnlceorYjTYOq4IwW6gVzN14bs5PEa6wk7iXvFjIJ6cVVPlv7wWOiDH7PISMjgKR1zXPavM7YOcgdAa33DwWcf8ACSxYnOdo/wAaw9UEjvIbfiRRnlc5ohvc6aNnexzw1cWlwyG1DIch1bowPXiqTaJomoIZrEXVo38SHDqB7HrT9S1G6in8tNGF0B1dzgt/hS22qvCCLm1hs3Jz5cJ7ehzXUk1rH8zNpN6o0NsE9qLdpV8kAct6j1qC1tRAkqROGjIJYnoB3P0pbcQXMbGFMbuTjpVq2aK2LLMS0ciGN8ehGKm7Whb2uYy7Y2+0QSiRFBwQec+hoqvZae1s9xGr4iYHBx3B4orS0W9Ra9D0J9Pt7m+WeBxkNkgHOf8ACtgs7RJGSUT+ID+L3rEs9IuLW/YxsREW+U7u/oBRZ62rakbaYYBJUH0I9a5WnL4Xex1p23N9IFkjW0yVQnPynHHp9K9B0nd/ZCbowuEICr39K85SUW7/AGoNu8vkjrx6112navhonR91s4GAOcE1y1otrQxxcHLYzAwSV/Mtm3AkZz0qW3Z/N2xYbtz2rS8W2UjWT3Nl8su052989DXJ+D7ua60dTcH9/GSkgY4O4HFVH34cyMYtSVzT1RJpLZ4rRjG46DPSrMMbLbIrNvk2ZIPQmnmNpxGI8rJGeg9KYRtBKt8o71N9LFN6IrXJaEoBIpJYfuwOgrlhpOoHx5NfXsjrpscGYB0UexHrXXogILMDu6gCpI40MUhuQ7I3BA61cZuF7ddAck9zlpL5NTtGuIstGJCFJGM44zWBrl4NNiEkMamaRuSB1x61017YxafYFIRsiyWUL2HpXJapq0dtHteLMrHiPGTj39K3ppN+6tDqk1yrUisvEMm5YrhIIRNwCFG9jV+8vYbe2VL1IJYwflWZN20+1Z00kP2q1lhsk89sElhkr7CmeI7CS+jIjkxKDwCOK05YuSvoR9kt3FzJPEr2pRoycAoOAPpUnzNbr57YBPDd6qaDbGythHK4Zgfmx0FS3yS3G3yziNeBnjH1osr2Q03Ys28K4ITa7EYGetOaLyhhVCt3B9KijnWxiVpXwegGe/tT1nM2ZWIYc89j70vML9BqM3PI4/WuWuZbae4USkzMSVI5JDZ7V0RIdgoOTntVO0itbS4maIBrjcWLHqPXHoKqLUbimr2HahOun6cssjJCpP8AHgce9cBq+qx3Vw11erGIkYC2QckH+9iuj8RK2s7VlkiS2iO9mPOB7e9cxdW9lOSluhi8hgNhPLe/rzV00lvuZVG2/I6bRdd0o2C29w/7w4LSGNj+gHFT3dzA1wDbGSXcwKyFdoI9cVxyzas+rKdHjaNlQGTOAhHpiusNzqiwgzWZjuI870ChgSRxim4pO6/MhOXXb0OltgyoSBkbgSAaW5iJlDAgMMjPXFY+l6tKjImoKsEynD/3ee/vWzdvkHyioLkEHHT8KxmmnqbRknqVDFc3d7FKluZZHz5kmcBRUF/BMsiJFLGCOHJ5BHt/jV2Sd4YWUviP+IA/lUcETSWreZEATnDHk4ouwtYrTSRw2AZ1LnsB3qPStQa7fy5YAq4yCePzqXUCw0/cYVO3AAzjn61VjE0liBaIEJbLk9SKpJNag276EupR3U8yCPHl/wAWOwrE1+Sw0m/jX/SZAQCxUZwa6OBpkswZV3Sr+ft9azpftlyT/GD0UxA0Rdn5A9Vcn8Na3FeTqbQyI0eCSw2nbmu8t4ioLxESK7kn6+tcZYWzJBH9phCS552Lj+Vdfo04aymMg2ukhTGP4exFY1bXuhttRNB97AgYIPX1FcpYrf33iWa9mnePTrFjFHFj/WPjkn2rrPNLMWC9toI9KhYrHtPVS3zcVlCXLdHM7dSVo5bmBgCyiQ7fl7fX2rmYLO+0mWV0v2LvJmVWT5dvoPeukikAaVHZVSTrzjHpUEtsSCdxbBypNEZON10DfcydR162sr2ytpVkaS5bZ7KPU1ZstVstQt7o2wLrBKYjF/tDqfpWfd6EdQ1KC/ullFvBztVfvHtUui6Lb6Gty1qJVe4OSX7D0HvWjVPl8yGncmCiWzhtokEMSuSqqOpPWtm0thYWXns26coQp7Y6Vm6XbNJPtDKqg5Zz2HYfWt68hN1GyM8UagYGG6YrOpLW3QcrLQ5+XxHYaZNFBqF+I2lONjDOfSrOu2017cgJxbIucg4H1rE1vwpband293MJGMZG9R93g8Z9K6Biyw+WZ4yr4GxT0Aq3yq0obkpO5nuxVHZMMpAUevvUE9nYahApu1j2wN5heRc7celbkdsmDBMFEQG4cc/Womjt4IZSwPzcKpGSw96Sn2LknHcr6fcQtEn2CQNbSttXA+8B3qXULS2iUnByBnHrVDRLaW1ijilh8tFlZo2/vIefwqbVBKIriaFFklP3FY4AoaXNo9CNbliD7JbIDcsJbkKGaMjhAf60wajbGQWbXRMm0lB3Htj0rC8P3mq3s00evRI7bt0MsGBtX+6w71eTT7ZdRW4O7dghGx0GKpwSbUgjdrszbt2ltI5stuLKMFcYx6/Ws67R5RGjlWjY+nX8Ks2yEOvl7nTOM465HSnFU5AJ8xedoHT/AOvUJ2dykrMvPKsFgqxcR+n8qoxz+WZCeVK4Jxxn0rl/EviKe21aCwhQMoALnHXNDeJIpdaudMCM32aDz5ZQfukdsVcaMreonZaMveHpdRWPWH1KNniUfulA+8fQetZ/ge71a5vNQl1K0eK3dwYkccj1Arbt9egufDcdzAGGCSR/FRo1xPfWfmvGBvbA9uaq7tK6Jsr3NjVogXhdYSsQUMVPQGuXF6m6/KMG6Lx/Ku013elpbpwR0JB9q8futP1C21C+dW2xy3iugz0XvxU0EprU0oyaWiJdZur6CdPskYkXg7/f6VXtg1/JN9sslZ87iWJGT6itWZZYIj5tvG2TkSq2V/8ArVSsru985t8aMueAvNdK20LerHbVtbZ47ZlEnpnkVWsYbi43ksxPX5uKfqVjLJciW2UBX5ZSeVPtVovLBZpn5324Y9s076aD33FaNrezUNyy5PB/SiobeVp0YTKBkY3Afzop6LcPQ9Qtts1uJCxWaPhm9fessWGgjUFa51BIJA2RvGNzduagbUP7Obe4yCcMfT6+1TzaPp/iiDfC0aXBxlM/+g1x25dW2kds4pX1Law/Z72VBMjR8ngghh6VX0kXun/aoI2UxSMDA7DIi3e3fHp3pdP8NppliLbTVVDG3mTecxP1x9e1a1nLay6na29wRtd8bR0P+FKUlrbVEuTcLy6bnZwM39kSG9P7sRcv+HWuT06G3iDvbbSJDv3AZBz6V3BsVezmtWY+S8Zjx6ZGK8z8JpLp0FxpV2WW5spGjxj7y5yrA9xiueirxk0edTndtI6VCIwzeYV4wAOpNLBllI4Le/Gahg8vkPyzU5QGcq2V5wO9UaEkamP+EAjO7aeTStJGR5R+8Bk464qtuZpcbxnJwDwTSxyRtM6AFnRecUWHymZrG6exlBj2P/Dzk4rgDdwf2k7XNptCH97M/tXpd4FlxCMZY4yeOteVeO7O8W7WzhhdkRvnUHJY9ifaunDtP3WdSd43saO5by5W5ttyovzBh0b8KjkuEllYrMGx/CpxUujxZ0iSzklVLpoyqsDwG/uk1h2elXltqC77V4AvVs5UitUk7rsK9nYvjVFE3lKoLHG4Ec/hWmyEEZ4HrVf7LbQv50hC4PAJ71ajkSch0ZXHt0pSa6FLzMjWIJbm4BHzR4x1xir0MTRW8aj5RjGSazL4t9ukLs4Un90V7fWtOCN54Rv3FtvI9feqeiRHVitHukXBGB1I45rn9TnW2SeNS7zbS7qvBA7DPfJronnRSELcDC5I71zepXfmfaYfKEKz4EdyTxuHQH0GaIXvqRUehBpRuLaC3ivI7WSIh2nAPIY9BzXPS6ZZapdmaGOUOzfvHHCj29xWzogS5vpZNStVinWPbIqyEqG6bgPetnSNPjtNPuYH2ySop8syOEwG6fhVt8rbW5nFJpX2MXSLYuUit4mEaN5a/NznPY+lelzeHb3T9Oa6idbloxmaFzllX1B71H4M8GSHymmkxbxnfvB6t14ruNbtmNq6Ltz5e4uSAfTA/rXnVa3vaHbWrQi404fM8Q8XTQ2qxSogmt5BvV8ZAU9fyNLoAuL6LyndS0YDKmfmPPVaTVdMnOnX2mSOqbWM9vIx+43Uj6GqXgjVE1GF45Tsv7Xh9v5ZH1rvjJOnoc1am6dTlfXY3o5HRbqOYFfLbGOp4q1ZO5XY+djgge1SwqtuyS/Jl+Ajc7qJ52e4AZUjAGAijAA9qhyuOKaYs6q6CPlt2MqKyr8XEJVbZQsXcr1rTZWEwKEAj0qW2cJG29QUJxn3qU7FMpqXMMZ27ZCvJ9TVPUNRtYJ4lvJphtGWI4B9uKfq0VxMAlu2wfxc4zVe3tXy0E8aS5GVL8gH601bdifYg0PxBasl9b39wd7EfZgjc59D7V6DaXAubW0kjIEhQKw9x0zXmEkUqXCxHT4kZWz8iDP1J7ivQNEdgkW8bXIG5fQ+gpV4q10TDsbccqMwRQVk64PAptwwkTYAQ/Ug8YqOW2lZwxUqQchvWlcFmKbj5jcYJ61grbmMtXoV7nIlRiCVC81oW8gWHzQQwC85P3W+npVWeKQAxy4XI6D9KzvD6X073kWsw7VhfEcqDHnA9ABTa5o3fQlytY3GuJPslupyI2kBIHSq0rl5g0mNm0tj05q7cRSRrGJwkMUZzHEDlifU1HfBF06EMgWYMQo7kH1qItEXHyQW0MJZMgOBkr61R8pPNfZ7YBqjLbancXSSKWe26gA4C/hWzbo9yDEjIGHYjr9Kv4VuP1Irm+Y2ot44/LJOH75pkNgqKskj7S3zLT7jyIbh1mcM6NwgGR+NZ9rrFzftdW4tTaxWpHLck++aEnb3QWj0LFvpl3I5ubx3jiLYWPODUmpmK1WaecnyrZd2B/E3YA1ALi4lmRT5mzIIX1Pan6rLuAtXxId2+bK8Z7L+FCTurl1akqj1MrT9YutVj8+7tWtQsm1BnO5a2ZpoxblxMFHQKerf/WrPg2GMecQqkkjPAFc/NrOmQ3Ltd3RWIH5pFXdV8vO7RWwSjGC1Z0W6JJhJDEkbEYYq2c5p0bH5I22+Wx+XHY1Vm1HRW0yK6sp1uojnBUY59DU+k6lFe2iusBjJJCAc5H+FJp2vYUPe2Jrm78kqNxUv8oKVNYi4M+5mJGPvHqav2+lC5fesajH5Zq1DbYmeMgkg4zUOatZA5JaHM+INIt5bqK5K/vhwMdzXE+HdetW1jWI9T0nydUu1+ziSLPzjOOVPf3Feta1ZbUt5D9xHBPsK5lNa0+bxLOLvTIRNbj91cAckE1pRm3Fq1yJvmUWipovhmXTLQQ3Ux8l9xEeOc1t2luIzawjAiLAgDr75qyY5tQE0y75APuj0rP0W4nlVjeQ+TNE5UDdkjHQilzSmm29QOi8VDdpeFXgOPw9643UYIpdySD94cbcd67jWmWTTQshK78de9cdfR7LlSwwu3gHvWdF2Rthn7tvU5eV7iJGjljMtux+/Eclfw71mgyW9wr2pWeEnHyDBH1HY1panv8okb0w3AWs6C5ERVm3K/chcjPvXfHYJaMj1NLpr8GPJiwAm1ipBrdSI+WnmjMhUbh1GaqXrzxxRyIuYT97jkGnWly8sZChg+cAmk22kNJJuw3VpGigQo2VJwQBiipLkRzK1rJJE8h6hDmiqjJJaitfVHaX9pHdwNvGUkXriuU08y6HqhjuJGihJ+RwOFPrXR3909lFDIMPC47cjHtVTVdSAtLYrBFPG+RIsnVfTH1rnhzJW3TO3nVteh1lpqdvdmJrlPLuAu1sfclB7/WsjQba+m1m+f5I4WfEEanJCjrXL2PiK2ttYWwu43ht5B8jSfd59DXQWd7Kl2zEvC1puLx9mBHDE9wOoxUOm4XstyEovSLO48FeKo9YuJ9Kut6ana53hhw654YVf8T2iloZUULJnYSOrVx/w1t4k8S319vSRbtN0Td155A9q7DxWxEcS7iN3I/wrlqRjGt7hwKm4VeUybWJC0izN8/GAeBWVrN1PbCP7HAZz5mGIz8o9frWjMJLy0ETxFZAcqV4JA6g1zXi7Xr3TL+1sNI0+O7uWj3sXk2ke2K2pxcpWNX3ZvWzS3EBlliCPkYAPNVNFSRb69e4JA3fL71W8MXWqX1q/9q2TWsoPChgcj1rd+ySW4uJo1LxOoYsB0Iol7jcWUuxHdyI1u4+UMSCCetc74509dThNxZyMsqqAxXqRj+lbd3PEbm3Z22GTATIJDH8KW4YR2xfy2GTtORgVEbwakjaNlZI8wsY7PQpEiknklmc8gjP51b157t7H/QMgk5Y9Dj2qeeyh82WaRNxXOB1/Csq3m1C9u0aIhIwcFNvGP8a7lq+bsEtNB11BNe6bavn96B8wYcfjVvT7T7LbgBuvX0q3q0FzBYebacFn2s393is7SZZ7mN450YSp3I6g0k246bArc3makaQSbizqpUZXK9T6UwkxOJEK4zjHTPtVMiODcpY5LfeHQGrMEW6Ih3J4yGqbWHe5XuoCYptoBDLvQdzWdYwSXVtckeVJbbMMrYXysdc1tqgEiRggjd8uf5VlajpkU2oxqlurXG7eGVtvA9fWqT6ETi+hmaXtLyQXIcNJEoRsYOQehNY/itJBcad5PmslxN5E77v09sV0viG1LJA1uWWIoST3z/8AWp1qtnc6davfhJY4ZkeVz1yOh+taRnZ8xlKF1ynrvg/TpbLSIYvN3IQMMTlvpXQywxuoEio2B/FzVewMEllE9uQIWUMoUdqr6rq9jp+xdRlESycK5HB9q8OTc5PuYSbnLRHNeN/DdtfWE00Y8mRASSo6juK8BtdBvoL281Oyuvs/2fhV6h19DXufjbxjZW+my29jJ58zoVG3pz6epryS21WaK3nhsogWuRuAf+Ejr1/lXo4L2kYs6ZJ+zXtPkX/C+tpqFpBcspikhZlZW7g8HH9K1p7WaPdKVfYOQ5PBrmNIjOUtggeXb+8fOMt1Ix7V10VrgIr5O0Z29q6KllLQKabVxIHkZUUEqTyT3xVe6imDHaxEY5PpmrUIWVHbPHQn6VUluJI5zGw+RRUa30NdjNs57qW7mcebhQVO4cH6VZ0KO82zPeYHzfuwT7/yxWi1zH5Y3lRGOwwOafcbJowbdHjBXjnO78aHN9iFBX3Ma4huprh9jqjKeme1dPoYwUDByMDLHufavOZb7U7K7c2ulFHJx5kzcfrxXWeEb64uZgZ7q3mn5V/KbIT2/wDr06kXy+QoTSlbqd8k5ij8ksTHnIyORUEyROTg7pgcgjiiPfMuJB82MAj+tVPEE6aVZeZIhkdiAgQ/MxJxXLFa2W5m2aWn2ZvA5klbzB91j0z6Go3klilYlCW6D0HvTJp7m30lFtt3mKPNLAcH2NXLaRbmyS5RP9avIz0PtS1Wr2MmR28LGRrq6kLbEJRG74rPluXYl7pHeQ/cfGFXNaaWsj3CxyPibZyp5VR2/GorSOW7ufs9y5jVc8KOGpppasRe0Voo7Hy5JFkYg4IU/rVRdOu8/aYpCwJ6A9K2wlnptu8nIGQD3J9qpzatCsm0kQqoyBjkj0rJSlduKFcz7u1htwscaGS4ZcSHGefc1WvpI7bTI4tv712Bcd8D1qS91qdnK2luqr/ebkmo7HSJb+bzbpwEY5fDc1olyq8yug6CCW2mmuvPDmZR5aAcximx2nnBt7bVzksx+8fSqDi9tdX+zzJKzu+BwSGXsQau64GBt7dQHIBZwr8huwFU07rXcEYFj4NubjVZmudYjmsZn3LEhJKt/hU1/wCGNAaaW1Mctw4IDKTwTU8UV15kUqL5Ui85Xrj3q9ZrKl1LdzAbiCcMP51o5zvfmDlaMjVPDWm6ToxhgjeJVYyFEbOc9qt+DtBE063guGZNgwoPA9q2NQgkuLHbdgfOu7zG4A9ql8FWZtoZSGOzOBniodSSpvXUpv8Ad3OmSNY02KNo9qcEVCTtAHt/OlwRjoPf1pQRgcg4NcZyFHWFEmnXAxzsJH1rhIhp0niG4BjI1BLeMsGOVIJ5OK73VONOmIwCF/CuFskY+JL7ZZ7pRbhVm29RjOK6KHwyNqfwlx9QngunAkKMhxjbx+VWiRPMJWWMAYdnHANY2kW+qT3TDWAkjFh5YHUj39qreM4tTvJhp1j+4gHzGXPH4VsoLm5dPU13sktTp7u4F5bvEpb5CHB7MDWZqMZBiV+R0zTtJs2sNLjgfdKyptLufvfSn3amVQh5Y8D61FktFsVC0ZI4TXxdJdn7JEPK7lTzn0IrPub7UYWh8hba4YjLxuoDKf61vaw4VminDJuG0uK5iNLYTFFvYXx13OBg12waaKqxcWaq6xPCM36rC552qKsRTrf28hjJ9DxUhMF1Gv2iO3mdRj74P61FNcw2rLGFWBcZUIOPrU6dFqMq2miXIuHuFO2HIb5m5z6D60VbuLxY4xJkKvsepoq1zS1J0idLDavcaLPYTks3342HQH0pdK02a60tre/T95buCswHJU1DY/akvnEylYSM8dPbFX/CXiqxv9R+x3eYiX24bjdWEublbjr1NZ2jqUbjRLK9jksNXmieXOYSpw/1FbNhbtbWQtpHMoSPy1Zlyx9ifSo/FWgxXlxCRIYrmzl3xSKcZXritY4Z4Tn93KAcj1qHPmitS4b3Oa8GX50HxoulXKsbedt0D/3Se1eva7apc6a7Nw8Y3A1xb28EmoRXJRHlWQeWxUf5FeioQ8CgruVh8w9M1zYid5RmtzkxL5ZqSOFSSWKP93IMtxhjj8c157/wi2taj4y+36jJthi4Dg5LegxXpd3b+TcS27gMoYlSR2qOzhZo2Ync0Zz1xz61rCq4XlHqaJpor2ZENx5kxOE42hcZ9qng1eG5k+ymRFdiWCqcYU9iKyfs8w1VnSdxE6lWRjn8RWX4a8LTaZ4hnu5Jd8bqfLJJ4b3o5INNtlS31OhuLPbMqQuFVMuufpTJUeSJfPbfGw+VavzL5UyqQrfL8vp+dVpm8uASE/Ix6MelQmCkc7q1kI/nXgkfMO1YGoTT2enGeGIK27acdQPWus1hfKUrsxCcK7k8AnnFcnqltcXJKQuYdnDgjgit6TvudLu43MvRL6+mlm+1uGt2HKf3q24cRqRFGqBvvc81zsNu6TZSRi6DABH8qsvrMcBS3bM0vRjjj6VvKN3oZppIlv2ghnQtuZ26qOAtWjv2qYxlSOCabcRxXCxtJ8rBRwev0qnc6pbqxgVyrLwDjgVKu9huy3NBxvi5Iyp5IqCfzdqysiyjPVTgrSxMwiBLKSwzkdxUkTlHIk4U8DHalaw3qLCIL6wazIKS4LIc81y0tudNhlinm2q7h9x4yR610l0hinWaBsMpziq3iFINU04xmMG4YF1THJ9RVRfK/Jmco31JvC/jlLac+XdqSRh4WPGB3FHi7VdQ16JTF88UfzJ2BrzLV9NmSyzb2rC4U42ohBIrvPBeuTQ6UI9StJDIqhSFXOamrSiv3kNy6FRRneUde5zOom4MkS+WDKhzuIOFPsK1VS3hS1aVR9o8plhQn72fvE1Z1e6xPLOLMqr4IVhgAdyaxr69FxcWk3lLtUlXkx82z0FaRTaSsKvJObe4pguVvobpiYp4mU8DCkZ6Cu0u5mlt2eNtynqR29s1yd0JbyVFWRxFn5CVwTWzMrIsMEAJt412rg557k+9EtbXMo6PQs6USsExHJBOB61OswdVEwCseOfSmQKttbbGwGzuPPUmozBHLMssjsQOu3ms3qzX0Kmsac9xhYXCf0pqNJp2mLGZy4XJBxnn0FWb/wA/LSW8giVeh46UyzmSRCtxcRSMT90jmnduJOl7nJSWH9rXUT6jPdXSscFEbaoFdn4etdJ0a9T+zo49yn5lyTuqnexMgxAo+bn5OBWfFPNbzqoNumPvEDcap++rdCLcrPUQWIjkyBvO9WA4Yd1xT3FtNOGnTdkfKP7p9qzvCc8VxbvZ3ZO9/mhfOQD7elVtU1N7C/t7XY8rSArhBwvPLVxqL5nHqOdmdH5ka6XcLNKu92KovQ7azreOW3s4hE7PGozx1HNTLBi2Jkj5Uj5jywFWbK5iicrIxCFcKfWl8N7anOQLdyrfoRw4QF8/xDt+NV5793n3wqGG4tz1X6VYvJ7V0M+WhlAwg67vpVDJEWIo23/Trmqik9bAkja0+e4cySEq7qRtHWqkb219qT+Z8su8bV7k9xVvRrd4lEpctJtO6P1rEhOJpCx2yBzk9xUxSbdg3J9Yhhtr9y8nAXgIfu/Wq2malcxo4tg43tnI9ajgtpbm4ALfM54ye1XII72x+0ruTbj91GCM57Zq9FGz1YW6Et3rF1a24N9NszwAeCc1wNzqOtadrlu9wqT29xJtUrztz3z7VvxaFqs10LjXrmNFzuRM7hWp9rt4ZljjsluJBxzz+Qq4csNkmK3YgSe8hmLtKu1TycZDCtOO5F0VkZPLt/vsW6kCqV5qe2QNeJb2/tjkD6CsfXbq8vL2FdC1OJET5Jty58wegHpSUOZrSwnd7HVXt3BqMW5IpEWD5gr8bgRwa39ACjS4dpyGHX1NcfIETUoINwWCNAzHPBYj/PFbGgara6bEbK8l8sox2M/3WB96ynC8bRHNfu9DqM/Nk4K4xjpQcD1+vpVe3uIZk3wyRyIf4lOanPJ9+2a5vU5TJ1uYh7WLBZXfkDvRZyRteyKChK/J8p6Vn385bXJSGz5Ee3kcAnmmaNsiSSedgeQATxxW/L7up1qHuXF1nfa3LYACsNygdPpms9ne4TCRnOOWzgUmsaxpx1VImu4lyNiRs33mqO7EcTD7TcrC2NzbumK1jFpK6FCVnpuPjV52QP8Adj4znoKstGssm5WBjPT2ArhItd1a81K6TSYbVreBtqPKxyR6geldLocmoPCf7YWETElR5J4C+/vWk6bitWiua71KGv2bX6ShCvmAbj2rzvWPDNi58y+njt5n5XYM59yK9fmh8lt0g45B+hrkNYsoLp54pYFmKA7GAw3TOB61dKbWiN5tSWhynhTTLeykfaUnfnbIrHJHpjtXQPD58Oy+jk8teVkXgr+PpXMWmqxaZdFZNOljAGAWBBAru7XULS+0VoJiyrMnySY5H1rWpzJ8xkmrWRmhITBHFE24J0z3oqOCyhtGAgfLZ+Y7sj8KKG7FrXdHQtqrQSmJ4ycc5FZWorCZre/0iB5ZN2Z0A6HPYVfvYoppMRy+VMv6/jTbjUYtLixGUWYjLkDk+9KOjTitTaWu+x6HbmHWtMDtiO+hQb489R6e1SW1oy2aSsMRZwnsfevNfA8d1baw2p6fdNNBISLiFzkkeor0aXVrGx0rGoXYghZ8oMckn2rlq03F8sdTJSlFa7GbaXN3N4inRR/osQC7cfeY9xXqcIYQx44cAZyOMd64O1tx5B1C2ZRhh25J7V3VlMZ7WKXgFxk55rnxD5rWMMVrZo57xIgTUIiJNvnDBU+3Ss8SCEuTt2bSPfNaXjKzMn2W7B4jbaf6VgTvOzRLCFdlcZz6VVNXii6dpRTEhudjElQwPc9vxqPQ/Edrrkt3aWAMgtG2yPnC/hV+NJ5A6SQKpkyGBTgA/wCetSWOk6XoFlJBa20Vq0wLttbJZv60242d1r0Kqu8lYlvnikhhaP8Ah/h9K5bxebpLVFtGVY5ZQspPOweoq5PqkEd5DajgnBJz0JrYitbXU5GjkABA3DngkU4/urSewNKO5yvxDjay8Fia2lmutrI+087setY8Gopq+j2+o2mSsy+W7KPuN6H0rvJxDdQGCVI0k6M2coR34rnNP0FNIkuv7P2fY7rJaHPCsO61pCaUbPdM0pSd9djKUR2VmgmA81/m8wjnHtVUaXZPBcXEBRbjGUIPepdbimlceWTubjnsB6Vim4h0zMUjGSVuo9K2UXJXT1NJe69Sml4LWZ2mYyOPvKDk1NeQ2hj+0yghWGNo681ObOCSP7THCQ2dxX3qeS0F9ZbrlCAOAR2FaNrcmz6i2bQzWiLCpEedq5PSpy4j8wMoMeMEdDS6fDbW1qUCkKoJyx6N61Xa4t7hyFlRmHYGperHfTUekiTIdpJXtngiqtxcQuWUFHYcD1qdI1aRliVlZhgnsKqR6KsdyHuJQIifm8r5mb/Cj3eom2jD8RxqRCryXEZdc/upCOPc1RstVn02P5HeSOI8Z6n612d9BFLKSsUfkD7iS8nHpWVqpsUjjSSzG1jgLEvXPaqjK+liZR6sj1DXr3V7cxWcajzVA3nH3c8/QUy10uKCHDsWyMcipbNbWxUoIPJC8lPSrVxdI0WQVVcfKO5FJ6aRVkOEUtWxYIIVClSx2/dA5xVuONDliu3HYViTXTwokitgyAnIPSrOmG5lh8yVSozwD396Ti7XuXdXsQ65HLIw2pJ5BbHy9d3vUtmtzFbxhsqep9BVuSeOOT95IAxqfAMX7xv3bDgjuDRzO1hWVzNudRtJv9GkY5P3zH/P6VDt0/TpGLSuZB684HrU6aPbRyCVnbhcAH0qndJp91PlopXfOMjgfgKaae2xDTNCCwFzEZ2lknikGRtGAPSsW4l+wTuw0S5kUHO6Q7Qcd+a6GTUrXQ9LXz3eODbtEajcxrMtr6x8T3KR+VdwoBwJsqrH1zSjzatrQib6dSXw/reo3WoJvt7e2RSGVUlBfH0r0k26STtGVBVk3hh1GRXCWOj29lf74bZ3aNsebncB7itr+1ZrfxRaW0oP2GaPy43HXdWVVKb9zsNXjH3jeuBdLChwREF2c+3rVa1mhkuGeNwyAEAjnkdqtSxsiTxYfgZLZ4Nc1oNi2mvNEJTIZJWkUMc4z6VnFJxZNuZG+EaRt0kS4B3YzwB7elX4ZY00id7hNmH2oSep9axxFI8kalmctywHRRWzcaG/2dJ4pxIrD7jnbjPepnbRSZiyDTNQSDznDtI+Nqkjn8TWWZl3SNIWZi2OOta/2CVbVQ7RrCvUqQSapbYnmMUBEjryWxhB9TTTjdtDVhtp5NxFeE3KK0CgSID8yen51Y0e3mubxvMjRCo3b5R8xBqtomh2tubu5EhjjupN0jSNkuR2HtW7cT28kZliZZp4U6ICflHX60pys2okpt6EVxFiGYysTg8HPWsvSNNNxFcMk7QhgR5gHP51p6bdxa1byTeW0RDbFD1XvXksRLZKFU4yGLcHPXipjezitypKUHyvcpRaHblDGBwQWZ2Oa5XVdOvE1KKy0a1jiUfPJdcjI/uiu60+SUWTGRCwf7pHp3puowt5MTQrtJztb/69aRqSjKz1I30ZxF1pt8t1HJZ6jJEgIabf8272Arqby3/tWxiiurZYh0yoxuGOvtVy1trfTLVnu182dm+7wfpSXd6FWI7gmCS0WRz+FOVRyat06h10MHS47nw9DLc2vmG3Bw8a/OVx6itXTfFz6vExsQjbQQ6gEN/9ahjG5lmgSSBmTBkUfdP0pthFbWYlktrm2EzD94ygZH1Apyakm5LUbSvdot2kiWwla8UsXbJJPJyOlQXc0EUa+XIJNpyqkcY9KkaKK7kRN6Opbl93zc98elH2E2210hMuDxk8fj71npe7N4TildmNHZ6dJf8A2+XS4hMpLecexPfFTX6JqdtLDcrlJfukdTRPbSyys3zR8YEZbO7P9KtwQzKPLtxn5QWPXHqK1b8xNxeqRz0HhWO1uoZrK4fykPzJuyD7ZroLKCdWZ5EADHAqWOJEtiZCqq4+Xn9TVe633s4MEhUQ/dXs3/16HJy0bJtf0LViSzztOvOMDPauf12wF3ZOIgd6gltvBI+tbsUEkUDtfEB25Xac4+tZ864DeUc5HzD29qFpK6Lp2eh51PqHiJWZIYLWSBeA0uDj8TVnSJdSuGJvFtmXsqEcUniSI/Zp1djEqnG5Tg81yWlaBc3NwvkagPmOW2vggV2JKSu9BSXJLQ9Cu1klt3jQxRTKvykD73tmiqwRILdYp5C21cZZuT70VEWNxNnVY4rWUTXBKc52+pqhrckl5pwu7OCCQxthvNHatu6tIr1dkzEuB64+tVbh20/T5TIirCMBVHJaknt3N7X0ZkaL4oktlEMmkwQybgM2+Rj3rpPGt9Z3/hWW4a0kluYnUjHBUdyK4/Tnv/tfmxLskcHEeOg7E10thqaGdbQN512FO8gfKfb6VUopSUktjNJNctzf8H6zBf6JDJFI/l+WI8N13D1rtvDuupBH9mvCQo+4/Xb7GvPJ9NGo2CSaIUstXtiZESMbY7gd1I/vVZ0+3uL6eDVIrgRoy7LqBzgo47Y+tc1SnCabuPlUlyTR6nr+LjSJ2hZWIAbI54zmuEt7vU7SCaZoYhZR5Ky9WJ9a2dJ1L7C4jlbdbSoNwznPvWJ4tj1CDR510GZZ7VzkoRlkHcY9KwpRs+R9SYUnSvG1xvhvW9U1OymlvvlMzMIwByVq14m8M3Oo3FjfiWaCKxizwfvnvkVleDZFjs4t2dsa5GTyrd/w9q6eDWrqXzvPQtayH5jjO0f4VpO8JN09Byg+ZcqOEjC3Vjd6zFHm4sgdyA8Y7Vs+D9cbV4kmhUb1cb1Hr/hXP6vNc+G/E80tsEl0fU02tGB8pzwR+FWvC0Fr4X1C5tUnDNKwkiDHGARwPetpxTg332/VA1KbszqvE9pcXMnl2kgsY87pZTyzD0Wo7CAW+mrHvYrD82+Q5L59amEhKBThmlOPmGcE02K5k3fZwVLcpIvHaubXlURwsvUybuFJYXmC5wegGdtcT4pgkDL9nhLSSfefHSvQdJ83ULq8igAjW3IQE8bj3qpqunFJGWcbX/r2rWE/Zysa3UvdZxMl9LZaVEN3lhiBvI5PvW3JdRLbRtG2FYDG7+Mms/XtNMrRm+iZ0X+NTtFZWmaousa0mnafATFEMGQtwoHet7KS5kQ/ddmaN9KgzC24LIOueBWHBaKl6St2jfNnj+QrTvdVspdWfT4Y3mRflac8DPsOwqksVvcecmluZLpejdh9KcW0uwm1LVFrVfO3okBk2lRnHrUsLywBVnyQBznqKx7az1G0Anup2YrkMEbOfrVqxvrieYC4jxFtyxYYw1Vy6aCT11NEu8is6tuyejYFYF9Bcte7vlKHOST/AJxitK9eVMmEZFVXvBDpzz6hmNlbCjHLD1xSimtinbqSvFE/kCVtwiTaSejn/ClaBLmTYpVVAzxVeG0F7Yx3tvMGgkOAzcYI9qtxNHuwHUt0yo60mELdCeG2i8kDAZVHcVTj1BGd0jyqqdpOcflVxG2qzIxYqpOF/lWENR8q7wsMQPBJ254J/nRFXCUrGq9qkrA5xgYPXmrFtGYYdkTggEsc8/hVW/cyQPFbTASDoTxk+9ZVmuoiZUlbCdyTnJoSutRs6C5tjJFudtgAzxzWRb3sUMTpbySCQ9Cy4yP6Vt2RQW4S5yX7lTxjtVS602xzvWJmdjwqk4/GkmloyZJvYzrK01Sa5DSDeg6mUAritXUdQisrfyruJl2D5GRSzk/7Kima39tstMBs8+bjAwckLWF4fttWupw7uy/MC0jnmmrS95mck0uVFm21nV7q6j3W9zb2J/ilH7xx6ADpXVuL1dKItLM3FzG6yRrIPmX12+tQ6nqJ0W1WR4pLqY8RpGMjPv6Vztp4wvLu7jh8lmmDfvHVsLCv19aVnU1ikTdR91s9OTzpoEOCrsg3Bj/P3FR2481RMyLuiyoZf5Gq2gztettEoeRhkbv4v/r1aRXhlk3NIoziRF/ka5bcrsVJW1Rr6AFiguCYxvbsTkYqtrMk0TFgryA/cYfdA9KZC622M5ff1B6VZgvVikIXIUr8ynoKhq0nIxVjLUxnTZBIGSWI5ZWbhgfWpbK+AtZIJI4VDrhRGOgqa8jhvbZjPsilBPyKcb07E1XtpbS3ZiqlZI1HLYP4Cq0a2Lck733Lt9cW9ubE3AURRqPz9KuLJFJCt0mNpb5RHxiuc1CEX7GRGICZJUnpVnTfMltTFGWG7gexocE4pmbjY2QEu1d9PbKk4b5ehHXHvWQdKurjVjJOhjsyedzZO0ds1p2chitVt7XaJlJUqBjn1qlo91He3c1vqT4kjJwCcZPSlG8btCbZr3+z+zpFg/dLjGc447jFNt/KSO3eQp5eAAGPWqF/cOtkLZYzJcglVLDjb65rJ1K6h0exe+vy126Lt2L90H0FTGndWJ5Sz4htzeiSC2uGigXOWhUFgT2HpWX4f0Sw0y9E0qSvMB96RzIx+pP9KdoPiu31C723Fu9pMEIi3j5GyODmr11DKbCaSJ1u7+OE+UmcKG/rW1pwXI9A3NK/uZpUBsRCbBgAW4/EHvXBX3h77JqIvNEnNo7HLo+dsgzVnwtPr/l6k2qW1qrLFvijiflnHY0zTL7X766CarpyQJsO1zJkE+gFaQg6bai1/X5kp90dBBOqkgEK7ABnRenrirVlFM1tMftLRRDoj91Pr6Go4La6Nu0clrGUIyGB6/SopLoEeXIrllGxhjORWbV9jS5k+HfDdzo2rXM1xfm5huRuiR2JCjPJrpJbmR4mgjt9gzlpcYyvrVCJTHcQwyzNGrHIUen9KtPLIDNCkYKBvmkfP9Kcm5O71YuW2gt5b2zfKkgUjBVS2dw9PY067WJNME1oxVScFiMEHuDVWCF5FkYrEEXGGyevvWlqKCaJFgj3pLgkJ0VqT0a1KUnsZySxybUY+XKRkEnJNNZjLCIvLUbSMk8E1T8Q215a2hOkos0qkHDL6dRVjVEltNKgvLgB2KAuAMEE9vSqsmk+5SlZ6GB4s02LVLdyqAOeGAOCMdxXHDw3aWUYm+1zoyctuGBXp0Qhcq0iHyp1w2eqmsDW9KsoQ8d3chUYFTubCke1aU5uPumzs9Th/t+n6heMjzyKzHA9D9KKtf8ACJ2/mrJZlZY88MhzRXRzRWzMdTuDdByibGWaVd5T+4vvVO4vYWtZDDLkL8vI5/AGpp7Vo9Ou2ty5upcLuHUL3xVWw0jNltv/AJpDz8pwcDvWa5bXOv3r2HaW0lzZTIg2KWC7z1OaZeXx0zfaaJarLfSjEt5KMhB6LWZFfXcuoxW1qpS234IPYepp+q2WoanqLQwXAt7OMfMc9vem0k9diUrq7NPSdbWK9giS5AuF+84HBNehR3cGq20ZSJBd9XKrhnrySB7DRZ4xbRPdz7sCU9B7gV1egaqXvIluFMcjv1zwPrUVaSfvJDUrs1PGDalpGoabd2Vu9zpE/wAkyImTE/QmtpJ1jmjZMIMA46E+tYnjvxJrXhaWwutOuVk0mU4dvL3Ip9Cam165bV9Bs9Tgl+yzyMU2oPl3AZwPY1jyOUIt2s+v+ZNGt77jIoa3cS+FZr29EJutNu2yQn/LFuxrttI163vNFtbiBUuIZwA4HT3H1rmPD17HrOloskW+OXMUsbjI3DrWrFaLZ2DWumWyRxIPlT+EN/jRUSa5ZrVDlD3ubdMreKn0zRoUExDWcj7o1YZ257fQVyHi+xudfntL3Tmj85FCb4+OnTitTx9HLfeHtP8AtFqbaRHZCvpitPStP/sbTdLcFXdolkcNzz701+7ipp66m2H5anuTV9DSsvPj0uOKfBugoVz3zUCaVbBzORIlyuSWDH5j70mvaulr4nhhbb5dzEskbL3zXR20cV7C/wAhaRFDNj+VZSlKKUu5zNqLsc5FI9tcNNAo3N8xI7n1rRiM12ks1yFIx07g1DcOqXG0RLEhGCBzgVIwKjar7HH8WcZolqOV1a5n3Vta3MU9rcoTDMpU/wCyfrXGaVo0GgT3dtaIxeVSm88sQa7zb5zbHPzHjp1qFbOOWQwOSrtxyOvtVKXKmuhpFp7nnieHVVSomAeVvnfGc1nXNheaaskViypbjLNLn5iK6PXtBZS/2h5rSFCS21uo+vpXO6b9hEhFglw1wPlDSMTn8K6oSbV73IkknYqaRqMqSBFhkmL8O7nArpd1qYCxB2j+Lp/On6faSPE634RQDkYAFUtX0tpIAsbLHEwK7f6ik5Rk+xSTiivbea0+5yfIP8QPNTXUcVwqxTDco7GqdvZNZxFXuFII4HQVft3JsY0baSCSH74pvuEexFqEKS2MUQBTZnATp9MVXsI7eCNhISn95iakGowTTpbAuxdtoZV4z9asPAF3xgjk7WU85+tJ3Ssxqzehjf2lF9r+RSE7ckmtcw28aB/LQN94P3FVbSC22F7dB8rFGG3lWB5Bp11DJ3bjoFPShtPYIrvqUUvLdZi4kY85zjj8avxhXYnblhzuHQg+tVY7CINlokDHrj+dXjayvAyQI6uemBkfjRKw1dDZJIbJfMvG2BhgCqN99qvdkumTM0ZPAXjBHXNVxElzcOl/IxYnA5xyK1TaRNavbWhNs/3vl6k+tPSOpGsiWKCe4sALskSjhmB/zzT9K04Ws7MZWKnnBPeqOgWV3aXi/bpwLVQS2SSWPbFbdvvnm3wnchJXbjipkrXswWq1RVuNRkjl2bVZc7RkZzVmFLK2t1zbRxbzu8tF+8fWop5tiTfZI45LlTyBzVnQ5XctJqirtzlV71L0VxD5dTnju7URokMQO7A4H/666hbuK8Z2h4kZAWTupH8xXBeNdQihtxPlQkJPloOrN2rK0nVNQsrK18yJ59RuWMhUnGwHoKXsueKktCG0nZnplzNILaSKNoxdOu6N255HtVXTdXuLvTniuFjW5gykyjrk/wAX0qBw19aIXfy7yPBVlP3Wq9b6fBJNHcunl3TR/vSDgNxyKy91LUl07O5m6/b3E9lMkLsqSJs8xTyPpSeGtGuYNPWKSfKg/KX5L1txhVtjJtMihTkdiB2pdN1gXVtHNDAkcJBBBHC+w96OeXLaIT9BtpbN9onR1ESpwd561LJbR2spL3HkDruQ5BFKpubuUOlu6wjq7dB9aDFb3d40c5Vo4s7jnAY1DeupDkzIOo/ZL9vIWSTzOFbPJFMmsnNyLvzl81udq8tn3rTubiymnkGniBpUXB2kcewpmn2t18jCJyHJBbgBB/StOayvsK/UqAXRb55unBDZ4rWixc2IhlQFexK55q1AgiaaRriN41XbjjGe1V7+4WSVHgJVgP4qhty0RN7soyWTLFJFcWolOcKOAqj09aW30yQqZLdRAAMbVJJJ96zdeuvEJuoF0OON4G4mLjLA/wCFdZa6oLeyjjuYQlyygOijOWpy5opNW1FzNlOx06VITPJCkj5LBc4yaC/lRpJdwKFkPCY6e4NNa+lnUZJhmUnanUVBqN7fPEXsWWWYD/VsBt//AF1PK29R8rZbuH8qFtgbnlSDmuJ1vxFq2l3QMdrG1uTxIgyfxrY0eXXH88X9sybTuTIGMdxVu5uIJVxNZEOBg7Wxk+taRioOzSYKOmqOSuvEzWgW6vF3yP8Aw5ywroNHv5LwKzsV81Nyjoce9UtT8JWeqKsrI6sOR5bYP4+tRanDf2d3ZSWW2SFAI5QR8xB4zWloT0W5t7W20TqLSfcxgJVif51NFfPZXJgl244+UDGTVKS0VrYB2KGNg3mRnkgetRas6yRJOOFXhT1zisuVSM3Zst6ld7AZHmVY+SUPUfWqskvn2fnSNuiZdojHKkemKqRXaXmnGCeHy0cEFT3PrS6amxfs0ULOnUZNXyWWokidlid1GPLi2A4PIFZGtaRFqSfZ7xS8RGOD+tdFttiyStGEZeAhPH1NZmtwfb7Um2YwSJ80LKc/MP6Uot3NYyZwUHhmHSJnmtZ7tNmTtE2FxRXQWV//AGukkV9bCO9iGJApwr+4FFbuT+3uJRXRGjbXCSQtJg4zgjPSiRmkwoGGIyGA7VSnuFsbYCFd4B/i/nVY63izaZ4iHU4C54Jp8t9UdfNbRlpQMSBEEbAcyDrWW1usVvLLLM5DD7idWqs2tXH2EyiMCSVsZ68VpR/a5rIm48tHKjcwG35fp2OKqziJNSdjN04oDuSJEA43E5atrZHKqmMqgPJyeTXNRzQyStb2+WfP4ManhWS1Jn1KRVQnCRA88elU46ijKx0iatE2k3+m3iGXTpVAkVuxzwR6Gu68MaJar4Vt7Bp2l058ESN/rI2HQ/SvLJNbtTpLzrYNOqOAqr/ET0JNegeGtWMunDzYXilnTJjzwvHQVz14S5dNNSXFSem5maZplx4e1S8hmPl27yF4xu+8c/eX612UdxFPbq8ZAkBw6k8n3rB8RhvEvhBmsopf7R0qUS24AO9wDhl/Kqv29ons5CgEcgAG3+Fv7p9DWck6iu9zWn76cZLY63UpNK1NYNI1KcR38q5iVup9Pxrldac+H5rOG8VntlJDuvXaPQ1F4l8O22vG0vYbyS2vrRt4fPQdcEda7W6stN8YeG1jWVCyr99SOWHUipTjTUb6rr5HNzypTdjD8S6foeu6fp0tq1ws0P8AqZI+u088+orofD0kcc7IWZZGTZz/ABGuV06OLwrb20F0wdEcsrSfdYZ6e1bOr3KxTJqMA8mNsOSDkK3Y/SplFtcid10NZ0k4q27K2o2ps9REUnyhieT3HoanlZWSFBhjg49cVf1BodVgt7pwAueoGfmx39qyXA+0JEv30PXt9aIu613RlJuSVyRXa13EkJxnBXI47Vm3NxIzF9xR85Ix1PtWvKpe1YiRiufukf1qC2thd33ls2NibhgdPammlqyU7asqXLPcRFNQXKhcYI5rk7yySxz9khECYy0irk/TNdsJcxMsiCUhiN56ge9Vhbx7zDcHMDnAZe2fenF8uxupJK0jxKS41SXW2a5k2BG/dxu+A2O+K3bOHUriU3OoSqwwQsSdB7mtbxZ4bSzupDbbcgFmmxuyK5HStTkimZU+0XAUY2HgGuxS9pG8SNIPU6e+udFMcQa4JnUAOCcgU7zoWtFWxx5OMhhyDWBd6WpAkeBIN4yQSOPzrUZLfybe1+0JHxjK8Co5VpYqLfUqzMlhAbvyw4VtoC9c+vtTdL1Q3955bwNCOhl64rYextrFFPmCbPLbWzgUxL2znlMFpbGEgcsxzk073WwddyZYTGAdkh3cnIxntmqzWLSKTtYEcncw4qZQskgE7uI+hYHOKpzaw1tMYrO2coDtyRkmpSfQqTsVbq5vI9RZYoGeIY2EAdKtaZr0K3ptbxHiHA3Buh9Dip7+/HkAwZmkIH7vgc96z9OMk1z5tzpgicdJW55+lVZNaoV30Z213oOgyRx3U5ZMMD5gPDH6Uy70GU4nsJ1nB5wRgj6VBpki30RR1yy9U7Z9a2YZ4rKJYbkyGaJSVOABjsOO3auVuUdE7lWcWZs+mX80AF3boCASrscGs3ToGtJpUv4JQvVGj5596fpPizULzVTDeQx/ZS2zGOQPWtjUi25gVfaq8Pt4x71dpxfLIhS5uljnzpxhDXaW8qg5YHoDXC2E+r6hrks+ZUiQksp4VR2H1r0f+0jcQ+W0hSEfeGcdKztTupY0DWMaB2OCwXNaQlJboUoXOWu7m4QRtNapcy7t8YkXOK6m1MuoWUFy0EUF6RhynAPuPSo7trpbSEuY1Ur8wwMg/wBBVSCeaayuobC4X7Qy+vCj1FNvmVyeWzLmm3iwal9mWUyy8tIitlUHufX2rtrGVJoPNYbwOMdCTXlKQS6HYPb2rb7qRhJPMTx9Aa1vC/ihhe+U2CknyqD3PrSqUuZXiJS05Wd3rF1dLaGOziX7Ug8xFAyMfSpLCA2+hxXF2I4Z5G3GAep7+xrY0meC4s3by0M5ADD2qtcWQSMMqiSPfzlvmH/1q5FJfC0J3vbYr2TyQ3kyvI4JXmMD5SP8arXGmQaol5aLcNbC4UqJF4xz2qvd2k8F82oWlwzK5wY5DgD2FbtsIFgd5JNhCgbcZz7Gql7vvRZnJWWpzvh/wfZeGbiURFri7mXCtIeB9K17qFhpsTrcvGzjmMHg/WiacF0bezkD5BnJzVgWl3DbxnaS5OWBPGPeiUpN3k9SVYzTBm0jliIhIGJUAO360nlvIuzy2kIHBB4/H2ramkuXtHFzDGi8A5qT7NcPbAQhQiDOVHBx0ANLntuHMiLTrafy3MzpGFGMY61zmq3sQ1WC1TzZrm44EcSjOB/EfQVbv7fVbxvKty0bOcMHPQewqrb+HZdLuri9vJhJPMoVcnGAOlVBRTvJ69hXszYtNPWRhhkMsZyxbkjHvUFzab3YLsX5smQHGD7ig3UlpErjLPJ8pZRn68VFLd2aBEkhZ33AE7+DUpSvcvlbehO7yQh0Z12ryP3nT6n0qvFcW0MkhvYhuIGwqwIP0ParN9JpMSebexiOFxj5m4Pt71yHxCuYF0NY9NWU5kCxR28e7efr6Crpx52o23IacVqdnaT/AGa4C3UAiicZUlsg++aW90m4us4jjHzZ81MdK83Oo3PhTwraW+rRTXbTOZN3J8kHtz/Ku/0jXYp9It3jLSKQCMdxROlKPvR1ITfTcYun3zxpHGF3J8rEkDdUr6cY7HY2ySQZP3uB+FOnupWilZMKB82S3f2rh7u61yy8RxzWwe5tJ8c7uLfHUk1UISm7XsNye51K2ZWCSbylLqcKB0+hpsV49vBui2Fucgjv6Zq8upfbUQI3l7vvcYyR3/Kq13C8M7xRncrp8oPPB6fjS1eki15mBo+rxaxPPbRsoniY+ZE3GPxrbt7KaYfLhAe5OBj2rPsdEtrO5luhH5bMu5gvHP8A9etGEymUqzrswEUL/D+NXNp/CN6PczptGWDWIrq3wQ+6NsevrRWzJE2xWhyxznA6ZorJtvqbpcyujlJYEuYJIpFUL0OBUSWMCw+VsBixn5uaKK6eZo6kkVb+6gsLWM+QrFeI8joao6TfSaoJ2mQKFG3rnJNFFaxiuS5nNtTsWbOwt7SV3RSZO7GobyxtrieS7vCzRxAnavoKKKlN3uaWXLschda/O0w+zxiKBW/dQg4UD3x1NdboevzIsSTShro/MAFIAFFFdMoRatY44TknudzbeLVBiBjMc+fmkXvTLe+i8QJev9kS3uraQxzmPhT3V/r60UVxzpRjFyW507Si13sYU91deIJpUilMGr2TmKWVDhZlPTP4V0vgqxn8Gabb2l5Os888xkgK5wi9wfeiiipLVUuj1/C5hKnFyv6/mdn460SHxLoGYQquMEZ/hNcf4btr/TtLew1B0lflI/4sx91NFFclKb5XT6F4RK+vQ0NJvILRmtZg7W54AHVK2g0E19brbJ8+zqejj1+oooontc6MVSjGTaItRxZzzwRFtgXlj1JqlZ3ElnsmhwysOVbv9aKKI6x1OBarUtmNDO8kaDhdzcYC57e9UVEkF6zqqvGhyUPTBooqYvob3HeKbFWtI7hFVEbChQOme9ebXVjJaXTCOMHJxuBA5oorag2kyqesTH1Lw/LczFprk7Bgn/Cm3xu7S3jg06GFlC8SSct+tFFdKm3uDglsN0k3kEnl37rMZOw6L71r+bEshSPaHPAO3HNFFN66iWmhn3WoQaZcquqGRkZcgRcE/XtWnoeqRXQN1aopSM7dki5oopuCcOZmak+ew2DSrY3DXafK+7dg9Mn2rNk1DUjcbUtYxFv2M7vnj1xRRUQd3qaSjbY3jfrpcwEbBkkwVVgckf0rbW8tr6yaSWJ0k/h284NFFROC5U+pdJuV79B2nukUu9I41I45XO78e1S6r9qkgKSzhI5CAQgzn86KKzaXMVL4jD1XTvJkjgV/MjYZBHGfrUsNi0MZUMMKO9FFVzOyCSXLcp3Nul1bvGwxn5hjvVHT9OWO0u1ila3lZNqyYyT7H2ooq72TRjKKMGZhp0csF6zzvOBkA8L71fEdjFGLzSyZUgQbGZdp3H1BoordK8OY572ny9DrdC182jwW9w2LiRN5254z2ruNOmivmVVYhyuSMce9FFcOJgormRqneDl2HSWcF2rbE3JFnGeNpHeqhkx8owSOSSOtFFZQ1umZta2E1GZbCMXOFVsj5lTOM1P9quNqBmBTIYk8miiqsuVMjlW5EzzzJtchgDnGe1aUt8wSKNIQwX34OPaiipaTJsmjPu9UuYrO5aBE+0kEQg/3scZNcRpFlqz3kd54ivWuL4A7UU/IinoKKK2g+RPlW5pGlG9zqbdLqdVjJQKD1yeRTb66ttISSaePzQgOVA60UVMfenyvYIrmZ5bdx3PjnxIzrNJb2kZysW75UUdhXotxZXdjpERsuBH7jPsaKK6MTLllGC2RMFZJ9zAv7+8k06a51FVkMYzk4O78K5XRdah1Z4oTNPZXQJPnQ/KuPTAoorfDxTi2TXdmkd/pd7Ndq8IlV4yu1iAVyKvW+nQ29oLW2LLCMKQTkj8aKK5qitJpFKz1IpbTNlJGrGJycBx1UVSu4tSSJf7PlUlRtAk7e+aKKUJO1x2uzTVX+xqL5l3hMyGPOGrMtNcsr6eW1svMEgGGZhwMUUVpTgpRlJkrdI0ozJEUDBzGc7n3DCnHp70UUVhy825tJJWP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Partial thickness epidermal dysplasia is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11974=[""].join("\n");
var outline_f11_44_11974=null;
var title_f11_44_11975="Epinephrine auto-inject PI";
var content_f11_44_11975=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F75436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F75436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Using an epinephrine auto-injector",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photo shows how to use an epinephrine auto-injector. When using an auto-injector, hold it in your fist, with your fingers away from either end. Press it firmly into your outer thigh and hold it in place for 10 seconds. It is best to sit down and if you feel dizzy, to lie down. If you pass out, another person should lower you to the ground and raise your legs up to help blood flow to your heart and brain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11975=[""].join("\n");
var outline_f11_44_11975=null;
var title_f11_44_11976="Meperidine (pethidine): Drug information";
var content_f11_44_11976=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Meperidine (pethidine): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?23/46/24293?source=see_link\">",
"    see \"Meperidine (pethidine): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=see_link\">",
"    see \"Meperidine (pethidine): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F192763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Demerol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F192764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Demerol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F192784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic, Opioid",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F192767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     The American Pain Society (2008) and ISMP (2007) do not recommend meperidine&rsquo;s use as an analgesic. If use in acute pain (in patients without renal or CNS disease) cannot be avoided, treatment should be limited to &le;48 hours and doses should not exceed 600 mg/24 hours. Oral route is not recommended for treatment of acute or chronic pain.  If I.V. route is required, consider a reduced dose.  Patients with prior opioid exposure may require higher initial doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pain (analgesic):",
"     </b>",
"     Oral, I.M., SubQ: 50-150 mg every 3-4 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Preoperatively:",
"     </i>",
"     I.M., SubQ: 50-150 mg given 30-90 minutes before the beginning of anesthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Obstetrical analgesia:",
"     </i>",
"     I.M., SubQ: 50-100 mg when pain becomes regular; may repeat at every 1-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Postoperative shivering (unlabeled use):",
"     </b>",
"     I.V.: 25-50 mg once (Crowley, 2008; Kranke, 2002; Mercandante, 1994; Wang, 1999)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F192778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=see_link\">",
"      see \"Meperidine (pethidine): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     The American Pain Society (2008) and ISMP (2007) do not recommend meperidine&rsquo;s use as an analgesic. If use in acute pain (in patients without renal or CNS disease) cannot be avoided, treatment should be limited to &le;48 hours and doses should not exceed 600 mg/24 hours. Oral route is not recommended for treatment of acute or chronic pain.  If I.V. route is required, consider a reduced dose.  Patients with prior opioid exposure may require higher initial doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Pain (analgesic):",
"     </b>",
"     Oral, I.M., SubQ: 1.1-1.8 mg/kg/dose every 3-4 hours as needed (maximum: 50-150 mg/dose)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Preoperatively:",
"     </i>",
"     I.M., SubQ: 1.1-2.2 mg/kg given 30-90 minutes before the beginning of anesthesia (maximum: 50-150 mg/dose)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F192768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid use (American Pain Society, 2008; ISMP, 2007).",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F5359939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid use in renal impairment (American Pain Society, 2008; ISMP, 2007).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F192770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in severe hepatic impairment; consider a lower initial dose when initiating therapy.  An increased opioid effect may be seen in patients with cirrhosis; dose reduction is more important for the oral than I.V. route.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F192737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 25 mg/mL (1 mL); 50 mg/mL (1 mL [DSC]); 100 mg/mL (1 mL [DSC])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Demerol&reg;: 25 mg/mL (1 mL); 25 mg/0.5 mL (0.5 mL); 50 mg/mL (1 mL, 1.5 mL, 2 mL, 30 mL); 75 mg/mL (1 mL); 100 mg/mL (1 mL, 20 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [for PCA pump]: 10 mg/mL (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral, as hydrochloride: 50 mg/5 mL (500 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 50 mg, 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Demerol&reg;: 50 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Demerol&reg;: 100 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F192720\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F192786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-II",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F192742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for injection: Meperidine may be administered I.M., SubQ, or I.V.; I.V. push should be administered slowly using a diluted solution, use of a 10 mg/mL concentration has been recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral solution: Administer solution in",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     glass of water; undiluted solution may exert topical anesthetic effect on mucous membranes",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F192793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in dextran 6% in dextrose, dextran 6% in NS, D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amifostine, amikacin, ampicillin, ampicillin/sulbactam, anidulafungin, aztreonam, bivalirudin, bumetanide, caspofungin, cefazolin, cefotaxime, cefotetan, cefoxitin, ceftazidime, cefuroxime, chloramphenicol, cisatracurium, cladribine, clindamycin, dexamethasone sodium phosphate, dexmedetomidine, digoxin, diltiazem, diphenhydramine, dobutamine, docetaxel, dopamine, doripenem, doxycycline, droperidol, eptifibatide, erythromycin lactobionate, etoposide phosphate, famotidine, fenoldopam, filgrastim, fluconazole, fludarabine, gallium nitrate, gemcitabine, gentamicin, granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), hydrocortisone sodium succinate, insulin (regular), kanamycin, labetalol, lidocaine, linezolid, magnesium sulfate, melphalan, methyldopate, methylprednisolone sodium succinate, metoclopramide, metoprolol, metronidazole, micafungin, ondansetron, oxacillin, oxaliplatin, oxytocin, paclitaxel, palonosetron, pemetrexed, penicillin G potassium, piperacillin, piperacillin/tazobactam, potassium chloride, propofol, propranolol, ranitidine, remifentanil, sargramostim, teniposide, thiotepa, ticarcillin/clavulanate, tobramycin, trimethoprim/sulfamethoxazole, vancomycin, verapamil, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Allopurinol, amphotericin B cholesteryl sulfate complex, cefepime, doxorubicin liposome, idarubicin, imipenem/cilastatin, micafungin, minocycline.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Acyclovir, ceftriaxone, furosemide, nafcillin, nesiritide, pantoprazole.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Atropine, atropine with hydroxyzine, atropine with promethazine, butorphanol, chlorpromazine, cimetidine, dimenhydrinate, diphenhydramine, droperidol, fentanyl, glycopyrrolate, hydroxyzine, ketamine, metoclopramide, midazolam, ondansetron, pentazocine, pentazocine with perphenazine, prochlorperazine edisylate, promethazine, ranitidine, scopolamine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Ceftriaxone, furosemide, heparin, morphine, pantoprazole, pentobarbital, thiopental.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Diazepam.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F192741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of moderate-to-severe pain; adjunct to anesthesia and preoperative sedation",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F803879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduce postoperative shivering; reduce rigors from amphotericin B (conventional)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F192795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Meperidine may be confused with meprobamate",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Demerol&reg; may be confused with Demulen&reg;, Desyrel, Dilaudid&reg;, Pamelor&trade;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - high; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Avoid the use of meperidine for pain control, especially in elderly and renally-compromised patients because of the risk of neurotoxicity (American Pain Society, 2008; Institute for Safe Medication Practices [ISMP], 2007)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F192782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, cardiac arrest, circulatory depression, hypotension, palpitation, shock, syncope, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, confusion, delirium, disorientation, dizziness, drowsiness, dysphoria, euphoria, fatigue, flushing, hallucinations, headache, intracranial pressure increased, lightheadedness, malaise, mental depression, nervousness, paradoxical CNS stimulation, restlessness, sedation, seizure (associated with metabolite accumulation), serotonin syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, anorexia, biliary spasm, constipation, nausea, paralytic ileus, sphincter of Oddi spasm, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Ureteral spasms, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction (including pain, wheal, and flare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Muscle twitching, myoclonus, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Visual disturbances",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea, respiratory arrest, respiratory depression",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, diaphoresis, histamine release, hypersensitivity reactions, physical and psychological dependence",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F192745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to meperidine or any component of the formulation; use with or within 14 days of MAO inhibitors; severe respiratory insufficiency",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F192724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS events: Normeperidine (an active metabolite and CNS stimulant) may accumulate and precipitate anxiety, tremors, or seizures; risk increases with preexisting CNS or renal dysfunction, prolonged use (&gt;48 hours), and cumulative dose (&gt;600 mg/24 hours). Oral meperidine should not be used since first-pass metabolism decreases efficacy while increasing normeperidine concentrations (American Pain Society, 2008).",
"     <b>",
"      Note:",
"     </b>",
"     Naloxone does not reverse, and may even worsen, neurotoxicity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypotension: May cause hypotension (including orthostatic hypotension); use with caution in patients with hypovolemia, cardiovascular disease (including acute MI), or drugs which may exaggerate hypotensive effects (including phenothiazines or general anesthetics).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abdominal conditions: May obscure diagnosis or clinical course of patients with acute abdominal conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal insufficiency: Use with caution in patients with adrenal insufficiency, including Addison's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Biliary tract impairment: Use with caution in patients with biliary tract dysfunction; acute pancreatitis may cause constriction of sphincter of Oddi.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression/coma: Use with caution in patients with CNS depression or coma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Delirium tremens: Use with caution in patients with delirium tremens.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Head trauma: Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure; exaggerated elevation of ICP may occur; may obscure clinical course of patients with head injury.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic disorders; meperidine and to a lesser degree normeperidine may accumulate and precipitate either CNS depression or CNS excitation (eg, anxiety, tremors, or seizures) (Danzinger, 1994; Tegeder, 1999).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Obesity: Use with caution in patients who are morbidly obese.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pheochromocytoma: Use with caution in patients with pheochromocytoma; use may provoke hypertension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary stricture: Use with caution in patients with prostatic hyperplasia and/or urinary stricture.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychoses: Use with caution in patients with toxic psychoses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Avoid use in patients with renal impairment; normeperidine may accumulate and precipitate anxiety, tremors, or seizures.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with pre-existing respiratory compromise (hypoxia and/or hypercapnia), COPD or other obstructive pulmonary disease, and kyphoscoliosis or other skeletal disorder which may alter respiratory function; critical respiratory depression may occur, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorders: Use with caution in patients with seizure disorders, may cause seizures if high doses used.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sickle-cell disease: Use is not recommended; increased risk of normeperidine-induced seizures.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tachycardia: Use with caution in patients with supraventricular tachycardia (including atrial flutter); use may increase ventricular response rate possibly due to a vagolytic effect.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction, including myxedema and hypothyroidism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Mixed agonist/antagonist opioids: Concomitant administration of mixed agonist/antagonist opioids (eg, pentazocine, butorphanol) may reduce analgesic efficacy and/or precipitate withdrawal symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects (eg, sedation, respiratory depression, hypotension) may be potentiated when used with other sedative/hypnotic drugs, general anesthetics, phenothiazines, or ethanol; consider reduced dose of meperidine if using concomitantly.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients; there is a greater potential for critical respiratory depression, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use in the elderly; meperidine is not an effective oral analgesic at commonly used doses. May cause neurotoxicity; other agents are preferred in the elderly (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfites: Some preparations contain sulfites which may cause allergic reaction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abuse/misuse/diversion: Healthcare provider should be alert to problems of abuse, misuse, and diversion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Acute and/or cancer pain management: Meperidine offers no advantage over other opioids as an analgesic and has unique neurotoxicity. The use of meperidine in this setting should be avoided (American Pain Society [APS], 2008; ISMP, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Chronic pain management: Use is not recommended for the management of chronic pain.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Abrupt discontinuation following prolonged use may also lead to withdrawal symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F803880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F192729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May enhance the CNS depressant effect of Meperidine. Barbiturates may increase serum concentrations of the active metabolite(s) of Meperidine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of Meperidine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of Meperidine. Management: Consider a decrease in meperidine dose, as appropriate, when used together with hydroxyzine.  With concurrent use, monitor patients closely for excessive response to the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the serotonergic effect of Meperidine. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of Meperidine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May enhance the adverse/toxic effect of Meperidine. Protease Inhibitors may decrease the serum concentration of Meperidine. Concentrations of the toxic Normeperidine metabolite may be increased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F192759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid valerian, St John's wort, kava kava, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F192732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F192747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Meperidine is known to cross the placenta, which may result in respiratory or CNS depression in the newborn.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F192774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended  (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F192748\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Meperidine is excreted in breast milk and may cause CNS and/or respiratory depression in the nursing infant.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F5989404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Demerol Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg/0.5 mL (0.5 mL): $0.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg/mL (1 mL): $2.47",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg/mL (1 mL): $2.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     75 mg/1.5 mL (1.5 mL): $1.39",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     75 mg/mL (1 mL): $2.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/2 mL (2 mL): $1.51",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/mL (1 mL): $2.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Meperidine HCl Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/mL (30 mL): $8.98",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg/mL (1 mL): $1.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg/mL (1 mL): $1.34",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/mL (1 mL): $1.38",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Meperidine HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg/5 mL (500 mL): $113.85",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Demerol Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $220.97",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $420.26",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Meperidine HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $68.12",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $129.57",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F192734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pain relief, respiratory and mental status, blood pressure; observe patient for excessive sedation, CNS depression, seizures, respiratory depression",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F192749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aldolan (TR);",
"     </li>",
"     <li>",
"      Alodan \"Gerot\" (AT);",
"     </li>",
"     <li>",
"      Cluyer (AR);",
"     </li>",
"     <li>",
"      Demero (UY, VE);",
"     </li>",
"     <li>",
"      Demerol HCl (CN, MX, PH);",
"     </li>",
"     <li>",
"      Dolantin (DE);",
"     </li>",
"     <li>",
"      Dolantine (BE);",
"     </li>",
"     <li>",
"      Dolargan (HN, PL);",
"     </li>",
"     <li>",
"      Dolestine (IL);",
"     </li>",
"     <li>",
"      Dolosal (BR);",
"     </li>",
"     <li>",
"      Dolsin (CZ);",
"     </li>",
"     <li>",
"      Lydol (BG);",
"     </li>",
"     <li>",
"      Meperdol (PY);",
"     </li>",
"     <li>",
"      Pethidin (CH);",
"     </li>",
"     <li>",
"      Pethidine (GB, HK, IN, KP, PK);",
"     </li>",
"     <li>",
"      Pethidine Injection (AU, NZ);",
"     </li>",
"     <li>",
"      Pethidine Roche (ZA);",
"     </li>",
"     <li>",
"      Pethidine Tablet (NZ);",
"     </li>",
"     <li>",
"      Petidin (DK, NO, SE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F192723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Binds to opioid receptors in the CNS, causing inhibition of ascending pain pathways, altering the perception of and response to pain; produces generalized CNS depression",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F192744\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Analgesic: Oral, SubQ: 10-15 minutes; I.V.: ~5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peak effect: SubQ.: ~1 hour; Oral: 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Oral, SubQ.: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M.: Erratic and highly variable",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 65% to 75%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic; hydrolyzed to meperidinic acid (inactive) or undergoes N-demethylation to normeperidine (active; has",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     the analgesic effect and 2-3 times the CNS effects of meperidine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~50% to 60%; increased with liver disease",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Parent drug: Terminal phase: Adults: 2.5-4 hours, Liver disease: 7-11 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Normeperidine (active metabolite): 15-30 hours; can accumulate with high doses (&gt;600 mg/day) or with decreased renal function",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Excretion: Urine (as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, &ldquo;Reappraisal of Lytic Cocktail/Demerol&reg;, Phenergan&reg;, and Thorazine&reg; (DPT) for the Sedation of Children,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1995, 95(4):598-602.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/7700765/pubmed\" id=\"7700765\" target=\"_blank\">",
"        7700765",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Armstrong PJ and Bersten A, &ldquo;Normeperidine Toxicity,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1986, 65(5):536-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/3963440/pubmed\" id=\"3963440\" target=\"_blank\">",
"        3963440",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Clark RF, Wei EM, and Anderson PO, &ldquo;Meperidine: Therapeutic Use and Toxicity,&rdquo;",
"      <i>",
"       J Emerg Med",
"      </i>",
"      , 1995,13(6):797-802.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/8747629/pubmed\" id=\"8747629\" target=\"_blank\">",
"        8747629",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cole TB, Sprinkle RH, Smith SJ, et al, &ldquo;Intravenous Narcotic Therapy for Children With Severe Sickle Cell Pain Crisis,&rdquo;",
"      <i>",
"       Am J Dis Child",
"      </i>",
"      , 1986, 140(12):1255-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/3776942/pubmed\" id=\"3776942\" target=\"_blank\">",
"        3776942",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Crowley LJ and Buggy DJ, &ldquo;Shivering and Neuraxial Anesthesia,&rdquo;",
"      <i>",
"       Reg Anesth Pain Med",
"      </i>",
"      , 2008, 33(3):241-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/18433676/pubmed\" id=\"18433676\" target=\"_blank\">",
"        18433676",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Danzinger LH, Martin SJ, and Blum RA, &ldquo;Central Nervous System Toxicity Associated with Meperidine Use in Hepatic Disease,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1994, 14(2):235-8.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ferrell BA, &ldquo;Pain Management in Elderly People,&rdquo;",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 1991, 39(1):64-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/1670940/pubmed\" id=\"1670940\" target=\"_blank\">",
"        1670940",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Golembiewski J, &ldquo;Safety Concerns With Meperidine,&rdquo;",
"      <i>",
"       J Perianesth Nurs",
"      </i>",
"      , 2002, 17(2):123-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/11925585/pubmed\" id=\"11925585\" target=\"_blank\">",
"        11925585",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Institute for Safe Medication Practice (ISMP), &ldquo;High Alert Medication Feature: Reducing Patient Harm From Opiates,&rdquo;",
"      <i>",
"       ISMP Medication Safety Alert",
"      </i>",
"      , February 22, 2007. Available at  file://www.ismp.org/Newsletters/acutecare/articles/20070222.asp",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jacobi J, Fraser GL, Coursin DB, et al, &ldquo;Clinical Practice Guidelines for the Sustained Use of Sedatives and Analgesics in the Critically Ill Adult,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2002, 30(1):119-41. Available at file://www.sccm.org/pdf/sedatives.pdf",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/11902253/pubmed\" id=\"11902253\" target=\"_blank\">",
"        11902253",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kranke P, Eberhart LH, Roewer N, et al, &ldquo;Pharmacologic Treatment of Postoperative Shivering: A Quantitative Systematic Review of Randomized Controlled Trials,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2002, 94(2):543-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/11812718/pubmed\" id=\"11812718\" target=\"_blank\">",
"        11812718",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kyff JV and Rice TL, &ldquo;Meperidine-Associated Seizures in a Child,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1990, 9(5):337-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/2350937/pubmed\" id=\"2350937\" target=\"_blank\">",
"        2350937",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Latta KS, Ginsberg B, and Barkin RL, &ldquo;Meperidine: A Critical Review,&rdquo;",
"      <i>",
"       Am J Ther",
"      </i>",
"      , 2002, 9(1):53-68.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/11782820/pubmed\" id=\"11782820\" target=\"_blank\">",
"        11782820",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mercadante S, De Michele P, Letterio G, et al, &ldquo;Effect of Clonidine on Postpartum Shivering After Epidural Analgesia: A Randomized, Controlled, Double-Blind Study,&rdquo;",
"      <i>",
"       J Pain Symptom Manage",
"      </i>",
"      , 1994, 9(5):294-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/7963779/pubmed\" id=\"7963779\" target=\"_blank\">",
"        7963779",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Miller RR and Jick H, &ldquo;Clinical Effects of Meperidine in Hospitalized Medical Patients,&rdquo;",
"      <i>",
"       J Clin Pharmacol",
"      </i>",
"      , 1978, 18(4):180-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/632364/pubmed\" id=\"632364\" target=\"_blank\">",
"        632364",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Olkkola KT, Hamunen K, and Maunuksela EL, &ldquo;Clinical Pharmacokinetics and Pharmacodynamics of Opioid Analgesics in Infants and Children,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1995, 28(5):385-404.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/7614777/pubmed\" id=\"7614777\" target=\"_blank\">",
"        7614777",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pokela ML, Olkkola KT, Koivisto ME, et al, &ldquo;Pharmacokinetics and Pharmacodynamics of Intravenous Meperidine in Neonates and Infants,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1992, 52(4):342-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/1424407/pubmed\" id=\"1424407\" target=\"_blank\">",
"        1424407",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,&rdquo; 6th ed, Glenview, IL: American Pain Society, 2008.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stone PA, Macintyre PE, and Jarvis DA, &ldquo;Norpethidine Toxicity and Patient Controlled Analgesia,&rdquo;",
"      <i>",
"       Br J Anaesth",
"      </i>",
"      , 1993, 71(5):738-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/8251291/pubmed\" id=\"8251291\" target=\"_blank\">",
"        8251291",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tegeder I, L&ouml;tsch J, and Geisslinger G, &ldquo;Pharmacokinetics of Opioids in Liver Disease,&rdquo;",
"      <i>",
"       Clin Pharmcokinet",
"      </i>",
"      , 1999, 37(1):17-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/10451781/pubmed\" id=\"10451781\" target=\"_blank\">",
"        10451781",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wang JJ, Ho ST, Lee SC, et al, &ldquo;A Comparison Among Nalbuphine, Meperidine, and Placebo for Treating Postanesthetic Shivering,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1999, 88(3):686-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/44/11976/abstract-text/10072029/pubmed\" id=\"10072029\" target=\"_blank\">",
"        10072029",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9608 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-1.234.2.38-35693F307E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11976=[""].join("\n");
var outline_f11_44_11976=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192763\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192764\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192784\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192767\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192778\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192768\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5359939\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192770\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192737\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192720\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192786\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192742\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192793\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192741\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F803879\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192795\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192782\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192745\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192724\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F803880\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192729\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192759\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192732\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192747\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192774\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192748\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5989404\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192734\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192749\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192723\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192744\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9608\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9608|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?23/46/24293?source=related_link\">",
"      Meperidine (pethidine): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=related_link\">",
"      Meperidine (pethidine): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_44_11977="Pancreatic necrosis CT";
var content_f11_44_11977=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F56043%7EGAST%2F66786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F56043%7EGAST%2F66786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pancreatic necrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDxCiiigAooooAKKKKACiiigAooooAKKKKACiikoAWiiigAoopKAFooooAKKKKACkpaDwOelABRQgZ+Y1Z/90E/yq/baNqd0u63sLh19duP50AUKK6CPwjqzLvYW8a998oGPwqx/wAIg6DM2p2qH0ALUAcvRXUjwpAGAfWYOvOIjS/8IxYEELrKZ7ZiOPxoA5WiunTwpE2cazbfihGabJ4OvCV+y3VpOT/t7aAOaorbuPCuswIXNk0ig4JjO6saWN4SRLG6EHHzqRzQA2ikBB6EGl7UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACUtFFABRRSUALRRRQAd6KKKACiiigAopKWgAopVVncKilnPRVGT+VbVl4Y1K5QSSxpaxH+OdtuR7CgDEoXLNtQFm9FGTXWwaRolkyC7nkvp/7i/KlaEd/DaxEafaQW4A4IXLfnQBytnoOp3iq0NnL5bHG9htA+ua0o/CUyki+vra3PYKd5NWZNQv7xVHnMyv1UHFQ42KTcOW7596AFbRtGtgokubm5kH3ggCrV7TY9LZ82mmJkDlpGLY/Cs9IxM+IkYnHzD+taVvEbK0bIIZwcqByRQBoXGq29sjx2kUSMOQUQDmsyXWLudiDckbRnA4zVTypjkxwSeh47Ui2c5yBBISeelAEkc7yIxkm4J4JPWoZwQAwkAJJwM1ai0m4MTl4H7HpVNrK5EpBifgUAPAkVT+9BB7U67nLKE2RnHG8ccVXlglO4CNw3U5Haog2Nu4YzwMjpQA+MyxEcgnsGqzAZFO5HJPqPXFU4l3R5fOV6EVoWcLy7NudhP5UAbGmatfQROu/I7A0671rzZQLtIJlx/HGCBSSERAqMbduQfQ1hTuzly4HJ4AoA0bm50qfC3Ol27ZORs+Xj6iqdxZ6BIAptbi3P96J8/wA6pAmHCt8x3Z+lLHKV3FkG3OeeooAtzaBoxVRFqFxHI3TeoYVXbwqjAi31W3kfoAy7c02Py5HBUnA4APrViyBW5dmiEgYZznAzQBRl8JaoilkFvMB2jkzVG50TU7VC09jOijr8uf5VttNMJMqGjj69akTVr5XVlmkUHoM0AcjIjxf61HT/AH1K/wA6QY7Gu/g1uWWKQXiRz8YXegNVWl0i4cG80uIt3aPK0AcVRXXNomiXG4x3NxbO33Q3zAVBJ4Rmc/6BfW1yAMncdhoA5iitO90DVbNWeexmCD+JRuH6VmMCjFXBVh2YYNABRR2ooAKKKKACiiigAooooASloooAKKKSgBaKKKAEpaKKACiiigAooooAKKKKACkpaKACiiigAopKWgAooooAKKltbae7mEVrE0sh42qK6a28N29iqza1Nvbr9miPP4n+lAHN2Nlc38wisoHmkPGF6fnXR2vhaK3Xfq90Ff8A54xck+xParM2rskQh09EtoB93YMZ+tVZXmuB85YyH9TQBfGp2mnIF0y0jg4+8Rls+uaq3F5PfDfcuwT1z/KpLTSLi4CGRCG6gnpWsulW8Ckzv5xJyEzwDQBzkUPnt+6DStnhlFatvol5OpbaFwMjJrodPmgClIIVjjI+8B0NW4ryMgr1UNjcvSgDAg8OSITulVVbkbexqzb6TZplWmL9zita6u40Q/LntgVm+VcKJGgTazfdU9KAGTXGmaYNqKDKB6ZNR2erRXspWO2AAHJIqKWxiO6eZWec9gOBTbZkgjBEQCg8jvQAtzq13GSkaKgzxgdRSQ3eoMTg5B5xtwRUktyDkRIpYDgkZqEzXZTBwN/BPegC/BqErwlZP9b0+tXoFEcZ3r87DOD1rEt7C7jIZp0VT0J7VoR3C23yyyLMxHy4PNAF5AxdlkiQgDrimNYWbpult0I3cYpjahFGV88bSepPenfaY2+SIxsv+9QBTgsdMncDymUq2ML0+tXYdGit4yyOw74buPams80ar5QVFPXavanNdMAA8mUU8k/yoALzSorm3wjhCR1rAufD8ynfJMg7KK2DNM+58jAG4ADtS/2gPL3OA/oD3oAw08PyugIeNmHfd1pknhy88sAqpb1zW7FdwSsq+WNwHJHrV6G5jUEbmwBjkdaAOPbQrxZNzRk8djxxUT6XeqASjgAZ4HSu5SVTsJYbie1S7vl7Fj1oA89ljmSPc8UgAHcVVd2VmDEl2GBntXpcio8XzgHPByOKy9Qhsj8r2yHIxuAoA42J8ovzYCjk+tI0uDyEdcdq6iHTLS5UrHCyoD1PFOXwvbRhsyNzzj0oAwIrQXKD5GVz0CGrX9mpaLGVuGB7gn8zXRaXokcPmSRvnb61JdadDdAgjBPAIoAxV1+e1QxxDzPXvxVe41qzvIgNTsIJkzjO3BPuTUt54ZkQkW05werDr9BWNPY3kAYTQkxAcYHWgB8+k6DeM32aWayc9AfmUVRvPCV/GC1m8N5H28tvmP4UMiyOFbMRJ4B6fU1LEZYnDRSkkdwaAObnhlt223ETxMTjDjGaZXoFpqaywyLfpHcxhcKHXJx7f41mXGk6TqA3WkhsZj/yzblKAOSorT1PQtQ00bp4S8X/AD1j+ZazByOOaACiiigAooooASloooAKKKKACiiigAooooASlpKWgAooooAKKKKACiiigAoopKAF7VuaJ4dnv1+0Xb/ZLLr5jDl/90VpaN4fhtLdb7WQC+N8Vtn8i3+FP1G/nv5NrZ2j7qLxt/CgC79utdMjNtpMIhXGXcjLN75rLUPclpS5Bzj61ctdPkcfNyxAxnpWpbWscOXk4wMDjrQBmWWlSTkPKBEB69MV0dtZ2Vsn7tlJ65Paoltprhh1jUDG31q7FYRkYbIb0/pQBn3d+MAQLvI4JH9KqJDdSEHICt69q6FUhiXHlrvzzgfrUbAMGBwc9B6UAZFvp7YZBM2GwSFrRjs1hIXOAPvehpwnWMD7oI4xSPKjL8z/AHvT0oAfEYlm2gZY8Z7U6Z9mW3ZwcYFVhNbwsvIKjkH2qTIlIMJB6/iKAHqzSSAxHaR1qlc25+1g9B+lSyXscLCNeWHp3qA6qHQq6sFPzAgcg0AMkVEctERnHSpYsTY3YBHPXrTTsmAaAjJALUkiOobaMuT1FAE8lsSMoSwboDVKSxHmiV4yHB7jgCrkdwFIZ3ZdvGMVMt26N843jqc8n6UAZ8tnJt3ZVxnO3vUE1jHJGZIyYZSeRWo0iSyByCgodoCCFdd3TGaAKMUlxDGUaVnwMVK08MATLLJH/Euehqx5YdcE8gc49KoXFkDDwN2RznvQBYEst3v8ghQeB71WfRtT28xFiDkhewqSzjlt7dVgXy2HcnjFaK3eo7Wb7QUAGMAfeoA563aSG5YFdr9wKnhmZlZTk5PXNSz6bcyMZi3zE5IpkQeIhI4xk53E84oAQTPFIojb5scjPSr9ldF2KltzA+tYtxq1ppzlJ1zL1KrzmqkPiezaYB7d4lJ5YUAdeb1o3UOpKAHFNVra4dQ2A+M9axxcHBlQ7oWGV57VFc3e2EC3TYzdHA6UAdSk8QKnsB0pRMC2TtJ9c9q5hbhgVIJdSME45zUwuHt1bcm5QOlAHSxvg4Q8HjA5zSu4GUXkYyT/AErn7TVDEQG4z2HarUeqocAAfOeTnmgDW3B1OTgdaRyrx7igMKnjPeqttdI6tjAA7noKl+0RyvjdkCgCG7sLS8B8y3VVI5OOTWPd+FkB32svlccK1dJuBPysu3v/AIVHLIJJBuQ4JwKAOHu9FvLQiQIXk/2T1FUHUncWjYS9h6/SvTHAUkLt5/IVRutPgusFowJB1kHBNAHIWWr3dsqecQV+60R6EUs+naTrAaRD9gvGPb7jH3Hb61f1fQtrFoH3Rjlm71hXEfkvwjKg9TyT6mgDH1XSbzSpdt3H8h+7IvKt+NUa7XT9WYRGG6RJ7Z+GiYZqlqnhyOaN7rQ2MqqMvbdWX6UAcvRR3PqKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigBKWiigBVBZgqgljwAOprs9E0yDRwtxfqsl8y5SI4IjHr9ai0bT00a3S9vIw1/IMxRH/lkPUj1ot7ObVZ3fc/XLGgCKOK51G8IjZ3LHnd/hXVaboyW0YEgyewz0q5p9rDbQhsASep7mrCeZIMPgrjGcUARBFGEWP5B/P3qcW6HDMBx+lOdo7aP5juU+9VWulZT+9AT2oAutKisNx56A1Xe8QviTAI4qhO4I8sEspqEW5cjJJB6etAFya5iVj84OenNU5rozZERKkdzU0dnaxvvcs56EdKvRPDEMRwoSeATyaAMqDT5JZPMcMd3GTwKutY7Im3MCTzyec1dcFVIlzjsBwM0RBXBU9f880AYUtlJPyXBYHAwMVZ0+zuYQ4dcjHy46VfaMSsqqSGB6etSoskJKr93PBz0NAGObCTzCWOO5yOKTykSTaZDnsSOK1ru/MK4ljV+cAio1NvOq+ZGVagCmsYtwXRS5/u4xUbpcXDq0YwCM+9a/k/uw0Tb3/pSE+UoymCRycc0AVhHsQZUORwc96ciOXGQoBNTpHLP8ijdn0HNa9hoEsrbrmURRAZ56/TNAHNyWfmSsrvgY49DUSWMcX7yNMyHOcjvXZ3K6PZKFYmRiM9M1i3WoQykiKEqvpigDGNrJuy0hAPOBximxyqsrIMnsD61dl2SseoPIAqF0VeQB9BQBF5nlBsgN/dGKwNb8QpY3BSJfNnH8JPC/WttomJOOCB37V5je7/tk4lOX3nJ/GgDTn8TapLLvWfy1HRVHFbeja3LfQzmQKJohuOOMj1ri60dDkKXEydpIWHHXgUAU7mZ7i4kllOXdiSaioooA6fwi73Mc1oSdkY3DPv2rvtD8P8Am25eRxgdiO1eY6PcSadZ3F6o5b92ufWtW08c6jbwmIhSp6kdaAOi1iH7Lcsg59AO3tVaJTdMQysq9M+pot7n7VCtxISARnc3U/hVhb0RwdFO7ketAEH2aQK0UX3G9eTSWdpGrCOXB9fWqOpeKEtF22YEl1/ET90e1U7bxdNNIqXcMSBiB5idVoA64IqRMeEUdqpxvbxzFcsGPOR3omufliHmbhjPI+9VmytI7gZldVJ7HjAoAcWWJTIJTt9T0qKPU2DFTKhXPOeuKto1krLDzMBxtU/1rE1BLNpytuGicHhT0z7UAbSzwqVHzITzn1q4qxzIp8wHsAKw4VR7FVSTFwOCSc4qG3llsJh+8LbuCOpY0AbF5YSswKuQM8Z9fpWZe20c523C+XOvBft/+uti2vi52vgNjpntUzxQXUZPykfrQBxF1p8iABQEXtjq3ufaq1nJcWU7SITGo7DgH8a62WBkBEibkJ/L8aoXuni4TDDB6Y/wFAGXe2lr4iVXi2W2pBcZAwkvt7GuQu7aa0uXguY2jmQ4ZWrpru1msWjAL4HO7+pq7LFb+IrYQTusd+g/dXDDGf8AZI7igDh6Spru2ms7l7e5jMcyHBU/z+lRUAFFFFABRSUtABRRRQAUUlLQAUUUUAJS0UlAB0FdVoWnR6darqd/GGnbm3ibt/tEVT0DTogn9o6iD9nQ/uoyP9a3+ArUt7afV9QMqSEpuyy/3fYUAPtbWfVr4yNuwTkk9DXX21vHaoEUBSBjcKWO3S1gCRDBUYJHWp0RmZS2Gjxkf4UAMSNp2Jfse1Mur2K2by+N3TK9qg1LUVgVkjJEp4HGKyfncb5sc8k+v1oAsTF5p1MZOGPKn1p00DW/UkuCAVYdarWtwpkOGYbfxxWkkf2pVVXLuf4vagBtrCLuRkXKnGfYfQ01QwdkjY/KcZPrU88wsLcbRvZiRuXtVbT0l3b2bKFup70AVJZ5TIwCkOTjOMitLTLdxl5s+x7VbjgTcMIMnmp12+Uwwfr6UAMuJMqqFTycHPaq2w/fAzg4/wB2rDsdgzg4H41DGxZsJnb+tAD4JCCC/bv3qXcC5wRyOQf51VPJOwZxzjoTT4xuUmQYxwG96AGy7GlxIPl6ZqW3Rd5D8KtNVQxO8biO/wDWpEAQlW5U9B1/EUAMgctcORlUU4UAVb88O+yRQZPU1DENsYCgE89+lWbC1ZrgvJwF5GRQBftAY9iRjDA88dKS+vlVShLSMOgHQU6VjE8m11+p7n0rJdgxLkkMep9KAK1xcSyuWOACcEDtSujKo34DnnjoaWdhAnmEYPp2+tRRzmRuSCD096AFRPNB4+fHSqkjnb8wwR1OM4+lXGdQ/pkYB9PanMyjJRV2gdPWgDF03U4Lq8ngLZkTt6iuC8QIya3eB1wd+ce1dVeeHpbTVU1CxuFyz72jbgc9s1N4m0RNSgFxb/Ldxj5vRh6GgDz+tDQFL6tAoGc5/lV3T/DF7eSBd0aKQec5rrPDnh630tzO7mWcjaGPT8KAPN5F2yOrcEMQR6c0IjyMEiUu7HAAHWvWIvClpqFz5zW4yx+Y1tjw9pekxgxQRxyDqxGSKAPJNdtpLK0s7ZshQu5v973rIhjaaRY0GWY4Feo6hbW947KIg/qSOBWSNPghn/0S1xIeC5HQetAEdpbZhSAk7UUb2J9Ki8SXQs9NjERAllO0EdQPWtW2jaOBwYwzk8D1965DxW0zagvmLhAg2jHANAGJSnpRSjAIJGRQB1Wn+JLe2sYhcxNNOoxhf8a2tK1i01G3laJDE0fLLIe3rmvOj1+vatjUof7M0yO0Y/6VP+8lGfur2FAHdwwRNDmM7d46rUc2nb2wWG0/560vg1Efw3bx7w20sS57ewqzfanYackYupFTP3RjJI9RQBm2+l+VIjxynCnkdjVqaBnILgL/AHQOpog1/RAC73qE9cYrOHiWxudQEECSMW+USHv9KANQHbFuHzAHnaOfoKYtzLFkquOc+4+tYPiHX7mwmW2s9scgGWbb0+lUbPxXOzBNSRJYieXRcMPwoA9BtrmO4XaxG89ABUc8PluSx49ucfU1hWt1by4mtJQ0RP8ACen+9710Ftcq6lJQMjpnv9KAIJ4YbpQjIvmY44zn6Vx+q6Vc2dz5ibgDzweRXXTo1tOdufKx94HkfjT22XFsY32g4xuoA5OeGHWrQW9wypfxDEMh6t/smuPnikgmeKZSkqHDKeoNdbqOnS2FyskOSmcg9MVFrECaza/aIUH9pQjEip/y1X/EUAcpRSfnmloAKKKKACiiigAooooAKKKKACtXQNL/ALQuC84ZbKLmV+mf9ke5qlYWkt9eR28A+dz17Adya6xvJ2RaZZbjboNpZT99u5NADG8zWb1IbdNttH8iovGwfSuusrSOwgCxgKw4Zh3qPStOSwteeXYcuetTxK0hDuCIx3HWgCeJCW3yHKZ6elVdX1FLSPC53HpgVYuLgqh2APnqR1FZy6U2oyGbJWPtnvQBmo5uXV2JznJU9DUkqlyxUFQB0zwa0riwjtkIQgHvurMlSdjsTmP260ANggDKdjhSec+laGmQNE7CafGRyV7iorWIRxyJwW/hNWrUqADncwGCtAE5t85cICp4x6e4qzDBtj4UMnp0rlta8TSabMIYo8sOfb6Vt+Gtbh1e234Eci/eQnNAF5uV+Re3HtQJGxkZOP1qVihJwGUAdR1z/hTI0CsQxznkZ7mgBpdJAQcAg9FprW4C7lbDY7dM+9P8tEQ7kzuPX0pUzGwTAIPI54P1oAgCO5UFQHA6jvVmJcrsYEo3OPU05XXcd+FZe9IrFNzKM85IHSgB7RbI8Mv/ANYe9V+IpAoPzdh3A9qsSNvj2sTluMenvVPcQdjNkjgGgCytvmXbGwIbqO9dKka29miP99+u7uK53TQrXUOSfMDDPfNbXiYSySRrGcYXPpQBg+IL4LMkFoMlfmZvSqlvMTHiQhu+cdaoXW5pirth8YJq3pgYRFJRwTwe/wCFADp45HiO4Fu+AeQKjgVJSdwJz26Ee4qSW4G4qmAQPm3elMhUP84UKT055AoAtywb2UhwduM56YqQRxvhcKMD5e35VQEqqAiMzMxwwJ61fYKsKAgLtHKigBrRIybHz0wf8ajhg2wbJAC/TA71Lbs7uXjQNtGBg5/Opdm9sM465Bxg/SgDKs4lhu2Dfuwcjd6VduVgh2RM27AyCTjJov7fdEpIJfdlfpVS8YXN2mFUPt6A9KAOisboQWalBuY9RXOa7qkvmGRw2AcAjoKltJ5FZopgVUcAdM1Q1QJLKVmlKxj5ce/0oArpeySPglQp67eKuNcweUsfPufWqHkxQwhVVinrjrSuSdpz07DnJ9KANSznswSm85b171X1LTba5QpPGrq3RR1A9ada2cThZ3VnmHRfSqF9POjhlUxw579SaAME+E1N3gXDCDPQDJHtmudv5I5LqTyECRKdqL7D1967+wuZJLgRsq/ONxyecVg6z4abzpZbQhSxLeUx4H0NAGFpUQluw7nbFEPMZsdMdKr3M73E8k0jFmc5yTXVxeHXXw1cCIGS+dgWC/3R2FV/C/hy4uLxJr6Ex2y9A/8AEaAMJrm6S0jgEkscQJYKCVz/AI1XlkklYGWRnI4yxzXbeP8AToYrKC5g+XY/llQOOfeuHoAKs6ZcLa6hBO4yqNkj2qtRQBpeIr5NR1Rp4QRHtCjIxWbRRQBp+HLw2mqQhm/dSHaw7HPevQlUGUMo346HPH515VXYeBLyae5mtZn3qse6MN2oA7dCLiFhIfmxjH+FUs/Z5/LdcY6FhmrMchVzt+6CMn1/Gpp4fOQlOWx1PQUAU7qEX9qQyKvb1NcnLDJpV6JN3lgN0HVhXU28ohkI+ZmHB9M03X7Fry2BAH2hfmGBQBwvibT412ajYI32Wc/vB/zzf/A1g12tlNGWksL85hmGwqOx9RXKanZSadfS2s2NyHgg5BXsaAKtJS0UAFFJRQAtFFFABRRWx4ZsluLxricZt7Yb2z3bsKANbTIl0XTSZE/026ALZPMadhW/4b0oQFrkyAyvycjGBWbo9rJqOoyXUwYqDk9xXSXl1HtjijA3HgUATRjz7g7WwFPOO9TXE5hRhEFMmMDHUfhSbVtLMs3GBnaT39jVCNXnIYjczc47igCa1ga5uBnP+0R0/GukWAIgWMfIoqCwtjbW4Y5Bb7x7irIwQTyp9+9AFDUIhKmSuQPaucmiRHLBwoz0IrsHUspIdQSOnaua1i3bcQq7mbmgCiHizySW9RxirVtGm395tAPRgaz4rd5OG2jnjPauL1+9m/tGSKOZ1RPlwDQBf8cIovlAZCccYOTTvCdu0Uu/d97+6en1rl2dmbczEn1NdDol8hjSOSMbgc5HDH/61AHoVu7OEZiS3YirYGCSvzg9Mdqw7diq7oW5AyV9KsrfnY2NnqQDQBpF1mJUsyY5II700kqQWAJHAK1RstShuj5QbDH35q6XIUjnA4xQAhCsScE+wpIpQHG9jkcHjr9ajO7OIx948+9QTXmwHKFiPlPHIoAtXskiANEN8WM5H8qpLdG4QKw+bGSO9Pt51X5BhkIwRnkUSQRyMzxnlT19qAHRzyWwG3PynOR2rXkmur1IpVJ2kY69vescOp42k+/Y1o2l8iRiArjsWzjFAFaTSZdrqzBge4qK3smjT53O1e2ehropHVcSbsjGBisue8gCGFo/mY4P19aAKUlv9oQCQIM9wev1qnNavDIQknAGduaszEwzAQAFB97IqvcRvfqUEgRxwPWgDMV53uw2QcHBHeta1upjKySLnjCk9x6VRfRbpSrhisgGAy/1qC2g1CDUUFxvZO/NAG1ZKFupHVmVk5ZT6VdN5Gyv5WGK8sO/1qvBFN5zKxAJG3OeaoanpktrJ5itgluWU8Y9DQBsWy3GpQxpErJC3Rj1q9JocFvbyGMkuo5JPOaTRrqNiQDsOAAQc5FXryZJ4JY1yMDAIPWgDmoNRRo5obiKMyKMK56j8ax40F9eYlOWXnPqPat2OztWlO5Tzwe4P1p72iRLmHamf4e5FAGVcRSJ8qlsYz04FV9Nj3zjzJBCD0aQcfWtqVvKgMrx5QDAJ4rmNS1RriRCECLGcY7H60Aeh6dZWwtGMMqyMwxuFcdqJw01rCPMuASQGPWqk2sTx2gW0UpKBgspwBVHR5JLrUFjaTdcSHG4npQB23h/REtrFbq4ijMjjPqRWLrkJnkaZAI7dePm6k12LQTWGmBDmbaMZ9TXKajcq7bGQySrzsPAFAHN2t7cWMjTFGZCNoXPX3+laFjrPm3O2ZwCQCR/drN1C6leUxvGqAdVxyarLEzJu8v5T94+n40AdtfW1prGnSWspBRudynG09iK85vvCuoWszgAPCM7XzjcPpXT6ReC2K5Ubeh5yBXSssd1sk3ZXPQ96APGZ4ZbeTZPG0bejDFR165q+mW97H5FxGhTqrt94fT0rkbzwa5djY3IKDosg6D60AcjQMZGelbc/hfU4iAsaSH0Vqq32j3NlZLcXBRdzbdgPIoAziQelbHhGfyNftifuvlCM+oqxbaBJPFb7leORuXx/drdsvCdrbTxXDXDyBWBC4xQB0c6sfl3EDPBA4qa0BCEPJhCSMVJG6nMYAxjigqsYbJWNSMlsUAVrtDEwaIqo6FiOn096baydVJYBeTuPLCrrZmjKqNxA6ngVjz+ZDOl2MsIxtcAf0oAyvE+nqki3UDMA3UAYA/Gs7WLYanpAlQ7ru0GcdNyd+Pau0liS8tSoGFkHAPY/XtXIWKfYNf8l5MMeGGM5X3oA4wHI4orT8Raf/Z2qSxpgwv+8jIORtPvWZQAUUUUAFFFFABz0AyTwBXVvC1lZ22mxj9+wEsvY5NZfhe0S51QPMpMFuvmvxkZHQV0ujJ9v1J7iYEhT948j/61AG/p1s1pp8aMm9j1PQ/nU0dsjT7pFLqfUYK1NlhKqKev5Ump3YtbV/lId+EI6k0AUr2cz3ywID5UQ+bnqa2dIst7mRzgjnjg1m6LZZ2lgSG5ZvWumWNVG0Dn0FAAzsMLnc386cxzwAdp7elIxJACjcPcULzwCY3A+7nIoAeTkjIUj0IwaztQgWbJIwAMEZ6VfjV2YngnHJFQXceY8qvzfXr9aAOdjtwyuhIJ5Azwa8u1iynsr+VLgH5mJVj/ABc16rOzebnYQwPf+lcn40g84KYrd5ZF7DOR70AcRUlu7RzK6nDDoajIKkgggjg5pcHbntQB1FlNcNHG22ZX/iIP3x7Vk6jdvDeuYJ3DBuQBgfQ1FZS3UsqrbysgjGQN33a2rmzN6ymcKxYf6xfvCgBmj6zCbgJcJtB6MOoNd7ZSpLbJhiUPKtXn9z4WuAha1kV+4VuCa6Xwg0sMLWl/EwlUdWPKj+tAHQOXDBlbYcduhoKQ3ieX8qzjv0zTjGijEoJQ9welH9kySfvIGAQchiec0AUnszFxKoJzjI4NHkBRujOAe1WzDOGbLhx061LFaJCdxBJxnGaAKMKtcKTEOh596JAVHmElRnBDir9xPCGBC/N1BAxUIddp8xhg8FeooAikvpUTYR8mOMDrVDa5nLJkqecseDT7jJY7JBn26CoY4rpY2Gdw6g//AFqAFkuZowQgd1P3jipbGG5ldWeMpHnIb1qSztpsETOCnt1zW1D/AKpSjYXG3DDvQA60drJsSkOp4IIzg1YuAhRJVwoJ5UioACp2SZyeuORTXDquRgrzktQA5mgZ8qc8fMPSqz2JvoWAdkx6cg0r/MAQFAHXjrUiOqc8+hweKAIbC3Fo5CkhT7ZNXlfEmCAqn72f50nmpI2FyG/hPpTXXoJCMf3getADAqljsIDZ+90BqeK3DSCNwCo5dj1qFF3DleSeQT+op3moh2h2VjwTigC1qT6fIDDORJEicBf72K4OHTXeU8cEkBT6V1mI0ZwRuB6sB3qNp4Q5Ea7WA5bHJ9qAMJ9EaMqG3FDxj0rMk0q5srjzbQHeDngZ/WuukvZMfdByME+3pSi5G0kEBccDHSgDNuvFGoNbRwum1lGCelY0t1PLcCUqwbrgdK6h3RgQYIzu7tStHbPwbcAdfk9aAORuZxKQ1wgEn3iRxmtOyvrc2jxtamPjALHlvetCfSopNzxFQR0yMkn/AArMutHuyxMZCnGcseBQBn+T84eJMgZPt+NXNOnmedefLVSM56VWe3e3JJ3ykc+gp89xHPErsSk6dFVuKAN27R5HACkjcDuJxmmlAitvYyNnkjoKj029WYJFKS745q5JhpCiIir2waAIYBvUOQW4+6KztRt1l/dS7TGTuweNp+taTBflVN+B94DgVn3MUfntuPBI/wBYen0oAdbxm4O6MfIvG9j19q0BFiMKSAF5IzUj7YreNbfb0zuHWqb4P3fMZiOpHegBDOsefKGST1xyPYUqzm6XBbA6VA8iozpgjIzu3fpUllaT3EHnW0GcHpnge9AF+x+dBuY4HFTRpEksgxuRxjnn9azoCkE5Ez4YdRjI/KtQZdAY1JXHAxtoAyLcC0uZInfvlM+n1rH8V2i5FzEPm9UHT/Guiv4UeMM20SL/AAp8xH41HdRpcWLKcE4yMjvQBxOpo2oeHlk2ETWbdxklD1+lctXc6ckK3MsE4Y+cpjZicKM1xV1C1tcywP1jYr1zQBHRRRQAUUU+GJp544UBLSMFAHXrQB02kRC10Ddu2T3b5z0OwdB+ddb4ege3sx5yBlfn0zXL6gWk1CGyjkBjhAjAI64rtrOPyrNY+QAMHnH6UALHtRi67lLdm9Kx1m+36uVBwkPT0J+ta+ohIbCSRH2sq/d7GqvgyxdI2uZFI3nOOtAHT6fB9njAQgBhkqw/rT5NgkC/Mh6jPQ08HB5zGfflTRECZMcEemeKAGkk/dfDHpkUPzkP97sSOlSTp5RVAFPcY5qNnA46++M4oAUDC54IblSpxSne6HOc/wB8dR9ac6fKNuMEbiFpFKqxAkZGI6Y60Ac9qRTzh83ze/H5VUvr+XT7XzRCkxAPHXNXNfXjLYZS3UDkVVs/LeJVkG4dMnofagDyrU7h7q/mmkiELOcmMdFquGIGO3XFeg+NPD0dysU+lwhZxxIg4BFclpukyy3zR3MciLHyQF6+1AEnhexgvr4i43BF5XHc16JHpFjEISqFXHQjtWJpWkwrMZIleMqd6gcDHpXVxgyRjCEnHO080ANSCJU+XkHnp0p4twAHKgns3qPSposrGdhPup60ZJOSpxnv3oAiYBEyyFuMhcYpkk5SMpDIV3DJXrmpnP8AEGKt2U9TT7aOJblfOxk5zgdfrQBQgZoT83Ddt1LJcSoSDyOqNnvTbwBZiq9B7daYF3EHI4OdtAFaeRmcknMg7A4BqJTgCSSVlj6HippkKsS8ZGOcA/rVUPNI5S3VZYhyAByKALKuijjLrjJIFXbXyJ48s4WQ9MdVFUBaXQYeYhRH9T90Vr2ul+WPNjKbugz/ABCgC5baPHIAyyfPnI57VJ/ZrRpIPMyF5qGKKaJgEm8s53MuOlTyxu4+aQ/MOMUALY2kZg/eyl4zySTypqrcqEyqSB1J+o/+tT/KmtIioQMueo9DSEEjaYsKfmwe9ACmB1jLqQcj7tVJI3IzFgjPIqfLrJlmJDdv7tAijMhkXAjz82e3uKAIWURfu9wGOeetTLG0iK0eGOOeKR4GkIbACDo3r9akiiKoSFYDPG09D60AQyFwvTbngEdapzTOAcY4GCfU1buFJJKOzbOD71nXEbRuAzYB6k9KAGOGkYAvsAHVTSbY+QzsfRu5pNqSKcYQj+LGQ1SDMceEyc/wj0oAGVgflkBx82PWpQxCZUgk9j6VE23nO78acCAh24bPPSgB8LHBx5e/oOOlOYqoDbzv6dOtIjl2XMYDAdh1q3GvmgEsoBPagCq8yAAp8ox16VNBMQNgUuvYetWxpWVZ/ve2MVny280TfNKU5/h/lQBY8qKdeI0UgHOe9cxqdq0EzMsSp2AxnNboIVeRkn2yTUu2O7iMc0ZUHoxPIoA5OwuDbXih9oJPLA5OP6V05mFyFaJtwBzkpgVmXmlG0II+ZOvIH+TUdhctAdrSExt6jp+FAGrIVG0hlLE4PHSo5YvNTYIxtY8sTzU0ESsN+d6EZU5xRIqkOV3g9tvSgA+SO28oBSVU9uBWUbjJVQ/mDvztH+NT390I08tP9Yy4wTxWaqMMzMqg55GKAEuFimmkeV02quNoHINdZ4D121ktJLRFUSJzuIycf0rjZ5EtV+WPc83p1/8ArUulXFxYT/uxFCjnkd/0oA6jxM9mt6LgSlZCQHUf0pLacSoyrnCnnPesF/JutWT7ROAOuWHNaCXAiuwA+Yn4Dnvj0oA1gisuNww3YDrVc7Ucrwx71LEd8WCeM9+KiyDIyg8g9PX8KAOQ1uIQagkuCzdVVOgrD8XxKuqJcRqqrcRhyAc5boa6rxdbgqjgEgH6D8qxPECtdeHLWfEZa3k2EqMYU0AcrRRRQAVs+E4BJqnnsPkt0MhPoe1Y1dHoieRoN1PhhJO4RW9VFAGjocYutWLSjcCS2cdDXbYZ2ROPXnrXM+C4/kmlkUH0PSuphYNISrduOOtAGd4mQtp2yM/O5AxW1oKta6XbwsoVtuSe1ZerIZ7q0iGcl8n0xXTq4ChSV2jjDCgBrMMZwCegoT924cIAevB4NSPGBHuThSeQe9Qr5kY4XrzgUATXZcucx8bc8cVCu7d0G1e4/rS+Y2NrblY005EjbSXHXJFAD0b5TzndwGB6U+NAfmkBGOM4phKkLlMH1HAqRQoG8NIuOOuQTQBlayjtHwMkcgj0+lY1qx3AptUDr9fpXSXuZywITKjqvWuelhPnD7hf34OKALiuGGQ46dRULxBpN4JJbpgYBpg3E7SPlPQdSPerj+WI1V2Af1oArxRsMgDac4APSrWDGQWADdyDUgjAwu5WBGCf8aiZmich1JC9AelADmm+YYALevf8aV53xzHvU9AD0qv5yn5Sy9MjjkU+3CsFBcenyjmgA83D7xhDk5B5NT2ojLEHBkIyFJqERNIx3xjb13DqaebMrG8iswWPkNjH60AO1OFTChC7ZAeuayZAY13M4YjvjFTO5c5kcOScLu6EU61iVpcEKRntyB60AOsdNkuXUyyHyc7hk9a3oYoLdtscKAH+IcZp9rEnlDaThfmUYp0wY52qCeoJ6CgCC7hhkKmcquB8pJqJJ4lVl25Kjqveo/sTyPJ5khO7naeRU8Fr9mcCP94f9o8UAPQ7oxJLlFPHPWkjC7ym8Bjzk1GRgPJICY2O35uxpVeDiMNzjg/4UALFbyS3gjdtpBzgHjFbH9niMkyL07E9fesEzy290j4JPTHXiun8/wAyFWAyrDgk8igDDvrIKobbJlecDvWfM+2RXkUrg/cHJNdJdSRm2faSdo+ZjxzWFokRv9TZ2yI1+XJGc+9AEttPaysq52jqQx5zT7rULdY/Ki6rzgH9c1keM9Amsy11ZF3jblmP8IrIs/sx055JJvLbHyorZLH1oA31RmCuqqB69ay7uEq4EnzgcqGHAqXStRDxhZDuj6YUYzVnUPMdUERUp3x/DQBmLkgfMqjv7fSl83axJUkH+6P5VG6/PkZbJ64oQSMN0sny9OOwoAA5GQNwz/ESOPrUkb5YlSB2AxxUYKKCqgP/AL3enh5ASykFh0QDigCUKoJO8g+o/lTkb/a3MDwo/wAag3542b26nIp4aUgEABj0TGCBQBdF7KqncMFemTUU100ozKRv7dqqsX/jjcN2/iJpjhwgbawx1LHpQBKkgCjaST27n86k80RbcAnnoOTms+PeCWaUgZ9OKtRPw5WSTb6MvegC+hNwpjdT0+U+lc7fxpaytG8WGzkHOc10FtdrHgPkEjqRmlubeK5Vm2CVj3IoA59GmA3mULxwuelRz6lL5Py5YDtnFaDWvlHDNjPC5GOKoanp6eVxKQ3XAHegDKmMt5Ks7lhGOASO9X5x5scSLJhTxgdz35rMm3nbHlnI5C4P6VprGkcaL5hQquSWOfwoAUKBE0bSxqqjgjqPxrOxlF+znzCrZ+Tj8zWpBGoSWVzlCvG4f0qC4QiNFSN5D1AVcAfjQBGbdm8uQqFyOdoqwsMUen+YzyHy23Z6flUlp5ioIsFi3OOo+gqSSF3WSGVgA68LnO3FAGvpNws0KkFfq3NSXHyXeRkbv4ugrN8GDzHkRQCVOCTya29chVZreR0DnOAWP9KAMPxEhayOw5fPGOtc4YVl0W/twMkx+YSvYrz1rq9RQSWT7zt7fIMmuc0cI13JBIh2yK0ZDH19qAOEU5APrRTnG13X+6xH60UAIeBmuwnP2TQtNtFRTlPMLH/a5rkoIzNPFGoyzuAB6812Grq76l5KFdqkIMH0oA6Xw/CLfTYyp5fnjmtaFx5RymVz1FVIoWgtoVQbQMZx1q2zmK3JYkgnqy0ANs902rh1LbY14HetzqG3AYx0PBrJ0INtlm7M2FKnORWqwMmMtuB9qAHrlYWReAexORTM7UwMj2B700jcMsWHODxSFAqfezzxznNAC/KzA7yD3xTQy7hulBJzzjFOXZuyuA2easzQBUDlNwJzx0oAgHADKpLe/wDhSmRVDLsG5v7pP6imHb5gU5H0NTuwJUIHGOOeM0ARKq7HZY+WGMqO/vWHcRhdz4f8q3MtID8ygnpzzVO+jdcYYMP4h6UAZ8OEAlSMggcc96kMofOVLknjaO9V32FlTIGDnk9c1Ou9WQLGCr/xA4C0ASRSK5Ib5iOxHIFSuqtzBIFJ/gaomUHJ2qGHYdaRvkbcyc4wAe9AEckZVg5JGOCQMinxBWwrMqnqClPFz5Zw4UDoAO1DzkfMFRUHtyaAJZFKOBOQQOhXhqiuLpjB5TMRGf4cY/Oq0krNKdzSE54xT33vnflhjBDDtQAxV3AMI8HGMZ/UVatYFiUu/BHJAHWptPRdq+dtA9DxRc3UcNzkHzFYYYdxQBOk7rCrR5xjIOOcVMLpFjDsc8Y21BBLG6llwqgcHtWTqYdoshHdN38PBH40AXku99wYySN/T3qpf3Zi3RxsvB5bPJqHT7eRplYCQKDk5HIptzZv9okeNApOcbmyKAI2uJ9wf962epJ4x/jWra7b6JWKtuQ5IAwRWZEHYYK+Yw684wa1LKzkjjCxttbOWbON3tQBYkQuuyUZx90A06C6lt12T5KKePSomn8ksGTA7Dd6d81UutQF1ugiwxU/MQKAJvEF5MmnLNBgo5wFHJNHgTWlgtpVmbawYjHcVl3dx5a+UeUIx5Y/h981RjmkgmO2LauMFgOlAHoOu6pBcadcRZDbkPToPrXksCu115wJcIcbMVs3N35sbKA6J339xSW62ot2WMhfM6Y/pQA3TJPtFyyRAq/AAPH511FwqpCFkwW25JXkH8a420IsrsS3T7Tkjy+uR7101uzXNlvt0RfRm5oAzwXXGzlDx70wFnLNyoHY85qWQhSSZMknkkYGahZAcOeSeh3cH8KAFPPOR65HWmsc5HzN64HFPREI4O0r2B/pTkkd1A2NtGRgjGKAHfMcbFYDHL55FI8gUfMVGO/c03bvBDk5/wBnv+NJGY0GI8M3qTnb+NAEm/cC3mso9PWmfI33wSOwAzUUJEjsEbO1udo6/SpsndhURQBwATk/U0k1JXRpVpTpS5JqzEQRr/Fgdt3apEWUs+0rj1bj9KjCMhxhSeoGM4p7ZkTHDdiWPSmZiI0QyCzM2erfw/QVPHdiJR5YOQf4RxVcHO5VVfl65FRb/mwxAUnovrQBqyhLyFvl8v3zyaynjkiby3k3Rt046VftZCduF5PB2+lTX4AeMAAKeu/kk/SgDKNovlAwMisDjdiq0unCba0hO/OMjqTUt4J7bLEBUJ4JHNVl1FZHCM/z/wC0cCgCe3012d0JLMOBk8D8qfcW8isFLDYvGc9KT7ZOqfu2HJ4wMVX8t54QbmbDZJPNAAwWO4Qu65HO1T2qeNovNKDktyKpz28dsiuu1mPQnqfwqO2mkaQb2kVc9FXAJoA1/AcJOo3amMYDdj/Oum8UxMLKKUHCq4GT0B/Dms7wPBFGJ5R829uijFbXii7H9kfZsYHmBvl6mgDl3XfbziQAYHFcZp0n2XVkBic7n43Ht9K7cMhjZdr8jv3rg79pY9WVhExAb5Snzfn6UAYniBAmu36qMKJTgY7UVc8ZAjXpCerxo5z7iigCr4ciM2uWajHD7zn0FdBFvn1zLHOX4BFZngpSdcDYJCwuTgdOK2NHCtrQwpAzzk0AdmAnygF1K9u1SXQcWpIY8DcO4prridMxsRjjngU66ISBQGdSeKANLSF22ce5VL4ySpxVkkjPysQOKYoZIhgBsAfMvBoT7xO0gkdzQBatreWRsIVOeSGqCdAkpDhoiv8Adqa3zChf5W3Dg9aq7yTlyRzwD0oAXd84LkPgde9WpJUlgVOMjoM4qs21QCV6jqD/AEprqWQcAr1BNADg7K5UqSPXGQKAxOG3g88rSHzI+FlVfx6U1piSFkbc2eNo60ATrjhFwv8Avjiq17buVPTGM57VPGI3c8sT0OTT5FCfIGyeuD0FAHOiMFwpQKw4yTxipcGJiFLFV4Kg8U/UPOScMmwxnqD0NQQSRBimWR+4xxQAscnlqdwyrHjPOKmd0EbMWGBgVAyFyAxfYO+OtO2AE7DkY4UDrQAyUI7/ADbunDE9aai5CjJ3ZwM9KbkMcEIcnkVLNu8pliOGH3UxyKAJChRhyoAHBPr7ikHD/vH+Xtg9aqxgooV5SJCcnJ5pcKpYOdxx6UAb1vHHParlwTngelQRRRpcnzgrkdGYYxVGO4eMYAAU9lHQU5rxpZFBGUxgEc4+tAFm5uAxaKNVHb5RSW95EgVHkViAQfQVSQqqjcSSTjdjv704WSbfmJCt97aM80AaRubaRT5TFmI6jtUW2LqJFZsVWWBEAEIZ8Dgj+tPEPAwCozu696ALQa38veWVTjgAZJqq73j28rQRMYlHJfjP0px8tHOApkx07CtGzje6RFnbaDwADxigDHtNOudTYZBP94g8VY/seK1Zo5VcMORz1rs7fybOERRhUQDOQOtZ2s39pcL5bbWlA6Ajj8aAMYpaxphtmOu4gcGrEP2KV0ZhGzYwFXHFYPky6lfmGMfIvG3Nddpnhm2tYysqvnru7mgDPeytZRkxofTcKydS0CORlNoqxyg5x2H0rqtU0/7JF5tur4XqDzmqUNw91FvRceobigDzK/t309JUurZ3Zm5k/lXUaVdpPp1q4xGMbNoPT61r6nYQXKbJwWIHA6gVxtxp7WN2glDrblgVySP0oA0pY2WRlZsgHjcM5qOMALvYjaOMbev0q9JN9og86HIx8pJHP4VRUHaSB5bZ5JNAB5Yf94oAK9GJxxQElKM6klVP8JpXUfKzshH8J9Kle6cQ+WoyFPULwaAIgNwLGRiO4zgCoL5pI4SIoxsPG5R/SpdsvmbiUUEcd81HMSY3ZSATxj68dKiqrwavY68BNQxNOTiparR7FfSiCsqlc9DuzjFXWdCT5j7voP5mki2KAzDaOnPJqXaVyMCNT0IqaNP2cFC+xpmeMWOxU8Qo8vNbTfZJDDsbrG7BeeTjP4UbkI+VdgPTIPNSEt0i8xn79CPzpqu27944V88c5ArU4CItG/8AC454LHCmnKMSbihPPVe30qTCYLO5kPv0/CjzlcARhgvsOB+NAD18oMqsWVieQxOcVpzR24t0eJG3q3U1lN9/fHtPOCen61oPKqRqJmXkYKJyc/WgCtIBNC4Zcc8bh1rndTTyZw0caKmeSOtdQsalD5S78/3jx+VUNSspJLT51RWB+lAFHTCsi5LocH7p6fnTr2YMJ0skWSWPG4dBz6Gq9lG8W4lvunGAP85rN13S5ri9L2t5IkkgAKDgYoAnhS5u3Uiby5Yzh127h+dWrqOdbqEkK4zzhulXbT7TDYrAIjtCYZsDLGkitT97DBsZJI5BoA2PDO6DzdzALuztFT+KJx5UePlyw96qaafLDHGWI9c5pfEzOY7U4QL78CgCJGY85jYAZ5b+lcXqeW1CQFQDuyMcV2VuzNGQVUjHUjFcXqx26pKAN577OBQBR8bxhL+1cH79uufwop3jJi40t2ULmAjA+tFAC+BwPtV83OVg7Vo6HLENUUAgOT0Ydaz/AAPtM+oAsFJg4zV2wTy9SjKsnXkgZoA75WiSJpG4IPeo7lkYRY53OOM5pjOzxBAQEOM+9Nv2RTaHeQDKBgCgDfIkUAqu0YxlqMttBkXPPUdaATkDLJj3zTn8zaP3ikH2oAZlZCTExP8AvcUhHJBUEd8DOacclMIy5B7dRUbttJyHJ60APY5VQIt4BpjLEVDMrA5/iNAkGNwZB7GneYGVQQQ3rjigAC9dm1hjPI5qQOR/rArH3wMUibslgBju2e1SWbRJIGkI5zghc0AQPDE+1lcb+mAOlPBKjCfvOedxzmidkMn3iFzw2OtRBSyk7wSTj5RQBS1pAbc7mBz8wX0rItphPguwOOMMcCtPV8iH/WISepPBA9KxIYyi/vW3fN93HOKANcIyureZtU8lS2RUQny5Hzkseg6Cmqd5G1SuBlT1xSZCABpI5G9hg0AWViJOJNuzGcY/rVa6ljhZkaQxn+Fgeafs83KRoSCPujqTVqw0N54JRNaHdt++/U/SgDEnvoolwFLEdz3+tVINXd2YkAJjg4q5c+Gr6MESocHoKzho80Vyh+YhOWBOAfxoA27CX7RGrqznPGRRfX0dnHlz14DKMVBojtPLKUiEXl8KpOMmr+qeHtR1O2VYoijKcktxQBBpN19pLuuZB0542itHeQGRXUqevGCK5rTvP0y++x36iJTzkNmunA+Xc2189G9R70AOAGQuxgezA9qeiNuKgDZj15HvUfEUWHkVcnKlRkVb0i3mv5ScMkR4Bx96gBsFt9omU7AFX7zY5atK7uYrO3YLEfObgD0FX7sw2MBJ2DaMbcdT6VzrSLO/mOjk+jDbge1ACeY88J82Zgzeh4ArjNZmuLW9aO3jZ3A+8TgEetdorR5O4Zb+73rA8UbWaOVYgZD8pyeAKAOt8AWca6YtzMAJW+8V55rro1KhvnLYH3Setcb4B1C3ezCPGVVTjPQA12YlSTDF1JPA2c0AJ5fmoyFWORyp5GK4DVVn0zVCLd++WQ1391dW0ETSXDiMLznPP5V5V4i1A32vIbN9sgbJDdxQB0dtdpeRsTKEkHBUsPyrP1WzRo+HVvcjJH41kTO7XjuoAmwDxwD9ahk1SaMNCRGx6/7v0oAia4trKQFmdYz8rK57+uavhbOdRJCVkbtzn/8AXXJamzXLlSGMjZyfarGgvcxSIiwgQgZ5HNAHRbZPNxtTA7HrTHjYHfna3ck8fQ1ZtLuGdcgbecHJ+bP0p9xYmQGRYyCDkMx4oAzmUEAyBtg5Bz3oYeYEDlNoOcdQaWWEwyfPlyedoPSlTbJwYSBnGOmPxpNXKjJwd47h85bLLjAxkn+VNRRvIRS7DqaVEbogOVb15qSSMKw3SEKOjDtTJItsaHAlWH2ySTQxVVykYbPGXH9KUSRgbykjsONxX+lOD/vC7MyjHcjrQA1TtOFIIPJBHSnO5BG9FUDoSePyoBbjcBjHU85ph3Z+704+ZccUAPVy6FgrZJxhRnNaFquYQh2jPPzev0rPVlzhXdyeR2FW7dC0gEgLKe3p+NAFtonLgguGHqwAP0p+oW0hs1c4ZT94KppZo1TGwNx0x1qOLUTGXikJKDigDDe1+bfHIMHoOpFWY4isO4q0jfTHFSyJNHc5jbahGfu/1pwyrAmQqvU7uaAKOoPcTaYx01limJ+UueR+FW7eQeTAkzqZto3k5GTWJd6ns1qxEBJt5CysxU5B9MVtu+LhSoT5hjcaALFshilYLtweQQcUusMZkhAG4rz04pljG32thcOzB/uYHarWqxC3lCKM5x980AUIlZlHTaeu35jXIa/ETeOURge+412Eaq8jDcOPU4xXGeJI86kwUuRjk7uKAMzxaCINJB6+S386KXxgu2LSRxnyW7570UAO8DswvLxVYrmA9BmprdkGpqfvMT0xiqvgaQrrEqBSxeB+nsKuLPGZ9rqUcH72KAO+gdWjjC7lIHIGDSansaGGQNnbIDyMECm6c6NZxEOpBHV6tXEKT20gJ3HGeKANZVLFTgkYzwKa5QN1Kk8DFQ2jM1tGVkIyBUzZLryOOc0ANwQM5DA8fMME0o3L3JH93rTiGKq6fdH4mmlmc52AZ680ADPk4IAGMYAoBbKncoI/vDoKRdxJCtlc9G7U9dhc7oiyDqc55oAYQ7n92y4B6EU6NW3qQq5x2qzPAscYdRuyPulqqqdrElGJx60APZZC53fLjjB6Go5SVB3SSAdBxj8jRuOwZwynsTg/Squp3BjgfDYHYYzg0AZd7I0jNsPy9DvHWqp4IaY7Mc4xwaZNcsCJZduAPlxnJPtVnStC1PV7kSSSMkHXnigDON1c3TpBpyvFGScsBnNdZo3hQttfUArEc9TxXS6XptvpcASBR5p5LkVLcXhCnevGeSf6UAJBZ2dv8scEagdSRnHvT2uII8hXPy9GPP6VmT3xdXWM/Nj0warNHKyYkG5s8LmgDcjnLHcMFeTll61g+LLSJ7TzYkAmB/5Z9/wqe1lZrsQsxwBwvYVr3UasiRAbSzA7iAc0AYHhrQFs4FkuT5krncA3OK6ZV2gIrFUA6MMA+1KFKj7ufUk9KjmnkSBuPMwecHNAHn/xD0q41DULY2EBaRfvOh4qvaaNq8SLGyEJxyzbiT/SutsdcsZb8xkhMHlT1rQ1PULaNFdJCpJ+8BQBhaf4eAdXu23Ec9eDW5Pe2dlbsJM5/hA6CuZ1vXZoYM26l2dtoB5P1rltU+2Rwq95KzhzgIDgg0AdRLfPqdyXbdHbqcRKx5PvU28hAkgVQRwCc1N4Z8I6lryQNfMbOIKCB0yPWvQtE0zQdBhmit7Ay3UQ/wBbcfNu+maAOEt7C+uCPsljLJkjDCM4H41X1jwp4guiixaW4OdxJHJr1h9Zums0MFuYkzltzYBHsBVWHVXluWxI0YB4APtQB5e1tqmmWPk3GkTxn7ownH14qpZXMzMeXideNoOK9eOtyxTYz5irn5SM596r32n6L4jhaPUEGn3pHEsS7WP+NAHj9/JLBG0j3LHdn/WH+VcXe3rLMrhTkHAPQt9DXcfEnwJe6DB9piuHvLJz8km7II9/Q155b21xJh4tvlg4y2Wx9KANbTtedboebvWIkAo69K1NctNM1KF7u2ZopVwMRnrXNTK2d7sG3fKGPU1ajilt75bS8m8vcoZWT096AGW9xFbW583LSdQx5Nb1ndoyRosaEEdjk/hWPqWnzxyKbWJpVYZLAf0qja3Cw4YwsMHG/kAN/SgDQuvP03WBcLOnkORneOa7i3KXlkrrJIcjOB0rhix1K6itiPMkPrzzWro162mXP2TUTsHKqpHJoA6OW32oRJHlSOG9KyZF3sY3LBc5Y57V0MN3Gy7QQU6qGX+VV7mwefLnGSPTH4UAYbLHH8vnKM8getRoU3gRB1x1461antBCSR85xjjoP8Kh+deCuF4535OaAG4HK9V7ZOMU1kHVjlu7HofwpxEhcHzOnX5RStuZuUUt65P/AOqgBpXb8wdimMYC5pS5UjajkqODmmo+wkHC+oY8U/dK2BvBBHBoARJyMg7FbOBkZOKsWpMzgc4HJwcVAWcFMovX7oGB+dWLRcO7PGoKnqrcCgC5LcCN1RjvIyPlHNUpYonct5cgbIOSe9aDoFj3bo23dPWqsjck8FhwRnrQA+VmSNQxUEDOepqheRxTorG48ra2c4xmrIj8wkmNVP1zisrWrSHVIVt5nkHlndtUYBoAn1mF4NLeSxCSTKNyKy9T61LpcJXTomlcSTsMvuHfuKWwVcAAMqR4Xk/eq3iLa25SSvOB1oAs6dIBKoCFRj1qxrMiNInluCdoyBVfTCGLuw2oo71CJQ4YNsYZyMcZH1oArxl9zDpg+ma4vV3VtTn35btnPSu4uGCwv5IAPU85Jrhr2SU3YwPlJ52jv9aAM/xkAv8AZiAEYgPB+tFJ45lLatFEVAEcC4wOuaKAI/A5A8RRBiQGjdeO/FalwJI5yQcKG6P9a53w9J5Wu2LltoEoBI9K6nWMxX0xwD82RuHWgDptGbzLfkxhvTbWpCWKsPl9AFPNYmhSGZOUXkZwvFa8QVJfvsrdxj+tAE+kGRYmR1+ZGODjpWjs3DMj49KoW+6K8Ylsq44BFaLGJXHzheMkUARhhgkyLjsKcQpXOQwPpnikO1hudVPvUkbxt8i/Lu4HOOaAIyOflBX/AHuhpg8vftbJ75XOK0CsULFix9OOc1Ukk80gRj5T1wcYoARn3pgSAr+tJFtBG1MY9OAabIVV8MSrY4IGQPrThIuOMOev1oAYZSiNJGVBJ+83OK5vUpZrmdlT52Y4G3vWpq90sUbI23p25rY8JaOkUX2y7QeY3Ma44UetAFXw94UClbnUEBZvuoTXVnyoUCKoVF42g8VFeTKvXnjscE1mSiSVST5iIDnr1oA03ZDH5nXy+oz0rGkcTSNvOQDnAOD9cVJZusc5IcsrDDID1+tTm1IDSRKQCeFx29jQBTE+0FUQ/wC+Rmh5IfLB3PvzggVoJY3MuDvUL0wQKeunlJkO9WZeSaAHabbhIwW2b+uen6VeWNmy7MPRVHamghBgEFj0DVLMHUMyyJgYGSKAIrm4WyQzzsFjHVu35Vx+reKI9Rilt9OtXLnjzMbF+p9a09Rs4tRvVPnEwBeV5wT9KtW2kQR4J5xwM8flQBh6FoUcFt9oufmdhn5+tcl4vF+lwWAmhgz8hz8ufpXqZWGFzkAkDAPWm3NpDqFrLBKpYshwCP1oA8q8P3U91OJ792ZIwRGoHGfWur8K6Y3ijxTZW1wwMCyB2x1wPWuc/s9tPtLzLfvAxUD2r2b4O6VDZadBqL7PtMy8+w9KAOv1aGG3+W3ULECI/mHt2rDljjzhnaNQvynrn8a6bWisqIHIIfrjqKwblbeIFIXAjQHC9TigCndRTQKodjI2A2X6Y9qdbq5LiQRkSrvUE4AFWbaNpdkdm7SSnqrdCD25q5BbpasYpI9oAJPf5qAMO1jKeY4Tyg+cDOQ1QRwFnlWSQ+aOit39hWzLbzbEfAKxk4XoDmoXTbb+eY42kDfd3daALOmrBeWDabqkYNtI+3b/AHT6+1eM/EjwbP4V1cvbSn7NOC0aA8Yz0+tetPbzloEchfOO4qPb3qD412Mc/gaG9ljYy2rKQw6gHjn2oA8IktPNgDYEjd0C9DWMYXbVEinBwFyr9/zrSsdRktL0R3jFUk5WUEBfpTLu1W7vWvLdXdUPzPn86AOmtlmsdMm8kGWUrknqMVyLIl7G7vt2Yw/OADWvc6/b/wBntFAxeXG3BrI0bRdR1AhbeBxAT1I+XPvQBBprzafdi4SPAXgMBkY9augtqOoiczEyE55HSuz0/wABW8ex9RmnlcjkIcKK3YvDmkwFGisoxtGCxOGPuaAOUs77yCFcGQH863Y7lNgdAWHcMckVqNo2nSbnMSqfQVCNItEJWGRlB4Y5zg0AYF5Mm9ncEK3TtWdHC91MQh+Q8c1sX9r9nJTh177uh+h7VSgngWV/3exhwRnmgDNdFt5AhBz35yBR5gJCFfl6ghic1rOkU6kbMHurYNVLmFIogJCMY+UqMUAU2x3yeeAODR8jIGLlQMgqRimKw6KSg9utL5fyNiRcjqSc/nQA4JtYAbSuON2TWjaBUj5ZTnsKz4kZZEJKkDjA/rWxACkf3147hcn8KAJZgfIyQAccbhis2KNDMQykbe+eCa1WuY5EKkCQJ1w3U/SqM4kUh1QBT0OM0AMkI2MCFK+q9qh8tEX5XO7+8RmrsId4csqhRwc9aYVfBAdcemOlAEYh8yNRIAxz95KS6cqhWMZB4x1qdv3ag5GPXGDVJ8NIAvl4JzlQaAJrbdHbsEUKzdcnGfwp6FVjUMyE45G3pRGg2AOqn0O05psjkDy1GCT364oAhvWY2pwkYZuBkGsCOHyJRCWUySNk45xW7qHlTEL5hRl+bntj2rmtNlzrk8ssqlYlLncMgAUAcv4vnWfxDdFekeIvyorLupmuLqaZzlpHLEjvzRQA2J9kiPkgqwbI9jXc6+3mSrOv3JkVwQO2O1cJ2I9a7m1d9Q8LWk6kb4P3T7TjGOmfwoAu6JeLFChVsnODz81dbBB5txBgMQ/XmvPdOLK0igBgOQQc8122i3pFzprq6qolVXHfrQBq6zamykTjlSDxVlJAyqxXII9q9A8f+G0e18+3UvhASDxxXmti4jDRSOAVOMY7UAWgCwPlouT/AHuKchkjCn92BjnHelLFlxEmCO/tTNg3fMB/uscmgCQs27LIM+gbNRyFnQZRQM4yxwaPlyCFJA5wDjFNyinbtfJ/KgACqOcIB3AbmldlG52jKADjmlJgT7yAMeBxVbUp2ht2beI4wOSRmgChplqusa75R3NbxkM7dB9K7y5eKCPODjG1QDXP+A4rcabLcpmUu5wdvWtK+uz5rgYHHGBwKAGGQSRhpnJAP3Mc1XeRmkzEHOO7j9AKtWMTyNhnUZHPFXBZRNt3KcLySW5P4UAULOIyyqzqqKOzDrWy0xijbJTAHTbxSSXKwIVSPdjoMZrMvrqSeHY6hT1yOAKAJprlAyrkFiM/L2qe3QLGDIzD688VnaeN0w3KigDjdzn8at6rOtrbZklxnhVoAtWyCXc7cRjoe/1pbzCQlInDyNwM9BWZpt/ElqzpIWjHc+tWbS7e8DSKFIzgbhigAgVbeMBWVpCPmYio5LiMt87DI6k9PwqrfXkhcgKSyjBc8CqUbkkNJGx4+8TmgCS4ednOXCt2wOorbs42FvukYKgHOeprItYFmlDB9qDoTnNXtXnFjpE0uV2AYDdyTQBxl/sknkfaFDSHGByfevZPBkJtNJtQSPmXJOexrxs7zEpeLey4YnoMV634Y1ET6fEgULtUAqFzgUAdFLFlSSXdFORk/wAqr+TEpMs+fNyc8dvSrJZBbbgXXB6DkirFtCk7AkNljlc+nqaALmkwWsDBwoMhHJx0qpfI7agzGPcinkJ6VPGxtroK6FgB25qxG6QA5ctOeeR29xQA4WaSWTv5YEjKdoJziuZktIwqsRuLHaVz/SuiN1IG3L8qhuc9GFZ9xYmO6aeL/VA5OenNAEtjFHCkEb2xJXld3ajx9bJeeENRt5FHzxHap9R0qcjz7tVjXK4Cn5eo+tYnxKung8PTRROq7f4yeRQB816rZM+ieWiK5xkEcjPpWLYTXAs5IriVYhGPm5wT9K7O6cDTZCQGDKTt7n6V5u/myMzRqSoYjZJwR7ZoA7z4feGYLyVru6VjZocqSOXNeiedDany1+WMDonpWJ4CkA8OwKySJjqF6VdvEP2l9hDMB36gUAaytuX5QzqecZx+VZuqSPDIoV2UkZyMEY9DUun3hgRba7wU7HOSKg154Rb5T52B5IXkigCxp13vQxS4ZexAqpcXCQzZ3NtH+z1qppMplmzgleCMHBH4Va1YLIMnhl59M0AOkW3u4gJAWB6AjArA1fR5EjJtgm0jqOc1atLphOokJ29Dz1q6L5klIO1os445oA89h1K7sbgxSbHRDzvyMfSukW8j1CxzAUZePlb+VM8Y6JDeWwuUZomXn5O9cbbwyRShrYFVXjexxn+lAHT8F+Y2bbx9KUKHUZCwlR09aLW5yBFeSbmxkZFaCCMgMm0H1K5I9/pQA2ygI+eTc4HI9ausQsnK5JHRe31pq7nlU+cz4XAx0/GtC3tGbmcI/Gcrx+dAGVDpxjdpEG136+9Wfs0rDaySKPbvWwE2qFZPkA696lR9o27+nIJ6UAZAsyg3CJue7HNVZxGhO6Qqf89a6YIjqdwyAMlW/pXN60FjnHlBsegOaAK08p/dhVQ7e5FQRIXYDPOeRSsHc8AMSM4AwRVmEmKIkKwPQqRyaAFUtggZwO5OKhlnjiZnnzgDpinqAQTuCnP8Rx+tYevXEsUbRFoxxwc8UAZetakkmZIC4OcKq1Tad7Lwve3MjAzXH7ldwAznr+lVrna8sUJVBn9TTfHLpbCw0yFsrDH5jjryelAHKgYAAopaKAErp/BU4c3mnTMAsyb4wf7wrmamsrh7O8huY/vxOGFAHQoTbzlTEdqnnaMZretJpEgDxHywhD4Pt/Oq+uxrIsOoW4DQzIGBzgA9xUGiXpWUDZuJOCF5/DmgD608PalDrvhvS9VRhJC8QjmX0xwa8z+Jnh/+w9aW/tot1rNyD29xVP4YeKD4evTpt5EBpN3zjdnYx7+1ereKNPtdd8K3NtGRK0SebAQ3JxzQB4zDMbmIOuSh6Y4AqTY21gjADuc1gQXjadcLG6hYJDwSeh9K3I9kirgs2704oAUoFJO4Y746mlikG0FVIH1zk0iRoHGWQnpgnOKcGySpxj+HAoAa53tkR5zz1rnvFjslmETCqTgkniukcfN85Qnt9a43xPKLrV7eBmV/mA2jpQB6B4LEcegW8e7aAMnHetT7Gjy73wV6gVHYxi3sIYkG0hAeFxVgRlySylRt6k8mgCU+WibRHgdctgZHtUbzjbuZUI9Mf1pv2UM6mMt6HJ6GmTWWQVkc577aAHrcxMQFVSQOxyBT2TKjAiC/3ajitI4F5Uc9cH+lSyHJASRNwHG4YxQBREMkczyKNqsOO4H0rmnjGq6q6GWR0jzluvP1ra16e5jZLK0k3zOOSp4UVRt7GO2Hl27BJG5ZgeWoA1LC1W1s/s8Maso5wTkn8aquZERokAQZ/wBV/wDXrYsmaG0ALKp9R3qESpOSEILH5Q2OBQBlSRHysMzI/rnI/Gq0U4LrHC6u+cHHH6VpXNlcKg8pg275fXFULLSpoLsSvhgDzjjmgDY06JkUFgN/8RxmuY+IOoebcWGnwZyX3vg88dMiutubmHTrSS4mKIqLknPWvKraSTW/ENxqDyB4x90L/U0Abc0f7tlk5YrklWqz4R8VzxuIJZfL29O4YelUdReK1spTuVQwwoI6mqdtZRxRwS3RILDhguADQB7h4W12z1GfyJEcTDllHANdgrCYbB+6UDsOOO2a8I05LiwIuobseUFz5g6/jWpD8QZyfLjuVlHOFC8g+9AHsw86ZdkRIA7HqfxoW0l6qo5+8ScsK8JvPHGrXIKLPMsfP3TtBqG08U6lBOjRXcqSjvvJH40Ae8Mo2CDbId38Tdc+lW0CvaBNp+Q4wf615jofxMeYLHqMMcpU/f6NXRT+PLBbWR7ZJvtDDA39AfWgDrkDJJGEXHHIHT8a85+LOp2a2v2UhWlf5evBNcvc+M9VhFztupHaTgn/AArgL2/vZ9UWa6MjhTjk5GT6CgC3fjyNLnIj+QKRgHJFeZeUGYkkyr1+XJx9a73xQ8qaO5Ux5fueoFZnhK1juLa+uZJkRYlHyrzk/SgDf+G2qE/8S24YfMMoSe1dDqAmtrg4Y7OzdRj0rzS3mks9bS5Vl2RtnjjI+leqRTR6nYo4LLuH3h2+tAFDz3RGkAMi9QP6Vejura6jj+zMsU5+8Q3I/Osq7tmtyTGwlI5PzZrF1S2jmRn3SxuORs4IFAGib9LXxDHDHIh/vMzYrQ1+8MqxIrrKSccHGa4JdHB3MGdpscGTk10M0zLo6Q3LhsEBWHB4oAnii810VxjBxjdyPyrWQwWowXIPpjOaxLV/MjBibcMdfWrG1y6jJT6DK0AdD5v2m0k2MnIwAR/SuK1aPycgBkCdAoBBNdrp0KiJm2jJH5VxfiMH7aytIqxsS3sTQBzv2lxdRBkLFn5XHGa7W0tppEUxFl46fexXN6GM6hK8TMUPADDI/Cu60uBI1JLMJM8jGCKAJrO0+zxg4BdgCx29/pWoI5CFIRue6kHFNi8xM5YgY4JPSpM+ZIpzGzA4+VuvvQBGxaNzlsbepHNN8zKsBk5744q3wp2sjRseOO9RDez/ACAP1IA60AM+Yx4JRl7EcYrltUAmmLbxjOPxrodQdEgyQY26/NxXOH95KCwPPcHn8jQAlvEoUMHyy9CFp9yxUANLjnJxU0jNBF975vpx+lU2uWJ7MpG446UAQ30kUKea0hOTxkYxXNavN9oufmj2oozuByDVrWbn7TcJE8beWp6o2cViahPHAjIZGUuep/qKAJdEslu9Y8xgoSP5m9MVy2s3Zv8AVrq452u52g9gOK6yW4bSvClxK+DLdnyoyPfqfyrhgMDAoAWiiigApKWigDqvB10t3b3Gj3J++N8BPY9xTbhHs5vLCuCh5/2v8K5qKR4pUliYpIhDKw7Gu9Fz/b2kC9hVBdRfLMpwDn1x6GgDW0O6F9AImO3A6L1ruvDfi650J1tZGZocYDOcjB7V5Dpdw9tdhmHyZ5OcCuwkji1G0+U79w429AaANfWreG+t5poSmC5I2r92ue0nV5be4azug6EdDnrUnh+5a3drV0PlscOWPP4VF4l00SN9otgxli5DKe1AHVW4SRAVVgpPVuOacAoON6jBzk81xeh6u+wxvvZwf4j0/CuiS+3AElWz2B6UAWLuSKOBmG2QnpgVyFm5m8U2zsUCB/4RW3qlyWgY4wuOgbmuQt5Hhu0lDhdjZ9/pQB7leOFjBiBL7eDnpWfDPMsql5HkPXb2rRs5Ev8ATIpcjYyDIUjr6Gs6aCVJBsJSP8s0AWxqkm3DKvB5BNL/AGjK77VxnuB0rOeGNgMshI7dzVq0iUSq5YKw4xjpQBZCyTgkRkKDkt70SSmJSW2sOgOMVJczxxxD5yVxxk4rGuZmmk5k3oOmKAKiBjeTTgBWY7d45OKfaxul55ijJPGWPFSKnmFRsIHbHQUu9UdQsZduPmPGPwoA2iJfsoLeVEG7dTWE+I5jJtdgDxtat5wklu3LBsenWqVrZgNuYfMODQA6weYxlim0N0BNWriSG3iaS4kXCDnByabdz29hEGmcgjpzmuT1K9k1NuEC2wJOGGM0AY3jDWJdSJSGOQWa8MV5JqtYXEMEYjgftyoGP0q9q0SraOFCrnAypqlY20cMQ/d8dSxHNADgv2nLsDtXnJPP/wBao5riW6lhgijklG7b8vUE1Fqd4PKaG3dUc8VufBW0/tDxXDDIgKRv5jSE8HHbFAHuXhjwXap4at7fUIyZJIgGHcZ/rXm3jb4bWPhMPqFjfSiO4Oza4yyfQ+le9XlwLS0lnZWYRqW2qOT7CvNPFFt4r1vTGnvbG2js1O9bZTucD396APHhBGBvSY/UHg/hTo7ZQSHYhsZKkY/EVJd/ZrO6ZGAUlvu52/lSPMrspMkYlPCrkE4oAYbWS8XybSOR7p/kjA6k13/hz4X+Jba38zUL62ZyMiIZOPYmsXw1e22jXiX19HLMkZ3ExIWK17t4a1+w8R6at7pkpkiztYEYZT6EUAfPnirT7rSLwWdygS4fq3Ye9Zd4kiWyxRbHmQhhjv8AWvTfj/oJk06PXLV9tzCPLZSPvDtXjOn30l60bxuFuEG1x0DUAX5VF1atFP8AKpB3Bxlc+1che2jWjukEm5GGCIuCPqO9dLqM8wBJiIbpwcg0+20a1nsleVGWduTyc0AcbAwMbJtk3r1ZupFeh/DrVPPt3sWJEi8gOeTWLc+Hv3J+zyHjt2rDimuNK1GKTytrRt94cbvrQB6NqsHlzsWwBnIA4xWdd6dPdRFIw2B8xcntW3Z30Ot2KyI8RYD5lPWrzyx2liFRNoxglRkH/CgDkfsM6ITIrFYxncrcmqtwFuRHFPKUSQ4Dovf3q/qNwz+akDEBhjHr+FZDQMtvAIpDvVwWiccEUAauj6OtvKy+c7IOB7/hXRxWNrEgLqqnHPJINZQ+VQ8iEY5SRO1NS8l+6zYz3znNAG6JFYGOMZjIxxjgV5x4slmh1UpENy/XGf8A69eg2wj+zFgyo+P4jjNcLdQnUdbfftKoenr+NAGr4RsXjjV2UZf58OvP51174KfNgbePXFVtPiWK3QKCSBxk1ZBycptLkcgigCaBSygMq5HRs5zUpSMAeYFDdiOtVIyEZlAIJ6qe/wBKlLMqENGzqBjIGcUASs42hRIrEHgZ5+opCxy5cZHrjBFR7Yz2PuGqtqV59mt8ZGewzQBk63dPJiKNmZTwc1UtUAQfKdwP3TwR9KrA/aLtpGUJu69cE16H8PvDf9rT/bNQUf2fbclm7sOw9aAM2fw5NDoovpFZVk52n0rhL+9aO4fBHAwoK8nFe8fEu9ii8LosgWNrmTZAmcYUd68EuYrf7RI4bZjgbxmgDBjeR5pZGcrgZAHGD9KoW0Ml/qYjJEgJx6nFT6pIyo0aOAWOSQBU+lyLo2k3GqSyL52NsK9CzHpQBkeOb1JtTis4MeTZpsyO7HrXN0sjvK7ySsWkc7mJ7k02gBaKKKACiiigArQ0LVJNI1BbhMtG3yyp/eXv+NZ9FAHoGuWVvLCt/Z5mglAYD0+tP8P6qUYW8rhYvU8YPpXP+Edb+xSmxvW3WE5xz/yzY9x6CtbX9OfT5gyCPyGO5XxnNAHVXFojsJoJCZj/AHRjNZUl7c2lwom3NGONvbHvUOi6yxdIiV2gY3N2roJ47eaNkY+YW6kDigDmNTsJUkF5YD925yVNSWuoySYLA+ZnGFXAHtWrFM9gRFJGXt8YVvT606WyikXzIMBzzkdqAK4KmPM3yknhV/xrJ1XTGj/fwtuUjJQHiuktdOWdNspJA554FQnTJbd2aGVZUwcp1oAXwL4ofS5UtL4KtpIcg91PrXqO5L+LzoG8yNxw3avB9XsGgmDxRHLc7mO4j/AVpaB4nvdHdVaUyoePKJ4oA9Ym0/BKxvlvTH9aRLWaNAWZQq9W9Pas3RPGtjqCiOVlgk754Fb6XdrKMLPEwJ9RQBjSqXZ22MVzjL9/oKFiym1RgfTitl41xkKmfUc0ggUElclunFAGKYZ8gh1AIxwO1WLW0EZVyCGB5INabQJH1ZQcck9aq3eo6fZoWeYNIvRBzmgC9HxGABhT0A/rWdqGpw2w2qQ0hODtFYeoarcXZxG5gtz/AAr3rIe4hh+XO9+uGbOKAL11O08haXcWzwuay7jU4oZWTYRs75zU4keRCFdcnnGP51i6viAxW9srTXEh+fjhaALX9oxywE3KoozuUdT9ax9T1ZJVCW5fcT91T1qSfRrzUZE80CGNDjA/iFOl8Oxxyh4CWRB93oaAEt7GOS1T7QW8xs7G29z616t8D/Dy2GpeaSpbG4tjkn/CvP8ASZRNcqHjxHEMEdh/jWzceLLrRti6e3kIzYJI5x6UAfTUkqCWOJuTJnA+lS8V4l4T+JyNfRNqRD7tsIHdF9a9sVg6hlOVIyCPSgDzf4veDrHUPD93qMEKxXkC+YWUfeH09a4b4M/Ds6hAdV1gnyN2I024L+v0Fe/yxJNE0cqh0YYZWGQRTbS2htLdILaNYoUGFRRgCgCrY6Pp9jAYbazhSMjBG0HP1qppmlRaZrl5LaIkVvdorNGgwA68Zx75rZdgilmIVRySegrhvEnxA0fSb6ExTpckbkkKHIT/ACaAKnxmlEugG1VwN2dw9a+ZbGCaGRp42Cxq5BA/rXreoeLR4iv7gOgZMnaMcYrgLlFg1qexVQkcg3BeD+NAGjb4uYQqoowM7lNS2xkDDfhc/KCD2rm7a+W3uXimm2BT1/pWrHqdtcHybdw8zc49KANbyyrAghNvGQc1R1TS4LqEkjee5Bp0cpjjAfeV/ibuKtQyROvysVI7DvQByFhLNomqbIzsGc4JyCK9Ot3TU9ND2zDJXOB2PpXH61p32qEtESZE+Ye9Zeg6zPpdy4feUP3owDkH1FAHUmwkedVwQV6g8Vdns0WSFpFVifTqKsWOqWupwpJFsckfMM4cfWprq3fzw8Z28dBzQAzVIYTbKyFBgdOzVz6QlpgGVcrzwcfjit+8Qy2+Bt3gYwOKq2unklHlDMF+7nv+NABfMsGlOXT+Hhh/WuY8OOXvGkKJtznIPWtfxXfxCAWsbEOfTnFc74YklOoN52cDqVGM/hQB6HA8YUhcLu7EZApzYIZ/vEd0bBH0qODLqByR6jt+FSvHlg3l5OeqdPxoAYhAHVyoHcZIqdEDKAmGHcg9fqKZHGfNyuOB0Peob29itk/eRgSdAPX8aALM8vkRfvFU46Fjg4rk9TupbuZlCKsY4GOaW+u5b0su11j6DJzipNOtGZ1jRFdj2PrQBq+FNBn1rVILFcFH+aSTHKqOpr3Vrey0nSwjlLXSbRNzE8bseted/Dq/0fw3b6jd3sxWU4DL97aB2Fcd8Q/GuoeL7kWtislvoqHIA4aQ+re3tQBS+IPi0+KNc82IZ0+LMduq+ncmuV1eeC3tArxkHqCM1owottHuj4C8k46/hXE6zdHUr/YoKsD90gkH6CgBdHsjqGpIyPKPmycqDgVX8b6ot5fLZW5X7LaDaNowGfucVuapcJ4c0NRGii/ul2oc8qO5rz/nuST1ye9ABRRRQAUUUUAFFFFABRRRQAh5rrfDOvRtbrpWsMGtj8sUrc+X7E+lcnSdRigDuNVs5dLnCrGHiPIcDjFXtK13BMFwAqrwD1rE8NeJVgg/s/Vz5lkeFlYbmi/xFaOs6OXjW404/aLd+UZRxQB1azRzKQpDqR27fjUID28hMTHYByQOPpXGaVqU+nyFbgs8Q42njFddZ6ta3a7UI8zGNq9aAJ/MknAJ3KMdBVrTpIUuEW+mEURbBZecVVkimky8MmzsVBzmqsw89Gju8xBey8ZoA9g/4VdaavpqT2eopLHMoIfGRWNdfAmeR/3epwqg5+5ya5Pwh4q1vwoqppE/2nT2OTDP8w/A9q9M0T41aVcMItXsrizm6ZUb0J+tAHC6n8DNetonawvLW5XORHyrfXNcdf6BrOjXHk3FvPDKvXzOPxB719Ht8R9FaEtAZZGxkLtxXmXjjxafEE6xRwAKv8T8ED2oA85TUNdtyAbh0jUdWNXbbU9Qdf3uoSbW4AHHPrVqaPem3Ace9PiiRXb5EGOtAEtvM7x/6RfyuQOV9qezwxIDDt9SxXOPeooUUfMI1XPfoSKl82MKVwuO5oAy797xoWe1VnU92GPyFVtFllNpIbpFMhbBz/KtGf8Ae4gi34J5OccVJHbW9rH2Q9PnOSaAKFzeyAtDbwnceAWHA/Gm6bbmK9aa+WTzGHDnkfQVpQxnJy4x0BxzThFyxLggdvQ0ASKCHdt3BOQrUsfzEs4AY8DmooN+DzznBJqaU8AR7fXI5zQBlyMlpeF2Y/MeQBmrd1BBOFZ4icgY56fWnvAs2N7bscn1pqoAhVVfr3NAEEthBLEVChWB4Yf0r1n4KeI7+aSfQ9TnM4hTfbyN94KP4c9680jRgPK+VgORjjHtW58O5ZI/iBpoiIQOxVwvcYoA+hbidIVyx59Kz/EeuWmgaTJfXz4RR8qj7zt2Aqjf7rjxLDb7XCgBtwryD4s63Jqni02qyf6HZny0UHhm/iJ/lQBF4m8a6x4i3Qz7rSxJz5MRxuHue9chdWltJdHIYORjaDwRWgyEMGyFXHrVXyHMrO0oZj7dBQBWtrCW3nWRDtQjkk84rJ1zzZddSS2h8wBMZHBFdBebgUj8wgn05z+NSQRMsY3xjJ79/wA6AMSz0mCaFpbu3G+T7wLdDUenaZHZXTnzCSDxnqoronjU5Dde4NZl9EltL9oAyVOG680AW+H4LHao596oNOI7tt/yRFflIqxazpcFngV1GcEe9ST2seGMwJZvyNAEVhrEV1M8UZyw/vDH61X1zTfOj+1Wu5ZE/CrMVvDF5YWMYB646VO/2hJ/3eDERjaaAOWspp1ud0LGObqykd66G38UXFuRFdLtKnhiOtU9T0mV7lZ4CIpgMnHQ1Rvo79o/LubdZlxluf5GgDpG8TuBukWNlz8p9ao33imXaFt9yevcD6GuP2BDtxIoBJVc5GfSogztxG5R8H+GgDSNw93fhp3HmjALH09665MRLHkKpPAZa4SKG7dkXYX/ANvaen0rsbCK4igjMq845B6EUAbcN+sRBcsxHUDrUg1dWw0LSoo9RxT9I0LUNSdRYafcuSfvsvyfnXX2Xw41t4/3nkW467d2c0AcRc31xOCmSEPzZ28VWFtJM2XZSfQnOa7/AFfwDqVhaSXbmBxEu5mj4wB7V5lqOuQqGVY1YepOPxoAvPstt5BCEDnByDWbHr7wF9yheCoKcH8qwJr291KULCrABuGbmtrTNIwwub7Mk46AH5RQBNpZkui9xdFkU/dDcg/WtGTPy4wrdjTZZkjhLuwC45HSuW1jXGG6CzcjP8R+YH2oAb4k1VXJt4A3mDhgR1+hpdBtYbW0bVb9lEUa7sPz+VR6Jo7Suby+YpbgbmLH/GsPxbr41ORbSyIGnRH5MLgufU0AZmualJq2py3cg2huET+6vYVQopKAFooooAKKKKACigHBBpWO5i2ACTnjpQAlFJS0AFFFFABWroWv3uiy5t2EkJ+9C/Kn6elZVFAHoSDS/E8ZeyZIL0feil4JPsO9ZV3p93p0hW7d1bqoiHH51yaMyOrxsUdTkMDgiup0jxhPAiwapCLy3xgt0cfj3oAs2es3EW3BPp6mty11W3mUfagD757+9VI7fRdajMmmXawXHJELnDCs+90a9sfmkUtH1AUEk+9AHUR28ch8y1kXA5C84qQyRE+VdKA3rjg1x9tqssJJld48dsYNben63Dcx4lUOOxIwR9KAOms5SsSoh4JwMU+TaZAoUEjjce1ZFtc5f9zIWx0Q8D8KvI2CpYjce3XFADoXMZcIgJBwC1SJwzOwJxzwOppFcAcYXnBzzmlHGcsAB1yaAEbeSSxKjPfrUbKG+6M8Z54pFYmRj/Cfut61JHwu3AH+0TQBGLbMu6RjnrtXoKJIg0gJjDNnr/dqViVGEOW6nPemhSr/ALw7yTkgHAoAeR0UNj/d5JqRYdh4OcnpSKNvIVVHXryaYVLfdZgDxntQASEISBuHrgZNKoKgOhIx2xUh5DDLEdCT3qJh5e0/Mw9CaAFD4dRvw/8AESKc4Uqx+8e4HGaSN92S+ORk4NIzMVwhxxztoAaH2yhSmV29c12fwh04yeMzdMxaOOFmAI6H2rjoELTr5ac+hPWvVfg/ALe2vLpw3J8sDHQ56UAdzqJisItR1NnYGOE/hgf/AKq+XLOSW71W5uLjIy5bd1JJPNfSPjG9EnhTVQVC7osAd6+f0VI48hACwxk0ATlFc7d4/wBr3qMqAmATkZ61F83OCG56VKDyUY4BHy47UACblQfu1GeM9eKa4f7obaM460seNg3MylRyB0NIfmJAQnHcjk0ACLJuKknpyxFIyqFw/wAwbjBFEahlIZmAz0PX8Kex+6OSB+lAGa1pHHdDyWeP8eM1atw5LBwS4OeKfJCTIjxNlT1VufyqTKliWzGw74oAa7ogBZmznj3HpSAAKDnKnpmnvuU4OHBPVuRSoWB6ZB5x1wPY0ACkLu7kngdRUbdPulh154Ip2Fddw4x0YdjSBmA2lgzDrnrj1oAzLvTIrl825w/UjjrUUemzJtkAVmHDA1rKgxtyFbHX1qTYQoIyhxwR3oApXOsAtFBNFHEy9So6isS58QTm5EdqQMHgMOD+NX9YtWvZkUFIycgyMMU/TNNtLNRlDI5+83UUAaug+NfFVmqpbyeVGDynavStO+LFytiFu9PSW6UYJWTANeaALtDjBbtxUcskaupLhcfnmgDb8YePfEOuwS2hItrSQEGKAckehbvXAxaLNMA9w5EJPzIRnHvWjda3b2xKx/LIOMZ61h3GuXMxChNhz/D3oA3ozb6XEI2MagDIZeprOufEbMWS2jZm+6GUZqlY6dqGoyESb0jB438rj2q9dXukeGIMHFzfn/lmh6fU9qAIE0jVdSlEsjssB45Pb3p8sui+H4S8s/n3Q6Qodxz7+lcrrHinVNTJVpvIh/55xcce571h989/WgDa1/xFd6wQjKkFspysUfGfqe9YtFFABRRRQAUUUUAFFFFABRRRQAlLRRQAUUUUAFFFFABRRRQADhgRwR0Irf0rxbqun7UaUXMI/gm5OPTPUVgUUAehJrHh3Xl23yNZXTDGWPy/gRUeo+G54Mz2DCWLHy7TkmuBq/pWsahpT5sbl417oeVP4UAb0H2+zkP2iNlI5+YH+daVjr/OHIYDjGOais/HUM67NZsQ2ePMj5AH0q9Fpmh6uPM029jWUjd5bcMD9DQBp2+rW8sfzMsf+9V+K5GzcSr56AdMVy1x4Zv7VTIu2UjOPas8TXlqxWaOWM9iOQfwoA7yOSKYByVIBztXgVKdgXG35etcNDrKrgOcuD/DxzV621Wcodjqcdd3agDqUHHUgdsjrQ23eMng1hDWJU2ZhLt3x6VMutW/Ty5FY92HagDYCqWJ2AEDj3pN52/NgjsqjgVmrqdq6syykp0qcXtvtG1/cigC0JUYHJwy8gGn7iQS7DJ4Ix2rMM8Lu8yTLnuPWlGpxFSyKeuMGgC/jeV24Cfd49KcrxR5XkqBjgVkT6lDHEAX29+DzVR9Xd0xbwvIV6hR1oA6BfkmMqygAjgA816D8L/FunaXaXcGtXAhO8NHkZzXj6JrF0rBLdYB1JY5pv8AY1y8Ra4v1SUEZwwHFAHvXjfx7od3oEsGmzrPcTEKFKkcfjXjS6w0k3l3kf8AHtAA6Csw6Dcrnyb7zehHOaYbbULec+ZCJYzwStAG+jrOXAjKbWwuaAGGIy2ccisW31eIMY5wVdezcflWnBcJOF8t1wO4PWgC0MCRgGz6e1CMW4JyQOgNRJKqkjID46+tL5qb9p6e3agCXhRt3EjPBIpWGE4YBge3eoQ+8gR5z0NPCuCjOuVHoevvQAkJEkmQ2xPp1NO83dKULY44PtSiUglSMjsPWkbIAK/e7Z6gUAIzNtwCSw43D+tIG2rzlD6epp/BBUY9/ekJGFDYOO5NAAu8NnaQvovOaaPmAbcN307VXk1KC3HzPgexziqj6ojSjajlR0fpn2oA1DKFGJB5m70H8qiw3GEYY7A8fjWNLrMMJP8AEp7A8qazrnxGQrshAAGDzg0AdFICR++kG3+6/Wq0l3b2zbYFaQk8YPSuZfVmcfODIW565xVixS7v2KRxnZjK5HX8aAL1zrh8wjO1lPIXisi61A79vzbXPy81r2/hO8kDGWX933HXIqwdN0HSo/8ASrtAw6KzZ/T1oAyNL0u41Fl+WRIgeXYda2L290Dw+cSyC4uVHMcfLZ+vasbXPG2YZLXREMSsNpnI6j2HY1w55JJJLHkk8k0AdTrfjW+1ANFZqLO3PHynLEfXtXLEkkliST3JzmiigAooooAKKKKACiiigAooooAKKKKACijvRQArKyxiRlYRk434+XPpn1pvbPavY/glBDdeHtRiuYo5ovPZtkihlztHODXmfjGGK31aVbeJIl81uEUL/KgDJpKUUlAC0UCigAoopKAFopO1LQAUUGigAo6HIOD6ikpe9AGvp3iXV7AbYLx2TOSsvzj9a3YfHbSYGpafFKBxmM4OPfNcXSUAeix6r4V1EgSbrZwMkuuBn61Omk6Pcgvp2pxbCOcPxmvM6ZJ1P1oA9OfwxdsuIbpW77lbrUa6Nq8JAZAw/wA9a4G2vLqJQI7mZB6LIRXUeHr+7cLvup25HWQn+tAGo1hq4Tm1RsHBGOtSW1hqbL89squTy39Kmmurjy1Pny53f3zVPWbu5WFcXEw47OfWgC7HoupnLFoo89qSfTYIVL3+qxxqODhxXns2oXj7g13cNyesjH+tZ6nLEnk+9AHo8mq+GdO/1TvdTDkFQWB/Gs+58dMjEaXp0UCHr5hyf0rjVH8qQ9aANm88UazdqVkvXRM5AjG3H5VkSSSTOWmkd29WYmm0UAWLa9u7XH2a5mix/ccgV0em+OdUtcLcrFdJnksNrY/CuUNAoA9Jt/FOg6moW9ia2kPJ3jIH41bGk6feRiXRr9QWHASTj8q8qPahXaKYNGxRgeCpwRQB6Y9nrNsPnRbhRxkHB+tRLc3NrE7PDKrA85GaPAd1cS2TmWeVzuP3nJrtlVWjTcoOTzkUAch/be0ZDYx2209dcw25ZI8MMYJ6VvXcEW5f3Sd/4RWDPbw+fjyo8ZP8IoADrBZcmSLAON3pTF1aYsPLljII4HertrBD5M37qP7p/hFcvNGilgqKAOmB0oA2JL64YqWnjUD0qjdThjue6Yp1POKyASbSYknIY4qXTQHkkVwGGzoee1AF2J0ZwLSB5JTyM8g1rR6LI8Il1ab7LEDlsHHFa/heKNbXKogIXsK4T4h3Ez6oI3mkaP8AuliR+VAGu994YtHIFw0xzneikj8amN34SlQt5qox7EH9a85/ipMdKAPRRrnha1UCON2K8/LGSD+NVL/x2ijGk2KxOOBLJ6fT1rhj0o7UAad7r2q3j5nvpvoh2j8hWY2WOWJJPc80UUABoopKAFopKWgAopO1FAC0UUUAFFFPtFD3aK4DKR0PIoAjyM4zzS13Xiu2gg8A6Y0MMUbNc8lEAJ4rhKAFopKKAP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Abdominal computed tomography (CT) showing a large area of infected pancreatic necrosis (arrow). The necrosis developed after severe acute pancreatitis with pancreatic duct disruption.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dia T Simmons, MD, Santhi Swaroop Vege, MD, and Suresh T Chari, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Infected pancreatic necrosis percutaneous drainage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomography (CT) scan showing a percutaneous drain catheter (arrow) inserted into a necrotic pancreatic fluid collection for drainage and lavage.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dia T Simmons, MD, Santhi Swaroop Vege, MD, and Suresh T Chari, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11977=[""].join("\n");
var outline_f11_44_11977=null;
var title_f11_44_11978="Microdeletion syndromes (chromosomes 12 to 22)";
var content_f11_44_11978=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Microdeletion syndromes (chromosomes 12 to 22)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/44/11978/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/44/11978/contributors\">",
"     Carlos A Bacino, MD, FACMG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/44/11978/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/44/11978/contributors\">",
"     Helen V Firth, DM, FRCP, DCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/44/11978/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/44/11978/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/44/11978/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H8964669\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chromosome deletions that span at least five megabases (Mb) are usually microscopically visible on chromosome banded karyotypes. Microdeletions, or submicroscopic deletions, are chromosomal deletions that are too small to be detected by light microscopy using conventional cytogenetic methods. Specialized testing is needed to identify these deletions. Microdeletions are typically one to three Mb long and involve several contiguous genes. The exact size and location of a microdeletion that causes a syndrome may vary, but a specific &ldquo;critical region&rdquo; is consistently involved. Most phenotypic effects of these microdeletions are due to haploinsufficiency of a few critical genes or in some cases a single gene.",
"   </p>",
"   <p>",
"    This topic reviews microdeletion syndromes involving chromosomes 12 through 22. Microdeletion syndromes involving chromosomes 1 through 11 are discussed separately, as are microduplication syndromes, and congenital abnormalities of the sex chromosomes. Other congenital chromosomal abnormalities, such as trisomies, are also reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/14/34025?source=see_link\">",
"     \"Microdeletion syndromes (chromosomes 1 to 11)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/17/37143?source=see_link\">",
"     \"Microduplication syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/50/10024?source=see_link\">",
"     \"Sex chromosome abnormalities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/0/23562?source=see_link\">",
"     \"Congenital cytogenetic abnormalities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4404803\">",
"    <span class=\"h1\">",
"     OVERVIEW OF GENOMIC DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genomic disorders are diseases that result from the loss or gain of",
"    <span class=\"nowrap\">",
"     chromosomal/DNA",
"    </span>",
"    material. The most common and better delineated genomic disorders are divided in two main categories, those resulting from copy number losses (deletion syndromes) and copy number gains (duplication syndromes). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link\">",
"     \"Genomic disorders: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Copy number variations (CNVs)",
"    <strong>",
"    </strong>",
"    are submicroscopic genomic differences in the number of copies of one or more sections of DNA that result in DNA gains or losses (",
"    <a class=\"graphic graphic_figure graphicRef67644 \" href=\"UTD.htm?40/28/41412\">",
"     figure 1",
"    </a>",
"    ). Some CNVs are pathogenic and cause syndromic disorders with consistent phenotypic features, as are discussed here. Other CNVs are associated with disease susceptibility or resistance and the same CNV can be associated with several diverse disorders. Still other CNVs are part of normal genetic variation and have no recognized disease association. Contiguous gene syndromes can occur when CNVs affect several adjacent genes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/63/5112?source=see_link&amp;anchor=H14#H14\">",
"     \"Overview of genetic variation\", section on 'Copy number variations (CNVs)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=see_link&amp;anchor=H1031916#H1031916\">",
"     \"Basic principles of genetic disease\", section on 'Copy number variation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The main mechanism that leads to disease in genomic disorders secondary to deletions and duplications is a change in the copy number of a dosage sensitive gene or genes. Other disease mechanisms include interference with imprinted genes and with regulatory elements outside genes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link&amp;anchor=H16722227#H16722227\">",
"     \"Genomic disorders: An overview\", section on 'Disease mechanisms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Genomic disorders are typically detected by array comparative genomic hybridization (array CGH) (",
"    <a class=\"graphic graphic_figure graphicRef58888 \" href=\"UTD.htm?28/63/29687\">",
"     figure 2",
"    </a>",
"    ). Most laboratories confirm gains or losses detected on an array with an independent method such as fluorescent",
"    <em>",
"     in situ",
"    </em>",
"    hybridization (FISH), multiple ligation dependent probe amplification (MLPA), or quantitative PCR (Q-PCR). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link&amp;anchor=H15538652#H15538652\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\", section on 'Array comparative genomic hybridization'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link&amp;anchor=H15538631#H15538631\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\", section on 'Fluorescence in situ hybridization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19035904\">",
"    <span class=\"h1\">",
"     13q14 DELETION SYNDROME (RETINOBLASTOMA SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with microdeletions of 13q14.11 have an increased risk of developing retinoblastomas (MIM #613884). Intellectual disability and facial dysmorphic features also may occur and depend upon the size of the deletion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/1\">",
"     1",
"    </a>",
"    ]. Retinoblastoma is caused by mutational inactivation of both alleles of the retinoblastoma (",
"    <em>",
"     RB1",
"    </em>",
"    ) gene that encodes a tumor suppressor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/18/32042?source=see_link&amp;anchor=H11#H11\">",
"     \"Pathogenetic factors in soft tissue and bone sarcomas\", section on 'Retinoblastoma gene'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27018?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of retinoblastoma\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964739\">",
"    <span class=\"h1\">",
"     15q11.2 DELETION SYNDROME (BP1-BP2)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The region proximal (more centromeric) to the",
"    <span class=\"nowrap\">",
"     Prader-Willi/Angelman",
"    </span>",
"    syndrome region in chromosome 15 has significant variability. The deletions and duplications of the region between breakpoints 1 and 2 (BP1-BP2) were considered benign and probably familial variations. However, several reports indicate that deletions in this region are associated with developmental delay and behavioral abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. There are four highly conserved genes in this region:",
"    <em>",
"     NIPA1",
"    </em>",
"    ,",
"    <em>",
"     NIPA2",
"    </em>",
"    ,",
"    <em>",
"     CYFIP1",
"    </em>",
"    , and",
"    <em>",
"     GCP5",
"    </em>",
"    . These genes are not imprinted and patients with this deletion have a normal methylation pattern.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86261867\">",
"    <span class=\"h1\">",
"     15q11-13 MATERNAL DELETION SYNDROME (ANGELMAN SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small interstitial deletion between 15q11 and 15q13 can result in two completely different clinical syndromes depending upon the parental origin of the chromosome. A paternally-derived chromosome 15 with this deletion results in Prader-Willi syndrome, whereas a maternally-derived chromosome 15 with a similar deletion is associated with Angelman syndrome. (See",
"    <a class=\"local\" href=\"#H8964746\">",
"     '15q11-13 paternal deletion syndrome (Prader-Willi syndrome)'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Angelman syndrome (AS, MIM #105830) is a neurodevelopmental disorder characterized by severe to profound intellectual disability, postnatal microcephaly, and a movement or balance disorder, usually in the form of gait ataxia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tremulous movement of limbs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. AS patients may have any combination of the following behavior characteristics: frequent laughter or smiling; apparent happy demeanor; an easily excitable personality, often with hand flapping movements; hypermotoric behavior; fascination with water; mouthing behaviors, and a short attention span. More than 80 percent of individuals with AS have seizures and abnormal electroencephalograms with large amplitude slow-spike waves on electroencephalogram (EEG) are seen even in the absence of seizures. Sleep is often compromised with frequent waking and altered sleep cycles.",
"   </p>",
"   <p>",
"    AS is caused by absence of the maternally inherited copy of the",
"    <em>",
"     UBE3A",
"    </em>",
"    gene.",
"    <em>",
"     UBE3A",
"    </em>",
"    maps to chromosome 15q11-q13 and encodes E6 associated protein ubiquitin protein ligase 3A [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"    <em>",
"     UBE3A",
"    </em>",
"    is subject to genomic imprinting (the differential expression of genetic information depending upon whether the information is inherited from the father or the mother). The maternally inherited copy of the",
"    <em>",
"     UBE3A",
"    </em>",
"    gene is functional and the paternally inherited copy is inactive or silenced. In the normal situation, a functional copy of",
"    <em>",
"     UBE3A",
"    </em>",
"    from the maternal chromosome prevents AS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=see_link\">",
"     \"Basic principles of genetic disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=see_link&amp;anchor=H1497302#H1497302\">",
"     \"Basic principles of genetic disease\", section on 'Imprinting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are four known molecular defects of",
"    <em>",
"     UBE3A",
"    </em>",
"    that result in AS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Large ~4 Mb deletions of maternal chromosome 15q11-q13, [",
"      <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Paternal uniparental disomy (UPD) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/13\">",
"       13",
"      </a>",
"      ], where both copies of chromosome 15 are inherited from the father, and no chromosome 15 is inherited from the mother",
"     </li>",
"     <li>",
"      Imprinting center defects, causing the maternal chromosome to have the methylation and gene expression pattern of a paternal chromosome [",
"      <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Point mutations in",
"      <em>",
"       UBE3A",
"      </em>",
"      which produce no functional gene product [",
"      <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Deletions account for over 70 percent of cases of AS. There are a number of breakpoints (BP, chromosome regions prone to breakage) in the 15q11-q13 region known as BP1 to BP3. Deletions in this region can be subclassified into class I and class II deletions based upon these BPs. Class I deletions are larger and extend from BP1 to BP3, while class II deletions extend from BP2 to BP3 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients with class I deletions tend to have greater disease severity when compared with class II patients, with greater difficulties in expressive language, need for more seizure medications, and higher incidence of autism spectrum disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If AS is suspected, the workup should include methylation studies and chromosome microarray (array CGH). If methylation studies are positive, the next step is to determine by microarray if the patient has a class I or class II deletion. If the array is negative, consider UPD studies to determine if the patient has paternal UPD using microsatellite DNA markers or if available single nucleotide polymorphisms (SNP) array. If UPD studies are negative, imprinting center studies are warranted. Imprinting center abnormalities can be a result of deletions that are familial and inherited. They can also be the result of epimutations (heritable changes in gene expression that do not alter the DNA sequence) that are sporadic and have a low recurrence risk. Sometimes epimutations are postzygotic, resulting in mosaicism [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/14,17-19\">",
"     14,17-19",
"    </a>",
"    ]. If the methylation studies are negative and suspicion for AS remains, sequencing studies for",
"    <em>",
"     UBE3A",
"    </em>",
"    should be obtained.",
"   </p>",
"   <p>",
"    Screening and monitoring studies include developmental evaluations and EEG to check for seizures. The EEG is often abnormal, therefore the author suggests obtaining an EEG after one year of age in all children with AS. Patients should also be evaluated for feeding problems and gastroesophageal reflux. Referrals to physical, occupational, and speech therapy are recommended. Augmentative communication methods may be beneficial. Consider melatonin",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"     clonidine",
"    </a>",
"    to alleviate severe sleep disturbances. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link\">",
"     \"Developmental and behavioral screening tests in primary care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/4/14409?source=see_link\">",
"     \"Clinical and laboratory diagnosis of seizures in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"     \"Overview of the treatment of seizures and epileptic syndromes in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13034?source=see_link\">",
"     \"Physiology and clinical use of melatonin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964746\">",
"    <span class=\"h1\">",
"     15q11-13 PATERNAL DELETION SYNDROME (PRADER-WILLI SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This deletion is associated with Prader-Willi syndrome (MIM #176270), which is characterized by hypotonia; poor feeding in infancy with failure to thrive, but increased appetite and obesity in children and adults; genital hypoplasia; small hands and feet; and distinctive facial features (eg, almond-shaped eyes, narrowed bifrontal diameter, thin upper lip). Mild intellectual disability occurs in two-thirds of cases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Prader-Willi syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16516?source=see_link\">",
"     \"Epidemiology and genetics of Prader-Willi syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964753\">",
"    <span class=\"h1\">",
"     15q13.3 DELETION SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;This 1.5 Mb microdeletion (MIM #612001) has a variable phenotype and extends between BP4 and BP5 (breakpoints 4 and 5 are adjacent and distal to BP1 to BP3 involved in",
"    <span class=\"nowrap\">",
"     Prader-Willi/Angelman",
"    </span>",
"    syndrome deletions) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/20-23\">",
"     20-23",
"    </a>",
"    ]. The clinical manifestations range from mild to severe intellectual disabilities, behavioral abnormalities, autism, and schizophrenia. This deletion may also predispose to epilepsy. The region contains six genes, but",
"    <em>",
"     CHRNA7",
"    </em>",
"    , a cholinergic receptor gene, appears linked to seizures and the clinical phenotype. Some authors hypothesize that this deletion alone is not sufficient to cause disease and that other abnormalities or modifiers are needed. Several patients whose deletion involves",
"    <em>",
"     KLF13",
"    </em>",
"    , a gene located in the critical region, have congenital heart defects.",
"   </p>",
"   <p>",
"    Screening and monitoring studies include formal developmental and psychologic evaluations and EEG. Echocardiography should also be considered. Patients may benefit from physical, occupational, and speech therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964760\">",
"    <span class=\"h1\">",
"     15q15.3 DELETION SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is an uncommon contiguous gene deletion syndrome (MIM #611102). The main clinical features associated with this syndrome are sensorineural hearing loss and male infertility due to sperm dysmotility [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/24\">",
"     24",
"    </a>",
"    ]. The disease is autosomal recessive and is caused by haploinsufficiency of",
"    <em>",
"     CATSPER2",
"    </em>",
"    and",
"    <em>",
"     STRC",
"    </em>",
"    , two genes included in the deleted region that are expressed in the sperm and inner ear, respectively. Males who inherit two",
"    <em>",
"     CATSPER2-STRC",
"    </em>",
"    deletions are infertile and deaf [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/25\">",
"     25",
"    </a>",
"    ]; females who inherit two",
"    <em>",
"     CATSPER2-STRC",
"    </em>",
"    deletions are deaf.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964767\">",
"    <span class=\"h1\">",
"     15q24 DELETION SYNDROME",
"    </span>",
"   </p>",
"   <p>",
"    This rare recurrent deletion disorder ranges from 1.7 to 3.9 Mb in size. The core cognitive features of the 15q24 microdeletion syndrome, including developmental delays and severe speech problems, are largely due to deletion of genes in a 1.1 Mb critical region [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The majority of breakpoints lie within segmental duplication (SD) blocks. The region is surrounded by multiple locus control regions (LCRs) that control chromatin structure and amplify expression of linked genes.",
"   </p>",
"   <p>",
"    The syndrome is characterized by mild to moderate intellectual disability, growth retardation, microcephaly, digital abnormalities, hypospadias, and connective tissue abnormalities (loose joints) (MIM #613406) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Patients have distinctive dysmorphic features including a receding hairline, hypertelorism, epicanthal folds, broad inner aspect of the eyebrows, downslanting palpebral fissures, broad nasal bridge, long smooth philtrum, thin upper lip, and a full lower lip. Skeletal findings include delayed bone age, brachydactyly, and broad phalanges with distal hypoplasia. Genital anomalies include hypospadias, micropenis, and a small scrotum. Congenital diaphragmatic hernia has been frequently reported in this deletion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <em>",
"     CYP11A1",
"    </em>",
"    encodes cytochrome P450 side-chain cleavage enzyme (P450scc) that converts progesterone to pregnenolone. Deletion of this gene may be responsible for the genital abnormalities in males (complete absence of this gene causes sex reversal in males, and congenital adrenal insufficiency). Other deleted genes include a number of enzymes involved in glycosylation (loss of both copies is usually required to exhibit symptoms; thus, this deletion may uncover recessive phenotypes).",
"   </p>",
"   <p>",
"    Screening and monitoring studies include formal developmental evaluation and skeletal survey to uncover skeletal anomalies. Males may need endocrine evaluations and other imaging studies should be considered to evaluate for diaphragmatic hernias. Patients may benefit from physical, occupational, and speech therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2157284\">",
"    <span class=\"h1\">",
"     16p13.3 DELETION SYNDROME (RUBINSTEIN-TAYBI SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A submicroscopic deletion that includes the CREB-binding protein gene,",
"    <em>",
"     CBP",
"    </em>",
"    , located on chromosome 16 at p13.3, has been identified in approximately 10 percent of individuals with Rubinstein-Taybi syndrome (RTS, MIM #180849) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. This clinical entity is characterized by prenatal and postnatal growth restriction, microcephaly, dysmorphic features, broad thumbs and toes, and intellectual disability [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/33-36\">",
"     33-36",
"    </a>",
"    ]. Facial features include highly arched eyebrows, long eyelashes, beaked nose with prominent septum extending below nares, downslanting palpebral fissures, high-arched palate, and micrognathia. The thumbs are broad and radially deviated, and the toes are also quite broad and internally deviated. The incisors may have talon cusps. Hirsutism is commonly seen. Congenital heart disease is seen in one-third of patients. Eye abnormalities may include glaucoma, cataracts, glaucoma, and strabismus.",
"   </p>",
"   <p>",
"    Mutation of the",
"    <em>",
"     CBP",
"    </em>",
"    gene has been detected in about 40 percent of affected individuals with RTS. Mutations in another gene,",
"    <em>",
"     EP300",
"    </em>",
"    , account for a small number of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Other yet unknown genes may also be responsible for this disorder, because approximately 50 percent of individuals with clinical features consistent with RTS do not have a detectable deletion or mutation in",
"    <em>",
"     CBP",
"    </em>",
"    or",
"    <em>",
"     EP300",
"    </em>",
"    .",
"   </p>",
"   <p>",
"    Screening and monitoring studies include developmental and ophthalmologic evaluations. An echocardiogram should be performed to evaluate for congenital heart disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2157436\">",
"    <span class=\"h1\">",
"     16p13.11 DELETION SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;A recurrent 1.65 Mb deletion of this region is associated with intellectual disabilities and multiple congenital anomalies. Clinical findings include developmental delay (motor, speech, and language delays), as well as",
"    <span class=\"nowrap\">",
"     behavioral/psychiatric",
"    </span>",
"    problems. Patients with this deletion also have microcephaly, short stature, and epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. Mild dysmorphic features are present but without a specific pattern. Polymicrogyria was reported in one patient. This deletion is reported as one of the most prevalent deletions predisposing patients to idiopathic epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/40,42\">",
"     40,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Screening studies include formal developmental evaluations, EEG, and brain MRI studies (to look for central nervous system anomalies such as polymicrogyria and other neuronal migration defects) in the presence of microcephaly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964781\">",
"    <span class=\"h1\">",
"     16p11.2 DELETION SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;This deletion in 16p11.2 spans almost 600 kb. It is recurrent in size due to flanking segments that mediate these rearrangements. Clinical findings include variable levels of intellectual disability with a high incidence of language delay, expressive more so than receptive [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/30,43-47\">",
"     30,43-47",
"    </a>",
"    ]. This chromosomal abnormality is considered one of the most common recurrent genomic disorders associated with autism spectrum disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/46\">",
"     46",
"    </a>",
"    ]. Some studies have shown that up to 55 percent of these deletion patients met criteria for autism or autism spectrum disorders, and the frequency of this microdeletion is around 0.6 percent in patients with autism [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Some patients with this deletion have been diagnosed with cervicothoracic syringomyelia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/50\">",
"     50",
"    </a>",
"    ] and are also at higher than average risk for seizures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    EEG abnormalities. There are some reported patients with a smaller deletion approximately 200 kb distal to the classical deletion who present with morbid obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Thus, obesity can be part of this deletion phenotype.",
"   </p>",
"   <p>",
"    Formal developmental and autism evaluations may be required. Spine MRIs should be considered, since syringomyelia may be asymptomatic. Other screening and monitoring studies include speech and hearing evaluation, EEG, and monitoring of weight gain and overall growth. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=see_link\">",
"     \"Diagnosis of autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14361?source=see_link\">",
"     \"Screening tools for autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link\">",
"     \"Developmental and behavioral screening tests in primary care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2157762\">",
"    <span class=\"h1\">",
"     17p13.3 DELETION SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several deletions in the 17p13.3 region and the clinical manifestations depend upon the size and genes involved. Larger deletions of the distal short arm of chromosome 17 are responsible for Miller-Dieker syndrome. These deletions involve",
"    <em>",
"     PAFAH1B1",
"    </em>",
"    (the lissencephaly gene formerly known as",
"    <em>",
"     LIS1",
"    </em>",
"    ). There are more distal deletions that encompass",
"    <em>",
"     YWHAE",
"    </em>",
"    (and do not involve",
"    <em>",
"     PAFAH1B1)",
"    </em>",
"    that have a distinct clinical phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2157776\">",
"    <span class=\"h2\">",
"     17p13.3 deletion including PAFAH1B1 (Miller-Dieker syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Miller-Dieker syndrome (MDS, MIM #247200) is a contiguous gene deletion syndrome that is characterized by lissencephaly, growth restriction, and dysmorphic features [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/54-58\">",
"     54-58",
"    </a>",
"    ]. Haploinsufficiency of",
"    <em>",
"     LIS1",
"    </em>",
"    (now called",
"    <em>",
"     PAFAH1B1",
"    </em>",
"    ) due to point mutations or deletions is causative of lissencephaly, a generalized agyria-pachygyria brain malformation that results from an arrest of neuronal migration at 9 to 13 weeks gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=see_link&amp;anchor=H13#H13\">",
"     \"Etiology and evaluation of microcephaly in infants and children\", section on 'Neuroanatomic abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The craniofacial clinical features seen in MDS include a prominent forehead, bitemporal hollowing, short nose with upturned nares, protuberant upper lip, thin vermilion border, and small jaw [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/61\">",
"     61",
"    </a>",
"    ]. The clinical course of these patients is marked by failure to thrive, severe psychomotor retardation, opisthotonos, seizures, and death early in life with very few children reaching 10 years of age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/15/1273?source=see_link&amp;anchor=H11#H11\">",
"     \"Etiology and pathogenesis of infantile spasms\", section on 'CNS malformations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/44/2762?source=see_link&amp;anchor=H17#H17\">",
"     \"Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly\", section on 'Lissencephaly'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients have smaller deletions that cause isolated lissencephaly (LIS type 1 or classic lissencephaly, MIM #607432) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients should undergo formal developmental evaluation. Brain MRI studies are recommended to delineate the degree of lissencephaly and structural central nervous system (CNS) abnormalities. Neurology evaluation and EEG is recommended for evaluation and management of seizures. Swallowing evaluations are usually necessary, and patients may need an intragastric or transpyloric feeding tube. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21912?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of the classification, etiology, and clinical features of pediatric seizures and epilepsy\", section on 'Neurodevelopmental lesions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"     \"Overview of the treatment of seizures and epileptic syndromes in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/16/11529?source=see_link\">",
"     \"Enteral nutrition in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33592?source=see_link\">",
"     \"Enteral feeding: Gastric versus post-pyloric\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2157783\">",
"    <span class=\"h2\">",
"     17p13.3 deletion including YWHAE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A series of patients with deletions including",
"    <em>",
"     YWHAE",
"    </em>",
"    but not",
"    <em>",
"     PAFAH1B1",
"    </em>",
"    presented with significant growth restriction, cognitive impairment, shared craniofacial features, and variable structural abnormalities of the brain but no lissencephaly [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/64\">",
"     64",
"    </a>",
"    ]. One patient in this group did not have growth restriction.",
"    <em>",
"     CRK",
"    </em>",
"    appears to be the gene responsible for growth restriction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/65\">",
"     65",
"    </a>",
"    ].",
"    <em>",
"     YWHAE,",
"    </em>",
"    a gene involved in the region that encodes tyrosine",
"    <span class=\"nowrap\">",
"     3-monooxygenase/tryptophan",
"    </span>",
"    5-monooxygenase activation protein &epsilon; is believed responsible for the brain findings.",
"   </p>",
"   <p>",
"    Features of this microdeletion syndrome include prenatal and postnatal growth retardation, macrocephaly, and dysmorphic features including prominent forehead, downslanting palpebral fissures, epicanthal folds, broad nasal root, low set ears, cleft palate, and eye abnormalities. Seizures have been reported. MRI studies show microcysts in the white matter and corpus callosum, ventricular dilatation, enlargement of subarachnoid spaces, and Chiari Type I malformation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/53,61,65\">",
"     53,61,65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients should undergo formal developmental evaluation. Brain MRI studies are recommended to determine the presence of structural CNS abnormalities. Neurology evaluation with EEG and ophthalmologic evaluation are also recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86262795\">",
"    <span class=\"h1\">",
"     17p11.2 DELETION SYNDROME (HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSY)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary neuropathy with liability to pressure palsy (HNPP, MIM #162500) is an autosomal entity characterized by recurrent mononeuropathy typically associated with minor compression or trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/66\">",
"     66",
"    </a>",
"    ]. It is associated with deletions in 17p11.2 involving",
"    <em>",
"     PMP22",
"    </em>",
"    (peripheral myelin protein 22) gene. Use of protective gear when practicing sports, protective pads at pressure points, and avoidance of repetitive movements or activities may prevent nerve trauma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/24/21895?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of hereditary neuropathies\", section on 'Hereditary neuropathy with liability to pressure palsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86262802\">",
"    <span class=\"h1\">",
"     17p11.2 DELETION SYNDROME (SMITH-MAGENIS SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This deletion of chromosome 17p11.2 (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67417 \" href=\"UTD.htm?35/21/36191\">",
"     image 1",
"    </a>",
"    ) involves the",
"    <em>",
"     RAI1",
"    </em>",
"    (retinoic acid-induced 1) gene that is suspected to be a transcriptional regulator. Both microdeletions and mutations of",
"    <em>",
"     RAI1",
"    </em>",
"    can cause Smith-Magenis syndrome (SMS, MIM #182290) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/67-72\">",
"     67-72",
"    </a>",
"    ]. The circadian defect seen in this disorder is due to disruption of transcription of the circadian locomotor output cycles kaput (",
"    <em>",
"     CLOCK",
"    </em>",
"    ) gene [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The syndrome is characterized by brachycephaly, midface hypoplasia, prognathism, hoarse voice, speech delay with or without hearing loss, psychomotor and growth retardation, and behavior problems [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/74-76\">",
"     74-76",
"    </a>",
"    ]. Feeding problems are seen in infants, along with hypotonia and sometimes lethargy. Patients have mild to moderate intellectual disability. Sleep problems are often significant and include difficulty falling asleep, shortened sleep cycles, frequent and prolonged nocturnal awakenings (altered REM), excessive daytime sleepiness, daytime napping, snoring, and bed-wetting [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/77\">",
"     77",
"    </a>",
"    ]. Behavioral abnormalities include head banging, hand and wrist biting, onychotillomania (pulling own nails), excessive nose picking, and polyembolokoilomania (inserting objects in body orifices) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/75\">",
"     75",
"    </a>",
"    ]. Self-hugging is also a typical behavior.",
"   </p>",
"   <p>",
"    Some patients display neurologic signs such as decreased or absent deep tendon reflexes, pes planus or pes cavus, decreased sensitivity to pain, and decreased leg muscle mass suggestive of peripheral neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/78\">",
"     78",
"    </a>",
"    ]. The deletion in these patients involves the",
"    <em>",
"     PMP22",
"    </em>",
"    gene. (See",
"    <a class=\"local\" href=\"#H86262795\">",
"     '17p11.2 deletion syndrome (Hereditary neuropathy with liability to pressure palsy)'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Elevated cholesterol and triglycerides is common. Hypothyroidism is reported in up to half of these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Screening laboratory studies include thyroid function tests and lipid panel. Patients should undergo a formal developmental evaluation. Swallowing evaluation is indicated in infants with feeding problems. Patients may benefit from occupational, physical, and speech therapies. Management of sleep and behavioral abnormalities may require psychotropic medications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/50/5929?source=see_link\">",
"     \"Assessment of sleep disorders in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964802\">",
"    <span class=\"h1\">",
"     17q12 DELETION SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;This deletion is recurrent in size due to flanking segments that mediate these rearrangements and spans approximately 1.5 Mb [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. The critical gene in this region is",
"    <em>",
"     HNF1B",
"    </em>",
"    (hepatocyte nuclear factor-1-beta, also called",
"    <em>",
"     TCF2",
"    </em>",
"    [transcription factor 2]). Clinical findings include congenital renal anomalies (multicystic kidney disease) and maturity-onset diabetes of the young type 5 (MODY5) (MIM #137920). Cognitive impairment and central nervous system (CNS) abnormalities may be part of the clinical spectrum [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/81\">",
"     81",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14874?source=see_link&amp;anchor=H12#H12\">",
"     \"Classification of diabetes mellitus and genetic diabetic syndromes\", section on 'Hepatocyte nuclear factor-1-alpha'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/41/2712?source=see_link\">",
"     \"Renal cystic diseases in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The reciprocal duplication appears to be associated with an increased risk for epilepsy, but the extent of the clinical consequences is not yet clear.",
"   </p>",
"   <p>",
"    Screening studies include renal ultrasound and brain MRI. Referral to an endocrinologist is recommended for management of diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36329?source=see_link\">",
"     \"Management of type 2 diabetes mellitus in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964809\">",
"    <span class=\"h1\">",
"     17q21.31 DELETION SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;This deletion involves the gene encoding microtubule associated protein tau (MAPT) and is associated with a common inversion polymorphism, known as the H2 inversion, in at least one of the parents. This inversion appears to mediate aberrant recombination events leading to the deletion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/82,83\">",
"     82,83",
"    </a>",
"    ]. The dosage sensitive gene responsible for the phenotype is a chromatin modifier,",
"    <em>",
"     KANSL1",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=see_link&amp;anchor=H5#H5\">",
"     \"Genetic and environmental causes of birth defects\", section on 'Nonallelic homologous recombination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinically this microdeletion is associated with mild to severe intellectual disability, hypotonia, and characteristic facies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/82,83,86-89\">",
"     82,83,86-89",
"    </a>",
"    ]. The hypotonia is also associated with poor sucking and feeding difficulties early on in infancy. Craniofacial features in these patients include a long face, large ears, and tubular or pear shaped nose with a bulbous nasal tip. Other features include seizures in over half of cases, cardiac defects (septal defects), cryptorchidism in almost 80 percent of males, and skeletal anomalies (slender lower limbs, hip dislocation, feet deformities, and scoliosis). Patients typically have a friendly disposition, sometimes with frequent laughing that is reminiscent of Angelman syndrome. Attention span problems and hyperactivity are also reported.",
"   </p>",
"   <p>",
"    Management of these patients includes developmental evaluations, an echocardiogram to examine for cardiac defects, brain MRI, and referral to neurology for EEG and management of seizures if present. Physical, occupational, and speech therapies are helpful, particularly for issues with hypotonia and feeding. Patients may also benefit from augmentative communication methods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1968950\">",
"    <span class=\"h1\">",
"     18p DELETION SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is one of the most common deletion syndromes after cri-du-chat syndrome. The estimated frequency of 18p deletion syndrome is 1 in 50,000 liveborn infants, with more females than males affected [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/90\">",
"     90",
"    </a>",
"    ]. Deletions can range in size from the whole short arm of chromosome 18 to microdeletions. The terminal deletion occurs de novo in about two-thirds of cases. The remaining cases are due to a de novo unbalanced translocation with loss of the 18p or malsegregation of parental chromosome rearrangement (balanced translocation or inversion) or a ring chromosome 18 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/91\">",
"     91",
"    </a>",
"    ]. Familial transmission of the del(18p) syndrome has been reported. The 18p deletion can usually be diagnosed by conventional cytogenetic analysis, but is now often detected by array CGH testing.",
"   </p>",
"   <p>",
"    The phenotype is variable, depending upon the size and location of the deleted region. Major clinical features may include hypotonia, short stature, microcephaly and brachycephaly, round face with short philtrum, palpebral ptosis, large ears with detached pinnae, downturned corners of the mouth, and mild to moderate cognitive impairment with speech delay [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/90,92,93\">",
"     90,92,93",
"    </a>",
"    ]. Approximately, 10 to 15 percent of cases present with holoprosencephaly (HP) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/90,94\">",
"     90,94",
"    </a>",
"    ]. Some patients with HP may present with bilateral cleft lip and palate, while others may display a single maxillary central incisor, a subtle manifestation of HP. Mutations in the",
"    <em>",
"     TGIF",
"    </em>",
"    gene that is located in 18p11.3 are associated with HP, but not all patients with deletion of",
"    <em>",
"     TGIF",
"    </em>",
"    have HP indicating a more complex interaction. About 10 percent of cases may present with congenital heart defects [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/95\">",
"     95",
"    </a>",
"    ]. Severe keratosis pilaris and ulerythema ophryogenes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/96\">",
"     96",
"    </a>",
"    ], autoimmune disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/93,97\">",
"     93,97",
"    </a>",
"    ], and antibody deficiencies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/98\">",
"     98",
"    </a>",
"    ] have also been reported.",
"   </p>",
"   <p>",
"    Patients with this deletion should have a brain MRI to assess for holoprosencephaly and other CNS abnormalities. An echocardiogram should be considered if clinically indicated. Other recommended clinical interventions include physical therapy for hypotonia and speech therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86263226\">",
"    <span class=\"h1\">",
"     20p11 DELETION SYNDROME (ALAGILLE SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alagille syndrome (MIM #118450) is mostly due to mutations in",
"    <em>",
"     JAG1",
"    </em>",
"    (Jagged-1), but some patients have a microdeletion that includes this entire gene [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/99\">",
"     99",
"    </a>",
"    ]. This syndrome is characterized by paucity of interlobular bile ducts, chronic cholestasis, cardiac anomalies, butterfly vertebrae, posterior embryotoxon of the eye, and dysmorphic facies. Alagille syndrome is covered in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/7/8314?source=see_link&amp;anchor=H29#H29\">",
"     \"Inherited disorders associated with conjugated hyperbilirubinemia\", section on 'Alagille syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86263283\">",
"    <span class=\"h1\">",
"     22q11.2 DELETION SYNDROMES (DiGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This region in chromosome 22 is surrounded by low copy repeats known as LCR22-1 through 6. The classic velocardiofacial syndrome",
"    <span class=\"nowrap\">",
"     (VCFS)/DiGeorge",
"    </span>",
"    deletion is approximately 3 Mb and includes the",
"    <em>",
"     TBX1",
"    </em>",
"    gene between LCR22-1 and LCR22-3 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 80 to 90 percent of patients with DiGeorge syndrome (MIM #188400) have microdeletions involving chromosome 22q11 (ie, 22q11.21-q11.23). This syndrome is characterized by abnormalities in the development of the third and fourth branchial arches, resulting in hypoplasia of the thymus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    parathyroid gland, conotruncal cardiac defects, and facial dysmorphism. Clinical manifestations may include neonatal hypocalcemia and susceptibility to infection, as well as a predisposition to autoimmune diseases later in life. Mild to moderate learning difficulties are common.",
"   </p>",
"   <p>",
"    Velocardiofacial syndrome (VCFS) has some overlapping features with DiGeorge syndrome, such as conotruncal cardiac defects and facial abnormalities, and is also caused by interstitial deletions of 22q11. Molecular deletions are detected in 90 percent of individuals, while cytogenetically visible deletions are observed in approximately 15 to 30 percent of cases.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=see_link\">",
"     \"DiGeorge syndrome: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964816\">",
"    <span class=\"h1\">",
"     22q11.2 DISTAL DELETION SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of deletions occur distally to the classic",
"    <span class=\"nowrap\">",
"     VCFS/DiGeorge",
"    </span>",
"    22q11.2 deletion (MIM #611867) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/101-103\">",
"     101-103",
"    </a>",
"    ], including one between LCR22-4 and LCR22-6 of approximately 2.1 Mb and another one between LCR22-5 and LCR22-6 spanning 1.4 Mb. All patients with these deletions presented with characteristic dysmorphic features, history of prematurity, prenatal and postnatal growth restriction that may correct in childhood, developmental",
"    <span class=\"nowrap\">",
"     delay/learning",
"    </span>",
"    disabilities, and mild skeletal abnormalities. The craniofacial features include arched eyebrows, deep-set eyes, a smooth philtrum, a thin upper lip, hypoplastic alae nasi, and a small, pointed chin. A few patients have cardiovascular malformations (truncus arteriosus, bicuspid aortic valve).",
"   </p>",
"   <p>",
"    Management of these patients includes developmental evaluations, an echocardiogram to examine for cardiac defects, and occupational and speech therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8964823\">",
"    <span class=\"h1\">",
"     22q13.3 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deletions of distal 22q13.3 (MIM #606232) are associated with generalized hypotonia, global developmental delay, severe speech delay, and normal to advanced growth [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/104-108\">",
"     104-108",
"    </a>",
"    ]. The deletion encompasses the",
"    <em>",
"     SHANK3",
"    </em>",
"    (SH3 and multiple ankyrin repeat domains 3) gene that is responsible for the neurologic findings [",
"    <a class=\"abstract\" href=\"UTD.htm?11/44/11978/abstract/109-111\">",
"     109-111",
"    </a>",
"    ]. This deletion is also associated with severe expressive language delays and autism.",
"   </p>",
"   <p>",
"    Formal developmental and autism evaluations are recommended. Management includes occupational and speech therapies. Patients may benefit from augmentative communication methods. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=see_link\">",
"     \"Diagnosis of autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14361?source=see_link\">",
"     \"Screening tools for autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link\">",
"     \"Developmental and behavioral screening tests in primary care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3846950\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Microdeletions, or submicroscopic deletions, are chromosomal deletions that are too small to be detected by light microscopy using conventional cytogenetics methods. (See",
"      <a class=\"local\" href=\"#H8964669\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genomic disorders are diseases that result from the loss or gain of",
"      <span class=\"nowrap\">",
"       chromosomal/DNA",
"      </span>",
"      material. The most common and better delineated genomic disorders are divided in two main categories, those resulting from copy number losses (deletion syndromes) and copy number gains (duplication syndromes). (See",
"      <a class=\"local\" href=\"#H4404803\">",
"       'Overview of genomic disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      15q11-13 deletion syndromes are some of the most common microdeletions. A paternally-derived chromosome 15 with this deletion results in Prader-Willi syndrome (PWS, MIM #176270), whereas a maternally-derived chromosome 15 with a similar deletion is associated with Angelman syndrome (AS, MIM #105830). PWS is characterized by hypotonia; poor feeding in infancy with failure to thrive, but increased appetite and obesity in children and adults; genital hypoplasia; small hands and feet; and distinctive facial features. AS is a neurodevelopmental disorder characterized by severe to profound intellectual disability, postnatal microcephaly, and a movement or balance disorder, usually in the form of gait ataxia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tremulous movement of limbs. Patients also often have seizures and characteristic behaviors. (See",
"      <a class=\"local\" href=\"#H86261867\">",
"       '15q11-13 maternal deletion syndrome (Angelman syndrome)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8964746\">",
"       '15q11-13 paternal deletion syndrome (Prader-Willi syndrome)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      16p11.2 deletion syndrome is one of the most common recurrent genomic disorders associated with autism spectrum disorders. Clinical findings include variable levels of intellectual disability with a high incidence of language delay, expressive more so than receptive. (See",
"      <a class=\"local\" href=\"#H8964781\">",
"       '16p11.2 deletion syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Approximately 80 to 90 percent of patients with DiGeorge syndrome (MIM #188400) have microdeletions involving chromosome 22q11.2. This syndrome is characterized by abnormalities in the development of the third and fourth branchial arches, resulting in hypoplasia of the thymus",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      parathyroid gland, conotruncal cardiac defects, and facial dysmorphism. Clinical manifestations may include neonatal hypocalcemia, susceptibility to infection, mild to moderate learning difficulties, as well as a predisposition to autoimmune diseases later in life. Velocardiofacial syndrome (VCFS) has some overlapping features with DiGeorge syndrome, such as conotruncal cardiac defects and facial abnormalities, and is also caused by interstitial deletions of 22q11. (See",
"      <a class=\"local\" href=\"#H86263283\">",
"       '22q11.2 deletion syndromes (DiGeorge syndrome/Velocardiofacial syndrome)'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/1\">",
"      Mitter D, Ullmann R, Muradyan A, et al. Genotype-phenotype correlations in patients with retinoblastoma and interstitial 13q deletions. Eur J Hum Genet 2011; 19:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/2\">",
"      Burnside RD, Pasion R, Mikhail FM, et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet 2011; 130:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/3\">",
"      Doornbos M, Sikkema-Raddatz B, Ruijvenkamp CA, et al. Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur J Med Genet 2009; 52:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/4\">",
"      Murthy SK, Nygren AO, El Shakankiry HM, et al. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet Genome Res 2007; 116:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/5\">",
"      Sempere P&eacute;rez A, Manch&oacute;n Trives I, Palaz&oacute;n Azor&iacute;n I, et al. [15Q11.2 (BP1-BP2) microdeletion, a new syndrome with variable expressivity]. An Pediatr (Barc) 2011; 75:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/6\">",
"      Williams CA, Angelman H, Clayton-Smith J, et al. Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet 1995; 56:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/7\">",
"      Williams CA, Beaudet AL, Clayton-Smith J, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A 2006; 140:413.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews: Angelman Syndrome. file://www.ncbi.nlm.nih.gov/books/NBK1144/ (Accessed on January 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/9\">",
"      Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 1997; 15:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/10\">",
"      Matsuura T, Sutcliffe JS, Fang P, et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 1997; 15:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/11\">",
"      Sahoo T, Peters SU, Madduri NS, et al. Microarray based comparative genomic hybridization testing in deletion bearing patients with Angelman syndrome: genotype-phenotype correlations. J Med Genet 2006; 43:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/12\">",
"      Saitoh S, Buiting K, Cassidy SB, et al. Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation. Am J Med Genet 1997; 68:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/13\">",
"      Malcolm S, Clayton-Smith J, Nichols M, et al. Uniparental paternal disomy in Angelman's syndrome. Lancet 1991; 337:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/14\">",
"      Buiting K, Gross S, Lich C, et al. Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am J Hum Genet 2003; 72:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/15\">",
"      Buiting K, Lich C, Cottrell S, et al. A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp. Hum Genet 1999; 105:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/16\">",
"      Abaied L, Trabelsi M, Chaabouni M, et al. A novel UBE3A truncating mutation in large Tunisian Angelman syndrome pedigree. Am J Med Genet A 2010; 152A:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/17\">",
"      Peters SU, Beaudet AL, Madduri N, Bacino CA. Autism in Angelman syndrome: implications for autism research. Clin Genet 2004; 66:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/18\">",
"      Horsthemke B, Buiting K. Imprinting defects on human chromosome 15. Cytogenet Genome Res 2006; 113:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/19\">",
"      Horsthemke B, Dittrich B, Buiting K. Imprinting mutations on human chromosome 15. Hum Mutat 1997; 10:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/20\">",
"      Miller DT, Shen Y, Weiss LA, et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 2009; 46:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/21\">",
"      Sharp AJ, Mefford HC, Li K, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008; 40:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/22\">",
"      van Bon BW, Mefford HC, Menten B, et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 2009; 46:511.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews: 15q13.3 Microdeletion. file://www.ncbi.nlm.nih.gov/books/NBK50780/ (Accessed on January 18, 2012).",
"    </li>",
"    <li>",
"     Hildebrand MS, Avenarius MR, Smith RJH. CATSPER-related male infertility. In: GeneReviews, Pagon RA, Bird TD, Dolan CR, Stephens K (Eds), Seattle (WA), University of Washington, Seattle; 1993-2009 Dec 03. PMID: 20301780.",
"    </li>",
"    <li>",
"     GeneReviews: CATSPER-Related Male Infertility. file://www.ncbi.nlm.nih.gov/books/NBK22925/ (Accessed on January 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/26\">",
"      Mefford HC, Rosenfeld JA, Shur N, et al. Further clinical and molecular delineation of the 15q24 microdeletion syndrome. J Med Genet 2012; 49:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/27\">",
"      Klopocki E, Graul-Neumann LM, Grieben U, et al. A further case of the recurrent 15q24 microdeletion syndrome, detected by array CGH. Eur J Pediatr 2008; 167:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/28\">",
"      McInnes LA, Nakamine A, Pilorge M, et al. A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critical region. Mol Autism 2010; 1:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/29\">",
"      Sharp AJ, Selzer RR, Veltman JA, et al. Characterization of a recurrent 15q24 microdeletion syndrome. Hum Mol Genet 2007; 16:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/30\">",
"      Van Esch H, Backx L, Pijkels E, Fryns JP. Congenital diaphragmatic hernia is part of the new 15q24 microdeletion syndrome. Eur J Med Genet 2009; 52:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/31\">",
"      Punnett HH, Zakai EH. Old syndromes and new cytogenetics. Dev Med Child Neurol 1990; 32:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/32\">",
"      Breuning MH, Dauwerse HG, Fugazza G, et al. Rubinstein-Taybi syndrome caused by submicroscopic deletions within 16p13.3. Am J Hum Genet 1993; 52:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/33\">",
"      RUBINSTEIN JH, TAYBI H. Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 1963; 105:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/34\">",
"      Hennekam RC. Rubinstein-Taybi syndrome. Eur J Hum Genet 2006; 14:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/35\">",
"      Hennekam RC, Lommen EJ, Strengers JL, et al. Rubinstein-Taybi syndrome in a mother and son. Eur J Pediatr 1989; 148:439.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews: Rubinstein-Taybi Syndrome. file://www.ncbi.nlm.nih.gov/books/NBK1526/ (Accessed on January 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/37\">",
"      Roelfsema JH, White SJ, Ariy&uuml;rek Y, et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005; 76:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/38\">",
"      Tsai AC, Dossett CJ, Walton CS, et al. Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH. Eur J Hum Genet 2011; 19:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/39\">",
"      Hannes FD, Sharp AJ, Mefford HC, et al. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet 2009; 46:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/40\">",
"      Heinzen EL, Radtke RA, Urban TJ, et al. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet 2010; 86:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/41\">",
"      Nagamani SC, Erez A, Bader P, et al. Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Hum Genet 2011; 19:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/42\">",
"      de Kovel CG, Trucks H, Helbig I, et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010; 133:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/43\">",
"      Ballif BC, Hornor SA, Jenkins E, et al. Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2. Nat Genet 2007; 39:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/44\">",
"      Fernandez BA, Roberts W, Chung B, et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet 2010; 47:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/45\">",
"      Hanson E, Nasir RH, Fong A, et al. Cognitive and behavioral characterization of 16p11.2 deletion syndrome. J Dev Behav Pediatr 2010; 31:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/46\">",
"      Kumar RA, KaraMohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008; 17:628.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews: 16p11.2 Microdeletion. file://www.ncbi.nlm.nih.gov/books/NBK11167/ (Accessed on January 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/48\">",
"      Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/49\">",
"      Kumar RA, Marshall CR, Badner JA, et al. Association and mutation analyses of 16p11.2 autism candidate genes. PLoS One 2009; 4:e4582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/50\">",
"      Schaaf CP, Goin-Kochel RP, Nowell KP, et al. Expanding the clinical spectrum of the 16p11.2 chromosomal rearrangements: three patients with syringomyelia. Eur J Hum Genet 2011; 19:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/51\">",
"      Bochukova EG, Huang N, Keogh J, et al. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 2010; 463:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/52\">",
"      Walters RG, Jacquemont S, Valsesia A, et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010; 463:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/53\">",
"      Bruno DL, Anderlid BM, Lindstrand A, et al. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J Med Genet 2010; 47:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/54\">",
"      Jones KL, Gilbert EF, Kaveggia EG, Opitz JM. The MIller-Dieker syndrome. Pediatrics 1980; 66:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/55\">",
"      Stratton RF, Dobyns WB, Airhart SD, Ledbetter DH. New chromosomal syndrome: Miller-Dieker syndrome and monosomy 17p13. Hum Genet 1984; 67:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/56\">",
"      Dobyns WB, Stratton RF, Parke JT, et al. Miller-Dieker syndrome: lissencephaly and monosomy 17p. J Pediatr 1983; 102:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/57\">",
"      Greenberg F, Stratton RF, Lockhart LH, et al. Familial Miller-Dieker syndrome associated with pericentric inversion of chromosome 17. Am J Med Genet 1986; 23:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/58\">",
"      vanTuinen P, Dobyns WB, Rich DC, et al. Molecular detection of microscopic and submicroscopic deletions associated with Miller-Dieker syndrome. Am J Hum Genet 1988; 43:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/59\">",
"      Dhellemmes C, Girard S, Dulac O, et al. Agyria--pachygyria and Miller-Dieker syndrome: clinical, genetic and chromosome studies. Hum Genet 1988; 79:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/60\">",
"      Oostra BA, de Rijk-van Andel JF, Eussen HJ, et al. DNA analysis in patients with lissencephaly type I and other cortical dysplasias. Am J Med Genet 1991; 40:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/61\">",
"      Nagamani SC, Zhang F, Shchelochkov OA, et al. Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet 2009; 46:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/62\">",
"      Pilz DT, Macha ME, Precht KS, et al. Fluorescence in situ hybridization analysis with LIS1 specific probes reveals a high deletion mutation rate in isolated lissencephaly sequence. Genet Med 1998; 1:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/63\">",
"      De Rijk-van Andel JF, Catsman-Berrevoets CE, Halley DJ, et al. Isolated lissencephaly sequence associated with a microdeletion at chromosome 17p13. Hum Genet 1991; 87:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/64\">",
"      Schiff M, Delahaye A, Andrieux J, et al. Further delineation of the 17p13.3 microdeletion involving YWHAE but distal to PAFAH1B1: four additional patients. Eur J Med Genet 2010; 53:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/65\">",
"      Tenney JR, Hopkin RJ, Schapiro MB. Deletion of 14-3-3{varepsilon} and CRK: a clinical syndrome with macrocephaly, developmental delay, and generalized epilepsy. J Child Neurol 2011; 26:223.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews: Hereditary Neuropathy with Liability to Pressure Palsies. file://www.ncbi.nlm.nih.gov/books/NBK1392/ (Accessed on January 25, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/67\">",
"      Carmona-Mora P, Walz K. Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior. Curr Genomics 2010; 11:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/68\">",
"      Greenberg F, Guzzetta V, Montes de Oca-Luna R, et al. Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2). Am J Hum Genet 1991; 49:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/69\">",
"      Seranski P, Hoff C, Radelof U, et al. RAI1 is a novel polyglutamine encoding gene that is deleted in Smith-Magenis syndrome patients. Gene 2001; 270:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/70\">",
"      Slager RE, Newton TL, Vlangos CN, et al. Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet 2003; 33:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/71\">",
"      Williams SR, Girirajan S, Tegay D, et al. Array comparative genomic hybridisation of 52 subjects with a Smith-Magenis-like phenotype: identification of dosage sensitive loci also associated with schizophrenia, autism, and developmental delay. J Med Genet 2010; 47:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/72\">",
"      Girirajan S, Elsas LJ 2nd, Devriendt K, Elsea SH. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. J Med Genet 2005; 42:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/73\">",
"      Williams SR, Zies D, Mullegama SV, et al. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. Am J Hum Genet 2012; 90:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/74\">",
"      Colley AF, Leversha MA, Voullaire LE, Rogers JG. Five cases demonstrating the distinctive behavioural features of chromosome deletion 17(p11.2 p11.2) (Smith-Magenis syndrome). J Paediatr Child Health 1990; 26:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/75\">",
"      Smith AC, Dykens E, Greenberg F. Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2). Am J Med Genet 1998; 81:179.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews: Smith-Magenis Syndrome. file://www.ncbi.nlm.nih.gov/books/NBK1310/ (Accessed on January 25, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/77\">",
"      Smith AC, Dykens E, Greenberg F. Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2). Am J Med Genet 1998; 81:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/78\">",
"      Gropman AL, Duncan WC, Smith AC. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2). Pediatr Neurol 2006; 34:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/79\">",
"      Potocki L, Shaw CJ, Stankiewicz P, Lupski JR. Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)]. Genet Med 2003; 5:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/80\">",
"      Mefford HC, Clauin S, Sharp AJ, et al. Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am J Hum Genet 2007; 81:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/81\">",
"      Nagamani SC, Erez A, Shen J, et al. Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12. Eur J Hum Genet 2010; 18:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/82\">",
"      Koolen DA, Vissers LE, Pfundt R, et al. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 2006; 38:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/83\">",
"      Sharp AJ, Hansen S, Selzer RR, et al. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet 2006; 38:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/84\">",
"      Koolen DA, Kramer JM, Neveling K, et al. Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat Genet 2012; 44:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/85\">",
"      Zollino M, Orteschi D, Murdolo M, et al. Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. Nat Genet 2012; 44:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/86\">",
"      Koolen DA, Sharp AJ, Hurst JA, et al. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet 2008; 45:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/87\">",
"      Sharkey FH, Morrison N, Murray R, et al. 17q21.31 microdeletion syndrome: further expanding the clinical phenotype. Cytogenet Genome Res 2009; 127:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/88\">",
"      Shaw-Smith C, Pittman AM, Willatt L, et al. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet 2006; 38:1032.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews: 17q21.31 Microdeletion Syndrome. file://www.ncbi.nlm.nih.gov/books/NBK24676/ (Accessed on January 25, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/90\">",
"      Turleau C. Monosomy 18p. Orphanet J Rare Dis 2008; 3:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/91\">",
"      Koshy B, Mandal K, Srivastava VM, et al. Familial 18p deletion syndrome and 18p partial trisomy inherited from a mother with balanced translocation. Clin Dysmorphol 2011; 20:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/92\">",
"      Margarit E, Morales C, Rodr&iacute;guez-Revenga L, et al. Familial 4.8&thinsp;MB deletion on 18q23 associated with growth hormone insufficiency and phenotypic variability. Am J Med Genet A 2012; 158A:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/93\">",
"      McGoey RR, Gedalia A, Marble M. Monosomy 18p and immunologic dysfunction: review of the literature and a new case report with thyroiditis, IgA deficiency, and systemic lupus erythematosus. Clin Dysmorphol 2011; 20:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/94\">",
"      Portno&iuml; MF, Gruchy N, Marlin S, et al. Midline defects in deletion 18p syndrome: clinical and molecular characterization of three patients. Clin Dysmorphol 2007; 16:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/95\">",
"      Xie CH, Yang JB, Gong FQ, Zhao ZY. Patent ductus arteriosus and pulmonary valve stenosis in a patient with 18p deletion syndrome. Yonsei Med J 2008; 49:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/96\">",
"      Carvalho CA, Carvalho AV, Kiss A, et al. Keratosis pilaris and ulerythema ophryogenes in a woman with monosomy of the short arm of chromosome 18. An Bras Dermatol 2011; 86:S42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/97\">",
"      Jain N, Reitnauer PJ, Rao KW, et al. Autoimmune polyendocrinopathy associated with ring chromosome 18. J Pediatr Endocrinol Metab 2011; 24:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/98\">",
"      Browning MJ. Specific polysaccharide antibody deficiency in chromosome 18p deletion syndrome and immunoglobulin A deficiency. J Investig Allergol Clin Immunol 2010; 20:263.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews: Alagille Syndrome. file://www.ncbi.nlm.nih.gov/books/NBK1273/ (Accessed on January 25, 2012).",
"    </li>",
"    <li>",
"     GeneReviews: 22q11.2 Deletion Syndrome. file://www.ncbi.nlm.nih.gov/books/NBK1523/ (Accessed on January 25, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/101\">",
"      Ben-Shachar S, Ou Z, Shaw CA, et al. 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am J Hum Genet 2008; 82:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/102\">",
"      Nogueira SI, Hacker AM, Bellucco FT, et al. Atypical 22q11.2 deletion in a patient with DGS/VCFS spectrum. Eur J Med Genet 2008; 51:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/103\">",
"      R&oslash;dningen OK, Prescott T, Eriksson AS, R&oslash;sby O. 1.4Mb recurrent 22q11.2 distal deletion syndrome, two new cases expand the phenotype. Eur J Med Genet 2008; 51:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/104\">",
"      Phelan MC, Rogers RC, Saul RA, et al. 22q13 deletion syndrome. Am J Med Genet 2001; 101:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/105\">",
"      Manning MA, Cassidy SB, Clericuzio C, et al. Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics 2004; 114:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/106\">",
"      Okamoto N, Kubota T, Nakamura Y, et al. 22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome? Am J Med Genet A 2007; 143A:2804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/107\">",
"      Peeters H, Vermeesch J, Fryns JP. A cryptic duplication 22q13.31 to qter leads to a distinct phenotype with mental retardation, microcephaly and mild facial dysmorphism. Genet Couns 2008; 19:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/108\">",
"      Prasad C, Prasad AN, Chodirker BN, et al. Genetic evaluation of pervasive developmental disorders: the terminal 22q13 deletion syndrome may represent a recognizable phenotype. Clin Genet 2000; 57:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/109\">",
"      Bonaglia MC, Giorda R, Mani E, et al. Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet 2006; 43:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/110\">",
"      Dhar SU, del Gaudio D, German JR, et al. 22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet A 2010; 152A:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/44/11978/abstract/111\">",
"      Wilson HL, Wong AC, Shaw SR, et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 2003; 40:575.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16648 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-218.28.111.102-5CC63B1F68-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11978=[""].join("\n");
var outline_f11_44_11978=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3846950\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964669\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4404803\">",
"      OVERVIEW OF GENOMIC DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19035904\">",
"      13q14 DELETION SYNDROME (RETINOBLASTOMA SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964739\">",
"      15q11.2 DELETION SYNDROME (BP1-BP2)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86261867\">",
"      15q11-13 MATERNAL DELETION SYNDROME (ANGELMAN SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964746\">",
"      15q11-13 PATERNAL DELETION SYNDROME (PRADER-WILLI SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964753\">",
"      15q13.3 DELETION SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964760\">",
"      15q15.3 DELETION SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964767\">",
"      15q24 DELETION SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2157284\">",
"      16p13.3 DELETION SYNDROME (RUBINSTEIN-TAYBI SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2157436\">",
"      16p13.11 DELETION SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964781\">",
"      16p11.2 DELETION SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2157762\">",
"      17p13.3 DELETION SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2157776\">",
"      17p13.3 deletion including PAFAH1B1 (Miller-Dieker syndrome)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2157783\">",
"      17p13.3 deletion including YWHAE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86262795\">",
"      17p11.2 DELETION SYNDROME (HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSY)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86262802\">",
"      17p11.2 DELETION SYNDROME (SMITH-MAGENIS SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964802\">",
"      17q12 DELETION SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964809\">",
"      17q21.31 DELETION SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1968950\">",
"      18p DELETION SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86263226\">",
"      20p11 DELETION SYNDROME (ALAGILLE SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86263283\">",
"      22q11.2 DELETION SYNDROMES (DiGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964816\">",
"      22q11.2 DISTAL DELETION SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8964823\">",
"      22q13.3 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3846950\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/16648\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/16648|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/21/36191\" title=\"diagnostic image 1\">",
"      Smith Magenis syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/16648|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/28/41412\" title=\"figure 1\">",
"      Nonhomologous recombination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/63/29687\" title=\"figure 2\">",
"      Schematic CGH for microarray setup",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/50/5929?source=related_link\">",
"      Assessment of sleep disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=related_link\">",
"      Basic principles of genetic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14874?source=related_link\">",
"      Classification of diabetes mellitus and genetic diabetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/4/14409?source=related_link\">",
"      Clinical and laboratory diagnosis of seizures in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/0/23562?source=related_link\">",
"      Congenital cytogenetic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=related_link\">",
"      Cytogenetic and molecular genetic diagnostic tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=related_link\">",
"      Developmental and behavioral screening tests in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=related_link\">",
"      DiGeorge syndrome: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=related_link\">",
"      DiGeorge syndrome: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=related_link\">",
"      Diagnosis of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33592?source=related_link\">",
"      Enteral feeding: Gastric versus post-pyloric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/16/11529?source=related_link\">",
"      Enteral nutrition in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16516?source=related_link\">",
"      Epidemiology and genetics of Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=related_link\">",
"      Etiology and evaluation of microcephaly in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/15/1273?source=related_link\">",
"      Etiology and pathogenesis of infantile spasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=related_link\">",
"      Genetic and environmental causes of birth defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=related_link\">",
"      Genomic disorders: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/7/8314?source=related_link\">",
"      Inherited disorders associated with conjugated hyperbilirubinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36329?source=related_link\">",
"      Management of type 2 diabetes mellitus in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/14/34025?source=related_link\">",
"      Microdeletion syndromes (chromosomes 1 to 11)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/17/37143?source=related_link\">",
"      Microduplication syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/63/5112?source=related_link\">",
"      Overview of genetic variation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/24/21895?source=related_link\">",
"      Overview of hereditary neuropathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27018?source=related_link\">",
"      Overview of retinoblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21912?source=related_link\">",
"      Overview of the classification, etiology, and clinical features of pediatric seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=related_link\">",
"      Overview of the treatment of seizures and epileptic syndromes in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/18/32042?source=related_link\">",
"      Pathogenetic factors in soft tissue and bone sarcomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13034?source=related_link\">",
"      Physiology and clinical use of melatonin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/44/2762?source=related_link\">",
"      Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/41/2712?source=related_link\">",
"      Renal cystic diseases in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14361?source=related_link\">",
"      Screening tools for autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/50/10024?source=related_link\">",
"      Sex chromosome abnormalities",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_44_11979="Role of GLP-1 in glucose homeostasis";
var content_f11_44_11979=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F51832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F51832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The role of GLP-1 in glucose homeostasis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        GLP-1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Deficiency",
"       </td>",
"       <td>",
"        Type 2 diabetes, +/- type 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Site of synthesis",
"       </td>",
"       <td>",
"        Small intestinal L cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucose-dependent stimulation of insulin secretion",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction of gastric emptying",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction of inappropriate glucagon secretion",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weight loss",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beta cell proliferation/regeneration",
"       </td>",
"       <td>",
"        Yes - in animals",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11979=[""].join("\n");
var outline_f11_44_11979=null;
var title_f11_44_11980="Diagnostic criteria in MCTD";
var content_f11_44_11980=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F68985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F68985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for mixed connective tissue disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Common symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Raynaud's phenomenon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Swollen fingers or hands",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Anti U1-RNP antibody",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mixed clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        SLE-like findings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Polyarthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lymphadenopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Facial erythema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pericarditis or pleuritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Leukopenia or thrombocytopenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Scleroderma-like findings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sclerodactyly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pulmonary fibrosis, restrictive changes or reduced diffusion capacity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hypomotility or dilation of the esophagus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Polymyositis-like findings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Muscle weakness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Elevated serum muscle enzymes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Myogenic pattern on EMG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diagnosis of MCTD is made when the following three conditions are fulfilled:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Positive in either of the two common symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Positive anti-U1 RNP antibody",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Positive in one or more findings in two or three of the above diseases",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Doria, A, Ghirardello, A, de Zambiasi, P, et al, J Rheumatol 1992; 19:259.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11980=[""].join("\n");
var outline_f11_44_11980=null;
var title_f11_44_11981="Survival residual dz ovarian CA";
var content_f11_44_11981=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F63199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F63199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Impact of residual tumor on survival in advanced ovarian cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Year",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Survival (months)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Optimal debulking (definition)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Suboptimal debulking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Hacker NF",
"       </td>",
"       <td rowspan=\"2\">",
"        1983",
"       </td>",
"       <td>",
"        18 (0.5&nbsp;to 1.5 cm)",
"       </td>",
"       <td>",
"        6 (&gt;1.5 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40 (&lt;0.5 cm)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vogl SE",
"       </td>",
"       <td>",
"        1983",
"       </td>",
"       <td>",
"        40+ (&le;2 cm)",
"       </td>",
"       <td>",
"        16 (&gt;2 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Delgado G",
"       </td>",
"       <td>",
"        1984",
"       </td>",
"       <td>",
"        45 (&lt;2 cm)",
"       </td>",
"       <td>",
"        16 (&gt;2 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pohl R",
"       </td>",
"       <td>",
"        1984",
"       </td>",
"       <td>",
"        45 (&lt;2 cm)",
"       </td>",
"       <td>",
"        16 (&gt;2 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Conte P",
"       </td>",
"       <td>",
"        1985",
"       </td>",
"       <td>",
"        25+ (&lt;2 cm)",
"       </td>",
"       <td>",
"        14 (&gt;2 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Posada JG",
"       </td>",
"       <td>",
"        1985",
"       </td>",
"       <td>",
"        30+ (&lt;2 cm)",
"       </td>",
"       <td>",
"        18 (&gt;2 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Louie KG",
"       </td>",
"       <td>",
"        1986",
"       </td>",
"       <td>",
"        24 (&lt;2 cm)",
"       </td>",
"       <td>",
"        15 (&ge;2 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hainsworth J",
"       </td>",
"       <td>",
"        1988",
"       </td>",
"       <td>",
"        72 (&le;3 cm)",
"       </td>",
"       <td>",
"        21 (&gt;3 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Piver MS",
"       </td>",
"       <td>",
"        1988",
"       </td>",
"       <td>",
"        48 (&le;1 cm)",
"       </td>",
"       <td>",
"        21 (&gt;1 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sutton GP",
"       </td>",
"       <td>",
"        1989",
"       </td>",
"       <td>",
"        45 (&lt;3 cm)",
"       </td>",
"       <td>",
"        23 (&ge;3 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Munkarah AR",
"       </td>",
"       <td>",
"        1997",
"       </td>",
"       <td>",
"        25 (&le;2 cm)",
"       </td>",
"       <td>",
"        15 (&gt;2 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bristow RE",
"       </td>",
"       <td>",
"        1999",
"       </td>",
"       <td>",
"        38 (&le;1 cm)",
"       </td>",
"       <td>",
"        10 (&gt;1 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zang RY",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        19 (&le;1 cm)",
"       </td>",
"       <td>",
"        8 (&gt;1 cm)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from Ozols, et al. Epithelial ovarian cancer. In: Principles and Practice of Gynecologic Oncology, 3rd edition, Hoskins WJ, et al (Eds), Lippincott, Williams &amp; Wilkins, Philadelphia 2000. p.1005.",
"     <br>",
"      <br>",
"       References:",
"       <br>",
"        <br>",
"         <ol>",
"          <li>",
"           Hacker NF, et al. Obstet Gynecol 1983; 61:413.",
"          </li>",
"          <li>",
"           Vogl SE, et al. Cancer 1983; 51:2024.",
"          </li>",
"          <li>",
"           Delgado et al. Gynecol Oncol 1984; 18:293.",
"          </li>",
"          <li>",
"           Pohl R, et al. Eur J Gynaecol Oncol 1984; 5:160.",
"          </li>",
"          <li>",
"           Conte PF, et al. Gynecol Oncol 1985; 20:290.",
"          </li>",
"          <li>",
"           Posada JG Jr, et al. Gynecol Oncol 1985; 20:23.",
"          </li>",
"          <li>",
"           Louie KG, et al. J Clin Oncol 1986; 4:1579.",
"          </li>",
"          <li>",
"           Hainsworth JD, et al. Ann Intern Med 1988;108:165.",
"          </li>",
"          <li>",
"           Piver MS, et al. J Clin Oncol 1988; 6:1679.",
"          </li>",
"          <li>",
"           Sutton GP, et al. J Clin Oncol 1989; 7:223.",
"          </li>",
"          <li>",
"           Munkarah AR, et al. Gynecol Oncol 1997; 64:13.",
"          </li>",
"          <li>",
"           Bristow RE, et al. Gynecol Oncol 1999; 72:278.",
"          </li>",
"          <li>",
"           Zang RY, et al. J Surg Oncol 2000; 75:24.",
"          </li>",
"         </ol>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11981=[""].join("\n");
var outline_f11_44_11981=null;
var title_f11_44_11982="Incidence of recurrent syncope";
var content_f11_44_11982=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cumulative incidence of syncope recurrence",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 311px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cumulative incidence of recurrent syncope over three years in 433 patients who initially presented to an emergency room with a complaint of syncope. Recurrence was common and was independent of whether the patient had a cardiovascular cause (CVD), a noncardiac etiology (Non-CVD), or syncope of unknown origin (SUO).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Kapoor WN. Prognosis and Risk Assessment in Cardiovascular Disease, Churchill Livingstone, New York, 1993, p. 317.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11982=[""].join("\n");
var outline_f11_44_11982=null;
var title_f11_44_11983="Survival of dialysis patients after ICDs";
var content_f11_44_11983=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F73475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F73475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 640px\">",
"   <div class=\"ttl\">",
"    Survival of dialysis patients after ICDs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 620px; height: 268px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Period prevalent ESRD patients, 1999-2008.",
"    <div class=\"footnotes\">",
"     n: number of patients.",
"    </div>",
"    <div class=\"reference\">",
"     Modified by Charles A Herzog, MD. From: US Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010. Full report available at:",
"     <a href=\"file://www.usrds.org/adr.htm\" target=\"_blank\">",
"      file://www.usrds.org/adr.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_44_11983=[""].join("\n");
var outline_f11_44_11983=null;
